Characterization and design of C2H2 zinc finger proteins as custom DNA binding domains by Sander, Jeffry D.
Graduate Theses and Dissertations Iowa State University Capstones, Theses andDissertations
2008
Characterization and design of C2H2 zinc finger
proteins as custom DNA binding domains
Jeffry D. Sander
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/etd
Part of the Cell and Developmental Biology Commons, and the Genetics and Genomics
Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Sander, Jeffry D., "Characterization and design of C2H2 zinc finger proteins as custom DNA binding domains" (2008). Graduate




























LIST OF FIGURES ............................................................................................................................ vii 
LIST OF TABLES ................................................................................................................................xi 

















































































































































































Table 2.2  Single module substitutions in ZFPs alter target affinity .................................. 28 
Table 3.S1  Barbas ZF modules that recognize pyrimidine‐rich DNA target sites bind 
with lower affinity than modules that recognize purine‐rich target sites....... 55 



















as  transcription  factors  and  repressors  to  regulate  the  flow  of  genetic  expression  and 
replication. By adapting  these DNA‐binding domains  to  target desired genome  locations, 
they  can  be harnessed  to  treat diseases  by  regulating  genes  and  repairing diseased  gene 
sequences.  
  The  C2H2  zinc  finger  motif  is  perhaps  the  most  promising  and  versatile  DNA 
binding  framework.    Each C2H2  zinc  finger  domain  (module)  is  capable  of  recognizing 
approximately three adjacent nucleotide bases in standard B form DNA.  Through directed 
mutagenesis, novel zinc finger modules (ZFMs) can be selected for most of the 64 possible 
DNA  triplets.    By  assembling  multiple  ZFMs  with  the  appropriate  linkers,  zinc  finger 
proteins (ZFPs) can be generated to specifically bind extended DNA sequence motifs. 
  Several methods of varying complexity are currently available for ZFP engineering. 
ZFPs  generated  from  the  relatively  simple modular design method  often  fail  to  function 
in vivo.  Those generated using the most reliable module subsets, those recognizing triplets 
with  a  5ʹ  guanine  (GNN),  only  function  successfully  only  an  estimated  50%  of  the  time, 
while modularly assembled ZFPs comprising primarily non‐GNN modules rarely function 
in  vivo.    These  low  success  rates  are  extremely  problematic  for  applications  requiring 
multiple  ZFPs  that  target  adjacent  sequence  motifs.    More  complex  ZFP  engineering 
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DNA  binding  proteins.    Although  ZF  proteins  have  been  successfully  exploited  as 
therapeutic  tools  in a number of studies,  they have not yet achieved  their  full potential as 
reagents  for  regulation  of  gene  expression  or  site‐specific modification  of  genomes.  The 
primary  reason  is  lack of  reliability  in ZF protein engineering.  It has not been possible  to 
predict whether a designed ZF protein will  efficiently  interact with  its  intended  target  to 
achieve the desired effect in vivo. 
In  this  work,  we  have  combined  computational  and  experimental  strategies  to 








also  provide  the  opportunity  for  precise  modification  of  the  genome  itself.   Through 




desired DNA  sequence(1‐3).  By developing our  capability  to  reliably  engineer  functional 
zinc finger proteins, we can harness their power to study individual genes and cure genetic 
diseases through direct modification of genomic DNA. 







As  evidenced  by  our  existence,  however,  there  is  sufficient  variation within  the 
major and minor grooves of  the DNA for proteins  to reliably distinguish DNA sequences. 
What may appear as a potential limitation, turns out to be a advantage:   the constraints of  
DNA‐protein  complexes  provide  a  simplified  interaction  framework,  compared  with 
protein‐protein complexes.  Due to the substrate similarity associated with the regularity of 
the  double  helix,  minor  mutations  in  protein  sequence  to  alter  can  target  specificity.  
Evolution  has  given  rise  to  numerous  families  of  DNA  binding  proteins  with  variable 













zinc  finger proteins arrays  can be designed  to bind adjacent nucleotide  triplets with both 
high specificity and affinity (Figure 1.1C)(5). 
 
A)         B)     C) 
                       
 
Figure 1.1 A) The zinc finger domain consists of two beta-strands and an alpha helix, coordinated by 
a zinc ion.  B) Residues -1, +3, +6 (relative to the start of the alpha helix) form base specific contacts 
with three adjacent DNA nucleotides.  C)  A tandem array of three zinc finger domains recognize an 




  By  fusing  ZFPs  to  other  functional  protein  domains  such  as  transcriptional 
activators, repressors, and nucleases, these domains can be targeted to specific and unique 
regions of the genome.   The zinc finger nuclease (ZFN), perhaps the most promising ZFP‐
fusion  construct  for  clinical  applications,  creates  site‐specific  double‐stranded  breaks  in 
DNA  which  can  generate  gene  knockouts  via  error‐prone  non‐homologous‐end‐joining 
(NHEJ) or enhance site‐specific homologous recombination using exogenous template DNA 
(6‐11) . 
  A  zinc  finger  nuclease  consists  of  two  ZFPs,  each  fused  to  a  single  C‐terminal 
monomeric  domain  of  a  dimeric  dsDNA  endonuclease.    The  ZFPs  targets  the  nuclease 
monomers  to  two  recognition  sequences  located  on  opposite‐stands  of  the  DNA  and 
separated by a spacer of 5‐7 bp, thereby promoting nuclease dimerization and inducing site‐







Figure 1.2:  A zinc finger nuclease consists of two individual zinc finger arrays, each fused to a 
nuclease monomer.  Specific binding by zinc finger helices (blue, red and yellow) to neighboring sites 
on opposite strands of dsDNA (orange), separated by 5-7 bp, bring two nuclease monomers (green) 
into the close proximity required to form a functional dimeric nuclease. 
 
PROJECT GOALS 
The goal of this research is to identify ZFP design characteristics, scoring algorithms, and 
experimental methods to aid in successful engineering of the C2H2 zinc finger domain to 
bind desired DNA targets with both high affinity and specificity.  To achieve this goal we 
have:  
 
1. Developed scoring schemes to predict which modularly designed arrays are 
most likely to function by generating ZFPs and testing their performance 
both in vivo and in vitro. (Chapter 2, Appendix B) 
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2. Characterized which DNA sites can be most reliably targeted by C2H2 zinc 
fingers and how ZFP protein sequences vary to bind their targets. (Chapter 
2, Chapter 3, Chapter 4) 
3. Generated machine learning classifiers that can predict the likely success of 
Oligomerized Pool ENgineering of ZFPs, based on target composition 
(Chapter 4) 
4. Created a web-server and database to aid in design of custom zinc finger 
proteins (Chapter 5, Chapter 6, Appendix D ) 
5. Generated experimental methods and biological reagents for design and 
synthesis of zinc finger proteins. (Appendix  A, Appendix C) 
6. Explored OPEN modules as source modules for ZFP modular assembly 
(Chapter 6) 
7. Analyzed the human genome for optimal candidates for zinc finger nuclease 
induced-knockout mutations (Chapter 6 ) 
DISSERTATION ORGANIZATION 
This  dissertation  has  six  chapters  and  four  appendices.    Chapter  1  is  a  general 
introduction  to  the composition, binding pattern and uses of C2H2 zinc  finger proteins as  
DNA binding domains.  Chapter 2 is a paper submitted to Nucleic Acids Research, in which 
custom zinc  finger proteins were generated and  tested, providing a module based scoring 





we  identified characteristics of nucleotide sequences  that can be successfully  targeted with 
C2H2  zinc  fingers  and  necessary  features  of  the  corresponding ZFPs.   My  contributions 
include project design, data analysis, and preparing the manuscript.  Chapter 4 is a paper to 




zinc  finger proteins  (17)   My contributions  include design and coding of  the ZiFiT  server 
and preparation and revisions to manuscript.   Chapter 6 contains general conclusions and 
suggested  directions  for  future work.  It  also  includes  preliminary  results    on  a  human 
genome‐wide  analysis  of  candidates  for  zinc  finger  nuclease‐induced  gene  knockouts, 
likelihood  of  success  scores,  and  similar  off  target  sites  as  commonly  observed  OPEN 




The zinc  finger modules provided  in  this paper come  from  the published work of Carlos 
Barbas, SANGAMO Biosciences  Inc, and Toolgen  Inc  (5,19‐22).   My contributions were  to 
create  the web‐server  for  identification of  targetable DNA  sequences and provide  text  for 





of  the  Joung  lab.    I  experimentally  generated  and  functionally  tested  several  ZFPs,  in 
addition  to providing software  for  rapid analysis and sequence verification of engineered 
ZFPs  and  their  corresponding  target  sequences.   Appendix C  is Zinc Finger Consortium 
manuscript, also spearheaded by the Joung lab and published in Molecular Cell in 2008 (24).  
This paper describes Oligomerized Pool Engineering  (OPEN),  a new method  for  reliably 
generating high affinity ZFPs using pools of modules for each triplet at each position.  The 
paper  compares  the  results  of  the  OPEN  method  against  that  of  modular  assembly  in 
several different organisms and makes the reagents available to the public via Addgene.   I 
added OPEN design and additional  functionality  to  the online web‐server  to aid  in ZFPs 
generated using  this powerful new method.   Appendix D  is a paper recently accepted for 
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Zinc  finger  proteins  (ZFPs)  have  long  been  recognized  for  their  potential  to 
manipulate genetic information because they can be engineered to bind novel DNA targets. 
Individual  zinc  finger  domains  bind  specific  DNA  triplet  sequences;  their  apparent 
modularity has led some groups to propose methods that allow virtually any desired DNA 
motif  to  be  targeted  in  vitro.  In practice,  however, ZFPs  engineered using  this  “modular 
assembly”  approach  do  not  always  function  well  in vivo.  Here  we  report  a  modular 
assembly  scoring  strategy  that  both  identifies  combinations  of  modules  least  likely  to 
function efficiently in vivo and provides accurate estimates of their relative binding affinities 
in vitro. Predicted binding affinities  for 53 “three‐finger” ZFPs, computed based on energy 
contributions  of  the  constituent  modules,  were  highly  correlated  (r = 0.80)  with  activity 
levels measured  in bacterial  two‐hybrid assays. Moreover, Kd values  for  seven modularly 
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assembled ZFPs and  their  intended  targets, measured using fluorescence anisotropy, were 
also  highly  correlated with  predictions  (r = 0.91). We  propose  that  success  rates  for  ZFP 




The  ability  to  reliably  engineer DNA  binding proteins  that  recognize  any desired 
DNA sequence would provide an unprecedented level of control over genetic information; 
for  example,  by  allowing  the  creation  of  site‐specific  nucleases  that  specifically  alter 
genomic DNA(1‐5). The C2H2 zinc finger domain (ZFD) is arguably the best characterized 
DNA  binding motif  and  offers  considerable  promise  for  the  rational  engineering  of  site‐
specific  DNA  binding  proteins  (6‐11).  Zinc  finger  proteins  (ZFPs)  consist  of  multiple 















Figure 2.1 | A three-finger ZFP with its DNA target site. A ZFP consisting of 3 adjacent ZFDs binds its 
target DNA through contacts between the amino acids of the DNA recognition helices and 
consecutive nucleotides in the DNA. The protein chain is drawn in the N- to C-terminal direction and 
the DNA target in the 3′ to 5′ direction. Note that an "unnatural″ extended array is shown to better 
illustrate the critical amino acid/nucleotide contacts. Structure diagrams were generated using PyMol 
(http://www.pymol.org). 
 
Several  research  groups  have  characterized  ZFDs  that  recognize many  of  the  64 
possible  DNA  triplets  (15‐20).  Using  a  “modular  assembly”  approach,  novel  ZFPs  that 
recognize variant DNA sites are assembled by simply stringing together individual ZFDs. In 






fingers  to  a  non‐specific  nuclease  domain)  by  this method  is  considerably  lower  (24,25). 
These  low  success  rates,  together with  the  inability  to  predict which  ZFPs  are  likely  to 
function  in vivo, have motivated our groups to  improve the procedures and design criteria 
for ZFP engineering (25,26). 
The  present  study was motivated  by  our  observation  that  among  a  small  set  of 
modularly  assembled ZFPs,  those  that  fail  to  function  in  vivo  are more  likely  to  possess 
modules previously shown to have relatively low affinity for target DNA. This observation 
implies  that  insufficient affinity can contribute  to poor function  in vivo and also suggested 
that it might be possible to predict the affinity of a modularly assembled ZFP using existing 
affinity data for component modules. Here we test these hypotheses and demonstrate that 
both  the  in vitro binding affinity and  the  lack of  in vivo activity of a ZFP can be predicted 
using the binding affinities of its component ZFDs. Our approach for predicting the binding 
of ZFPs to desired target sequences should  improve success rates of modular assembly by 





All ZFDs used  in  these experiments have been described by  the Barbas group  (15) 
and are referred to as “Barbas modules.” ZFPs containing desired 3‐finger (3‐module) arrays 
were  assembled by  iterative  ligation  and  cloning  of  restriction  fragments  encoding ZFDs 
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using  reagents  and  protocols  previously  described  by  the  Zinc  Finger  Consortium 
(http://www.zincfingers.org/)(27). ZFP‐encoding  fragments were  then  cloned  into  vectors 




A  series  of  bacterial  two‐hybrid  (B2H)  reporter plasmids,  each  harboring  a  target 
binding  site  for  one  of  27 different  3‐finger  ZFPs, was  constructed  by  cloning  synthetic 
target  oligonucleotides  into  reporter  plasmid  pBAC‐lacZ  as  previously  described  (27). 
Binding of a Gal11P‐ZFP hybrid protein to the target sequence on a B2H reporter plasmid 
triggers  transcriptional  activation  of  a  lacZ  reporter  gene  encoding  beta‐galactosidase. 
In vivo ZFP performance was  therefore assayed using a beta‐galactosidase assay  in which 












cultures were  inoculated  from  these  overnight  cultures  (1:100 dilution)  and  grown  to  an 
OD600 of 0.5 before a 2 hour induction with isopropyl β‐D‐1‐thiogalactopyranoside (IPTG). 
Cells were harvested by centrifugation for 10 min at 4000 g at 4 ºC and frozen overnight at 
‐20 ºC.  The  following  day,  cells  were  resuspended  in  4 ml WB1  (15 mM  Hepes  pH 7.8, 
200 mM NaCl,  20 μM ZnSO4)/1 mM PMSF/0.1% Nonidet™ P40  (NP‐40)  and  refrozen  at  ‐
70 ºC. Cells were then thawed in ice water and centrifuged at 9000 g at 4 ºC for 20 min. To 
remove  remaining nucleic  acids,  the  resulting  supernatant was  transferred  to  a new  cold 
tube and polyethyleneimine (PEI) was added to 0.1%. The supernatant was then incubated 
for 30 min before a second centrifugation at 16000 g at 4 ºC for 30 min.  
Amylose beads  (NEB) were prepared  in  50  μL  aliquots  in  1.5 ml micro‐centrifuge 
tubes  according  to  manufacturer’s  instructions.  Beads  were  washed  (suspended,  spun 
down, and supernatant removed) 3 times in 1 ml WB1/0.1% NP‐40 at 4 ºC and resuspended 
in 450 μl WB1. For affinity purification, 1 ml of clarified protein supernatant was added to 
prepared  beads,  and  incubated  at  4 ºC  for  30 min.  The  slurry  was  centrifuged  and  the 
supernatant was  removed. The proteins bound  to beads were washed 2 times with 700 μl 
WB1/NP‐40  and  2 times with  zinc  buffer A  (ZBA;  10 mM  Tris–HCl,  pH 7.5,  90 mM KCl, 
1 mM  MgCl2,  90 μM  ZnCl2)/NP‐40  (15).  Purified  proteins  were  then  eluted  in  200 μl 










Binding  reactions  were  performed  in  ZBA/0.1%  NP‐40/0.1 mg/ml  non‐acetylated 
BSA  (Sigma)  for 30 min on  ice with 5 nM  target DNA. Target sites  (shown  in Figure 2.2a) 
were  formed using hairpin DNA oligonucleotides as described  (15). HPLC purified, 3’‐6‐
FAM labeled oligonucleotides were ordered from Integrated DNA Technologies (Coralville, 
IA).  In  each  experiment,  two  serial  dilutions  of  purified  ZFP‐MBP  fusion  protein were 
performed over a range of 1000 nM to 0.122 nM. Reported binding affinity values are based 




width),  and  530 nm  emission wavelength  (20 nm  slit width)  at  880 V.  Background  light 
scattering  for  each  protein  sample  dilution was measured  and  subtracted  to  correct  for 






To  test  the  hypothesis  that  binding  affinities  of  individual  ZFDs  can  be  used  to 
predict  the  in vitro  binding  affinities  and  in vivo  performance  of  extended  ZFP  arrays, 
27 three‐module ZFPs were  constructed by  assembling GNN‐specific modules previously 
characterized  by  the Barbas  group  (15). ZFP  compositions were  chosen  to  systematically 
explore a wide range of predicted binding affinities and to test the  influence of context on 
module performance. As  shown  in Table 1, ZFDs were divided  into  three affinity  classes 
based on their reported affinity constants measured in a fixed context, namely as fingers in 
the  middle  position of  a  three‐finger  Zif268  variant  (15).  Modules  comprising  Zif268 
variants with Kd values < 10 nM were categorized as “strong,” Kd = 10‐30 nM as “moderate,” 
and  Kd > 30 nM  as  “weak”  (Table  1).  Using  three  different  modules  to  represent  each 
binding class, all possible combinations of strong, moderate, and weak affinity modules for 
a  three‐module  ZFP were  assembled.  To  allow  direct  comparisons  among  proteins  that 

















the  differences  in  measured  binding  constants  among  these  constructs  should  be 
attributable  to  the differences  in binding energy between  the F2 ZFDs. Thus, ΔΔG can be 





To  compare  binding  affinity measurements with  predicted  values,  the  predicted 






Thus,  using  Equation 4  and  binding  constants  for  ZFP  variants  published  by  the 








To  evaluate  in vivo  binding  of  the  27 modularly  assembled  ZFPs  to  their  cognate 
DNA  targets, we used a quantitative bacterial  two‐hybrid  (B2H) assay  (32).  In  this assay, 




studies have shown  that ZFP activity  in  this system  is an excellent predictor  for  failure of 
these proteins to function as ZFNs in human cells (24‐26). For 25 of the 27 ZFPs tested, the 
level  of  lacZ  activation  observed  was  in  excellent  agreement  with  predicted  energies 
(Figure 2.2A). Expression of the two ZFPs with the strongest predicted binding energy was 
toxic  to  cells,  preventing  analysis  of  these  constructs.  Several  models  describing  the 


































Table 2.1 | ZFP variants that differ in the middle (F2) position bind targets with variable affinities. The 
data in this table were reported by Segal et al., 1999. Each ZFD in the F2 position was selected to 
bind a particular target triplet. The F1 and F3 modules (derived from Zif268) were the same in each 
construct. A binding affinity constant for each ZFP variant was determined using an EMSA. Here, 
modules are classified based on the affinity of the ZFPs for their cognate target sites (Strong, 
Moderate, Weak). Three modules from each class were chosen to construct 27 diverse three-module 
ZFPs (Table 2).  
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exhibited  significantly  greater  activation  than  predicted  (Figure 2.2B,  red 
diamonds).Excluding  ZFPs  containing  this  module  from  the  analysis  increased  the 
correlation coefficient to 0.86 (Figure 2.2B, solid line).  
The  predictions described  above  relied  on  published  in vitro  binding  affinities  for 
ZFPs  in  which  modules  were  evaluated  in  a  fixed  context  (15)  to  estimate  binding 
contributions  of  individual  modules.  In  an  alternate  approach,  we  predicted  ZFP 
performance  by  solving  individual  module  contributions  as  component  variables  of  a 
system  of  linear  equations.  Briefly,  in  constructing  the  27  different  three‐finger  proteins, 
nine ZFDs were used approximately 8‐10 times (~3 times at each of the possible 3 positions, 
see Table  1). Assuming  that  affinities of  individual ZFDs  in  a ZFP  are  additive,  the B2H 
activity of each ZFP was  considered  to  result  from  its particular  combination of modules 
(Supplemental Figure 2.S1). Individual module contributions were calculated for each ZFP 
using a leave‐one‐out linear system solution. Expected lacZ activation in the B2H assay for 
each  of  the  ZFPs was  then  predicted  by  summing  individual module  contributions. As 
shown  in  Figure  2.3,  expected  levels  of  activation  computed  in  this manner were highly 
correlated with actual B2H activity measurements (r = 0.86).  
The  energy  contributions  computed using  a  system of  linear  equations  to  analyze 







Figure 2.2 | Predicted energies are highly correlated with in vivo activity in a bacterial two-hybrid 
(B2H) assay. Twenty-seven three-module zinc finger proteins were designed by modular assembly to 
span a broad range of predicted binding affinities. a) DNA recognition helix sequences, DNA 
sequence targets, predicted energies, and measured fold-activation in the B2H assay are listed for 
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Figure 2.2 | Continued each construct. Entries are sorted from highest to lowest predicted energy 
Constructs marked with an asterisk were also tested in vitro (see Figure 2.4). b) ZFP activities in the 
B2H assay are plotted versus predicted energies. The two constructs with greatest predicted affinity 
were toxic to their host cells and therefore could not be plotted. Points shown as red diamonds 
correspond to proteins containing the GTA-specific QSSSLVR module (see text). Best-fit lines from a 
segmental linear regression model using all points (dashed line, r = 0.77), or excluding red points 
(solid line, r = 0.86) are shown. (c) Same as (b), except that values indicated by red triangles were 
adjusted assuming a binding affinity of 2.5 nM, rather than 25 nM, for the GTA-specific QSSSLVR 
module; this increases the correlation coefficient to 0.86 (see text for details). 
 
predicted energies with the B2H data. This approach resulted in an estimated Kd of 2.5 nM 
for  this  module,  10‐fold  lower  than  the  previously  reported  value  of  25 nM  (15). 
Incorporating  this  new  estimate  improved  correlation  between  the  in vitro  energy model 
and in vivo fold activation data (r = 0.86, Figure 2.2C). 
To  directly  evaluate  the  effects  of  individual  module  affinities  on  in vivo 
performance,  sets  of  related  ZFPs  designed  to  vary  at  a  single  module  position  were 
analyzed  for differences  in B2H  activity  (Table 2).  For  all  3 sets  of ZFPs  in which  the  F1 
position was varied (while F2 and F3 were fixed), the greatest in vivo activity was observed 
when the F1 position contained a high affinity module; the least activity was observed with 









Figure 2.3 | ZFDs contribute additively to B2H activity, independent of context and position. For each 
ZF protein, the expected contribution to B2H activity from each of its component modules was 
estimated by solving a system of linear equations representing the other 24 proteins (see text). 
Comparison of actual versus predicted B2H activity (expressed as relative fold-activation in the B2H 
assay) reveals a high correlation (r = 0.86). 
 
In summary, three lines of analysis: i) predictions based on in vitro binding constants 
for modules  in  a  fixed  context,  ii) predictions derived  from  a  system  of  linear  equations 
















7  RSDNLVR  DPGHLVR TSGNLVR  3.11 
16  QSSSLVR  DPGHLVR TSGNLVR  1.88 
25  TSGELVR  DPGHLVR TSGNLVR  1.54 
8  RSDNLVR  DPGALVR TSGHLVR  2.59 
17  QSSSLVR  DPGALVR TSGHLVR  1.69 
26  TSGELVR  DPGALVR TSGHLVR  1.59 
9  RSDNLVR  TSGELVR  DPGALVR  2.47 
18  QSSSLVR  TSGELVR  DPGALVR  1.85 
1 
 
27  TSGELVR  TSGELVR  DPGALVR  1.71 
10  RSDELVR  TSGSLVR  TSGSLVR  1.77 
13  RSDELVR  QSSSLVR  TSGSLVR  2.19 
11  RSDELVR  TSGSLVR  RSDELVR  1.89 
14  RSDELVR  QSSSLVR  RSDELVR  2.81 
12  TSGHLVR  TSGSLVR  TSGELVR  1.43 
2 
15  TSGHLVR  QSSSLVR  TSGELVR  1.96 
1  TSGSLVR  RSDNLVR  RSDNLVR  Toxic 
2  TSGSLVR  RSDNLVR  QSSSLVR  4.88 
3  TSGSLVR  RSDNLVR  DPGHLVR  3.51 
4  TSGNLVR  TSGHLVR  RSDNLVR  Toxic 
5  TSGNLVR  TSGHLVR  RSDELVR  1.71 
6  TSGNLVR  TSGHLVR  DPGHLVR  1.41 
19  DPGHLVR  TSGNLVR  RSDNLVR  3.58 
20  DPGHLVR  TSGNLVR  QSSSLVR  3.09 
21  DPGHLVR  TSGNLVR  TSGELVR  0.92 
22  DPGALVR  RSDELVR  TSGSLVR  1.95 
23  DPGALVR  RSDELVR  QSSSLVR  1.69 
3 
 
24  DPGALVR  RSDELVR  TSGELVR  1.23 
Table 2.2 | Single module substitutions in ZFPs alter target affinity. Individual ZFDs, represented by 
their DNA recognition helix, are shaded to indicate their affinity class (Strong, Moderate, Weak, see 
Table 1). For each subgroup (demarcated by horizontal lines), modules in two positions were held 
constant while the position indicated in the leftmost column was varied. Fold activation denotes 
performance of the ZFP in the bacterial two hybrid assay. Toxic refers to the poor growth of E. coli 










determined  using  fluorescence  anisotropy  (FA),  a  rapid  and  reproducible  solution‐based 
DNA binding assay that allows computation of the bound fraction of a fluorescently‐labeled 
ligand, based on the decrease in its rotational velocity due to binding (33,34).  
As  shown  in Figure 2.5, binding  affinity  constants determined by FA were highly 
correlated with predicted  energies. The  two ZF proteins with highest predicted  affinities 
were  toxic  to bacterial  cells, prohibiting purification of  sufficient quantities of protein  for 
in vitro  analysis.  Energies  computed  based  on  previously  published  in vitro  affinity 
measurements  for modules  in  a  fixed  context  (15) were  proportional  to  the  log  of  Kdʹs 
measured in our experiments (r = 0.91) (Figure 2.5A). As before, assuming a Kd of 2.5 nM for 
the  QSSSLVR  module  significantly  improved  the  correlation  (r = 0.97).  Predicted  in vivo 
activation  levels  generated  by  the  leave‐one‐out,  linear  system method were  also  highly 
correlated with  experimentally determined binding  constants  (r = 0.93; Figure 2.5B). Thus, 
results obtained using a rapid and reliable spectroscopic method suggest that ZFP binding 
affinities measured  in vitro generally correspond  to results obtained  in vivo using  the B2H 
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To  evaluate  the  generality  of  this  rule‐based  approach,  we  calculated  predicted 
energies  for another set of modularly assembled ZFPs  that had been previously evaluated 
using  the  B2H  system  (25).  From  168 modularly  assembled  ZFPs, we  selected  all  ZFPs 
comprising  GNN  or  TGG  modules  for  which  published  in vitro  DNA  binding  affinity 
constants are available (measured in the F2 position of the standard Zif268 variant backbone 
(15)).  As  shown  in  Figure 2.6A,  based  on  a  segmental  linear  regression model,  binding 
energies for 24 of  these 26 ZFPs are highly correlated (r = 0.80) with reported B2H activity 





performed  by  us  (and  shown  in  Figure 2.2C)  to  predict  B2H  activity  for  the  24 ZFPs 
evaluated by Ramirez et al. (25). Again, the predicted and measured fold‐activation scores 
were in close agreement, with a correlation coefficient of 0.79 (Figure 2.6B). Taken together, 







Figure 2.4 | Determining binding affinity constants using fluorescence anisotropy (FA). B) A 
representative in vitro binding isotherm obtained using FA. Data points for each ZFP were collected 
using three separate purified protein preparations, each assayed for binding activity on a different 
day. Curve fitting was performed using Prism. B) Kd values for seven modularly assembled ZFPs, 
determined in FA experiments. Note that two ZFPs were toxic to host cells, preventing purification of 
proteins in quantities required for in vitro analysis. 
 
DISCUSSION 
Using  a  rule‐based  strategy  which  combines  experimentally  determined  binding 
energies of individual ZFDs, we were able to compute binding energies for ZFPs made from 
a  particular  set  of  well‐characterized  GNN‐modules  (15).  We  also  showed  that  these 
predicted binding energies are  in excellent agreement  (r = 0.91; Figure 2.5A) with binding 
affinity constants measured directly  in vitro. Furthermore, we showed a strong correlation 
between  these  computed  binding  energies  and  ZFP  activities  in  a  bacterial  two‐hybrid 
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system  for  two  different  sets  of  modularly‐assembled  three‐finger  ZFPs.  This  is  an 
important advance because a ZFP which  lacks activity  in  the B2H system will also have a 
high probability of failing to function as a ZFN in human cells (24‐26). Thus, using only our 
scoring method, researchers can now identify target sites which will have a high probability 
of  failing  to yield  functional zinc  finger arrays by  the method of modular assembly. Our 
rule‐based strategy will thus allow researchers to focus their modular assembly efforts on a 
smaller number of target sites with a higher probability of success. 
We believe  our  results  also provide  one potential  explanation  for  the discrepancy 
between  the overwhelming success rates  for a previous  in vitro report  (35) and  the  low  in 
vivo success rates observed for ZFPs  in  the recent study of Ramirez et al.(25): many of  the 
modules used to perform modular assembly likely possess low affinities. Our data suggest, 
in  fact,  that  30‐50%  of  potential  three‐finger  ZFPs made wholly  from  the  Barbas  GNN 
modules will  fail  to  function  in  the B2H  system,  a  result  in  agreement with  the  recently 
published results of Ramirez et al (25). 









arrays  when  paired  with  stronger  affinity  ZFDs.  In  addition,  our  data  also  show  that 
although strong fingers will sometimes be found in functional ZFPs, they can also be found 
in non‐functional ZFPs. Furthermore,  the use of  three  strong  fingers  in a ZFP can  lead  to 
toxicity  in  E.  coli  cells.  Although  the  precise  mechanism  of  this  toxicity  is  unclear,  a 
reasonable hypothesis  is  that excessively high affinity  leads  to binding  to  related but off‐
target  sequences  with  sufficient  affinity  to  cause  biological  consequences  (essentially, 
excessive affinity  leading  to problems of specificity). Thus, our data  further re‐enforce  the 
ideas  that  individual ZFDs do not  function  completely  independently and  that  the  specific 
attributes of neighboring fingers do matter in the context of engineering a multi‐finger ZFP.  
The  importance  of  context‐dependent  effects  also  suggests  that  identification  of 
additional ZFDs with variable affinities for GNN triplets may be needed if the efficiency of 
modular assembly  is  to be  improved.  If such ZFDs were available,  it might be possible  to 
achieve higher success rates for modular assembly by using it to create multiple ZFPs for a 
given  target  site  so as  to  identify a  combination  that balances affinities  (and presumably, 
specificities)  of  its  component  ZFDs.  However,  it  is  also  worth  noting  that  the  use  of 
additional modules would also  increase  the number of combinatorial possibilities and  the 
amount of labor required to perform modular assembly. A related point is that our findings 
also suggest one possible reason why more complex selection‐based methods  that account 
for  context‐dependent  effects  (e.g.  the  OPEN  method  recently  described  by  Joung  and 
colleagues (26,32)) may be more successful than modular assembly: these methods are able 











ZFP  binding  as  component  variables  of  a  system  of  linear  equations  that  describe  their 
activities (measured in vivo in this work, but in vitro binding constants could also be used). 
The  energy  scoring  scheme proposed here will  allow  researchers  to determine whether a 
modular assembly strategy  is  likely  to be  feasible  for specific  targets of  interest, based on 
currently  available well‐characterized modules,  or whether  an  alternative  selection‐based 
engineering strategy should be considered. 
A  recent  study  on  the  use  of  zinc  finger  nucleases  (ZFNs)  for  homologous 
recombination cited lack of specificity as a primary determinant of ZFN‐mediated toxicity in 
human  cells  (24).  A  likely  mechanism  for  ZFN‐induced  toxicity  is  through  binding  to 
genomic  sequences  similar  to  the desired  target  sequence. As  noted  above, we  observed 
toxicity in bacterial cells for several ZFPs, even in the absence of a fused nuclease domain, 
suggesting that ZFP binding to certain sites  in genomic DNA can be toxic, particularly for 





range, with  no  toxic  effects,  has  also  been  reported  (19,36,37). High‐throughput  chip  or 
microfluidics‐based DNA binding experiments (38‐41) could be used to obtain affinity and 
specificity data for virtually every possible target site for a given ZFP, providing additional 





Figure 2.5 | In vitro affinity constants for ZFPs are highly correlated with predictions. Using affinity 
constants for 7 ZFPs determined by fluorescence anisotropy (Figure 2.4B), log(Kd) is plotted against: 
A) predicted energies (r = 0.91) and B) predicted B2H activity from a leave-one-out system of linear 





A  correlation  between  ZFP  binding  constants  measured  in vitro  and  functional 
activity measured in vivo has also been observed by others using different reporter systems 
(37). A  similar  degree  of  correlation  was  observed  using  the  B2H  system  in  our  study 
(Supplemental Figure 2.2). Our results further demonstrate that measurable ZFP activity in 
an  in vitro  binding  assay  does  not  necessarily  translate  into  adequate  function  in vivo,  in 
agreement with Beerli  et  al.  (42). However,  the  energy  threshold we determined  for ZFP 
activity in vivo, using B2H assays, corresponds to a Kd of ~ 100 nM, and thus differs from the 
estimated  threshold  Kd  of  ~ 10 nM  reported  as  the minimum  affinity  necessary  for  ZFP 
function  in mammalian  cells  (42).  The  significance  of  this  difference  between  thresholds 





specific  contacts with  target  site  nucleotides  (43‐47). Our  results  complement  this  idea  by 
demonstrating  that  the  affinity  of  ZFPs  also  can  be  predicted,  using  affinity  data  for 
component  modules.  Our  application  of  the  binding  energy  additivity  concept  differs 
somewhat from  that Stormo has used  to predict specificity  in  that  it assumes additivity of 









Figure 2.6. Predicted ZFP performance agrees with in vivo activity for an independently-generated 
set of ZFPs. Data shown are for 24 of 26 ZFPs containing characterized GNN or TGG modules, 
constructed and evaluated by Ramirez et al. 2008.(25) A) A segmental linear regression model 
provides an excellent fit of in vivo ZF-induced fold activation measured in the B2H assay with 
predicted binding energies (r = 0.80). B) ZF-induced fold activation values measured in the B2H 
assay for 24 ZFPs from Ramirez et al. are also highly correlated (r = 0.79) with predicted fold-
activation levels calculated based on a scoring function derived from the segmental linear regression 
model fit for the 25 ZFPs shown in Figure 2.2A (see text for details). Note: Predictions for 2 of 26 
ZFPs containing characterized GNN or TGG modules from Ramirez et al. were considered outliers 






C2H2 ZFDs  as  the  domains  of  choice  for  designing  custom DNA  binding  proteins. Our 
results make it possible, for the first time, to reliably identify prospective binding sites that 
are  unlikely  to  yield  functional ZFDs  by modular  assembly  using  a  set  of GNN‐specific 
finger modules. The rule‐based strategy presented here can provide accurate guidance  for 
both  in vitro binding affinities and  in vivo  functionality  for engineered zinc  finger proteins 
by computing energy contributions of  individual ZFDs. We have updated  the Zinc Finger 
Targeter (ZiFiT) web server (http://bindr.gdcb.iastate.edu/ZiFiT) (48) so that it now provides 
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Supplemental Figure 2.S1 | Energetic contributions of individual zinc finger modules can be solved 
using a system of linear equations. If we assume that the measured B2H activity for each ZFP 
construct is equal to the sum of its individual module contributions, each zinc finger module can be 
represented as a variable (r-z) in a system of linear equations (e.g., r = RSDNLVR). Overlying box: 
Each equation represents one specific three-module ZFP construct (e.g., 2), in which the coefficients 
(0, 1 or 2) correspond to the number of times each module (variable) occurs within a specific three-
module ZFP construct analyzed in this study. Underlying table: Each row summarizes the number of 
times each of 9 different modules (variables; columns r-z) is included in one of the 25 ZFP constructs 
analyzed in this study. Values shown in the B2H activity column are the relative in vivo binding 
activities, measured in bacterial 2-hybrid assays (B2H) performed in this study. Thus, for each ZFP 
construct (equation), the energetic contribution of each individual module (value of each variable) can 
be calculated by solving the system of linear equations representing all the remaining constructs (i.e., 




Supplemental Figure 2.S2 | Fold activation in the B2H assay is logarithmically correlated with 
binding affinity. Seven ZFPs engineered in this study and Zif268 were assayed both for in vivo (B2H) 
and in vitro (FA) activity. Results from the assays are highly correlated (r = 0.79). 
 
 
Supplemental Figure 2.S3: | The affinity-based scoring method out-performs scoring schemes 
implemented in Zinc Finger Tools (http://www.zincfingertools.org).  Plots of observed ZFP-induced 
activation in the B2H assay versus scores generated by the "Base" (a) and "XNN" (b) specificity 
scoring functions reveal little correlation between predicted and actual ZFP function for the ZFPs 
analyzed in this study. The corresponding plot for results obtained using the linear system affinity-
based scoring method developed in this work (Fig. 3) is reproduced here (c) to facilitate comparison. 
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Supplemental Figure 2.S3: | continued A much higher degree of correlation between predicted and 
actual ZFP function is observed for this method. The affinity-based scoring method has been 
implemented in the ZiFiT v3.0 server (http://bindr.gdcb.iastate.edu/ZiFiT/). (Note: Two additional 
scoring functions implemented in Zinc Finger Tools, GNN and the GACT, generate the same score 









To  the editor:   Zinc  finger proteins  (ZFPs) can  target  linked  functional domains  to 
specific  sites  within  large  genomes.  Zinc  finger  nucleases,  for  example,  have  been 
successfully used  to enhance site‐specific homologous  recombination by  inducing double‐
stranded breaks  in DNA(1). Individual zinc‐finger modules (ZFMs), the building blocks of 




as  a  function  of  target  site  GNN  triplet  composition  for modularly  assembled  ZFPs(3). 
Analysis of the well‐characterized GNN module set of Barbas et al. (2)revealed that modules 
targeting  purine‐rich  triplets  generally  bind  with  higher  affinity  than  those  targeting 
pyrimidine‐rich  triplets  in  in  vitro  binding  assays(Supplemental  Table  3.S1).    These 
individual module  contributions have been identified as a critical component of in vitro and 
in  vivo  function  (4,5).  Taken  together,  these  observations  have  suggested  that  ZFP 





Figure 3.1 | Failure of ZFP-induced gene activation in a bacterial two-hybrid (B2H) functional assay 
can be predicted using a leave-one-out linear system solution, based on DNA triplet base 
composition. The graphs show measured increase in reporter gene activity (fold-activation) induced 
by ZFP binding plotted versus predicted B2H activity.A) Target triplet composition distinguishes 
sequences that are generally poor targets for ZFPs generated using modular assembly. B) ZFPs 
assembled via OPEN typically function with high activity in vivo.  However, a linear system solution 
based on triplet composition does not accurately predict the level of activation. 
 
hypothesis  for modular assembly as  illustrated  in Figure 3.1A, by computing  leave‐one‐out 
linear  system  solutions  for  bacterial  2‐hybrid  (B2H)  fold  activation  using  base  counts  by 
triplet  position  for  193  modularly‐assembled  ZFPs  (3,4).  As  illustrated  in  Figure  3.1A, 
elevated  pyrimidine  content,  particularly  a  thymine  in  position  one  and  cytosines  in 
positions  two and  three,  in  target sites was  indicative of  low    in vivo activity, while more 
favorable  bases  provided  an  upper  bound  for  B2H  activity.  Compared with  this  set  of 
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modularly  assembled  ZFPs,  a  set  of  ZFPs  generated  using  the  Oligomerized  Pool 




Figure 3.2 | Comparison of WebLogos for OPEN ZF module recognition helices (residues -1 to +6) 
that recognize pyrimidine-rich versus purine-rich triplets in target DNA. Among ZFPs generated using 
the OPEN procedure, DNA target sites enriched in pyrimidine bases (e.g., GCC, top row) result in an 
increase in polar or positively-charged residues in typically “non-contacting” positions within the 
recognition helix (e.g., S, R or K at position +1, S or R at +2, and K or R at +5), as compared with the 
same positions in purine-rich helices (e.g., GAG, bottom row), which typically contain more favorable 
positively-charged residues in the canonical base-contacting positions (-1, +3 and +6). F1, F2 and F3 






Among  zinc  finger  domains  analyzed,  those  rich  in  cytosine  contacts,  typically 
negatively  charged  aspartic  acid  and glutamic  acid, were more  likely  to  include  residues 
that favor backbone‐mediated contacts in the canonically “non‐base specific” helix positions 
(+1, +2, +5) (Figure 3.2).   As shown  in Figure 3.3, analysis of 449 ZFPs generated by OPEN 
(Supplemental  Table  2)(6)  reveals  a  steady  increase  in  positive  residues  in  non‐specific 
contacting positions of  the  recognition helix as  the number of purine specific amino acids 
(HKRNQ) descreases at canonical contact positions (‐1, +3, +6) (Figure 3.3). This increase in 
positively  charged  residues  might  provide  favorable  interactions  with  the  negatively‐
charged  DNA  backbone,  potentially  required  to  achieve  sufficient  affinity  for  function 
in vivo(4). 
Our observations  indicate  that purine‐rich DNA  sequences  typically provide more 
active target sites in vivo for modularly assembled ZFPs, given currently available reagents. 
In  addition,  they  suggest  that  the  OPEN  procedure  may  permit  more  efficient  in  vivo 
targeting  of  sequences with  higher  cytosine  content  than modular  assembly,  in  part  by 
selecting ZFPs with positively‐charged residues at positions in the recognition helix that are 
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(nM) Triplet Helix 
0.5 GAA QSSNLVR 
1  GAG RSDNLVR 
2 GCA QSGDLRR 
3 GGA QRAHLER 
3 GAT TSGNLVR 
3 GAC DPGNLVR 
5 GTT TSGSLVR 
6 GGG RSDKLVR 
9 GCG RSDDLVR 
15 GGT TSGHLVR 
15 GTG RSDELVR 
25 GTA QSSSLVR 
40 GGC DPGHLVR 
40 GTC DPGALVR 
65 GCT TSGELVR 
80 GCC DCRDLAR 
 
Supplemental Table 3.S1 | Barbas ZF modules that recognize pyrimidine-rich DNA target sites bind 
with lower affinity than modules that recognize purine-rich target sites. ZF modules and Kd values 


















desirable  to  identify  targets with  the  greatest  chance  of  generating  an  active  zinc  finger 
protein. 
Results:    Using  alternate  encodings  for  the  134  DNA  target  sites,  Naïve  Bayes 











Custom  zinc  finger  domains  can  be  engineered  to  specifically  bind  DNA  sequence 
triplets  through  base  specific  contact  in  the major  groove  of  double‐strand.    Using  the 
modular assembly approach, extended sequences can be recognized by stringing multiple 
domains  together  (1‐3).    Three module  arrays  generated  from  a  single  solution  for  each 
DNA  triplet have been  shown  to  specifically bind  their 9 bp  target  in vitro(4).   However, 
other  studies have demonstrated  that many arrays  fail  to  function  in vivo  (5,6).   This has 
been attributed to lack of affinity(6), and additional context dependencies(7), and chromatin 
context(8).    We  have  previously  provided  scoring  schemes  for  proteins  assembled  by 
modular assembly, which predict failure for most targets comprise of triplet subsites lacking 
a 5ʹ guanine base (GNN triplets) (5,6).   
Recently  we  have  described  zinc  finger  protein  design  using  Oligomerized  Pool 




that  function well  above  basal  levels  in  a  Bacterial  2‐hybrid  reporter  system.   However, 
OPEN does not guarantee  a ZFP with  exemplary  in  vivo  activity  (greater  than  three‐fold 
activation).  Because OPEN requires considerable time and molecular biology expertise, it is 
desirable to identify targets with a high probability of success.   In this study we use target 



















Window  0.48  81  83  94 








Triplet Base Counts  0.55  84  83  97 
Window  0.29  70  82  76 










(73%  positive)  using  leave‐one‐out  cross‐validation.    As  shown  in  Table  4.1,  classifiers 
optimized  for  correlation  coefficient  achieve  correlation  coefficients  around  of  0.5  with 
overall accuracies slightly better than 80%.    
  When multiple target sites are available it may be desirable to identify those 
with  the  greatest  chance  of  succeeding,  rather  than  optimizing  the  classifier  based  on 









To  help  understand  how  the  classifiers  use  target  composition  to  predict  active 
target sites we calculated average number of  time each base occurs for active and  inactive 
targets (Figure 4.2).  Average active sites comprise more guanines and fewer total thymines 
than  inactive  targets.      Because  pools  are  available  for  GNN  and  TNN  triplet  subsites, 
guanine and thymine counts are  inflated as compared to adenine and cytosine counts.   To 
account  for  this  bias  and  because most  nucleotides  specificity  varies  by  position within 
triplet  subsites,  average  occurrences  were  calculated  by  nucleotide  position  within  the 
triplets  (Figure  4.2B).   The differences  between  the positive  and negative  classes  identify 
thymine  composition  at  any  triplet  position  as  the  difference  between  the  positive  and 
negative  class.   Guanine, adenine, and  cytosine appear equally more often  in active  sites, 
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Residues propensities  for  thymine were negative, particularly  the  first and seventh 




the pools  that recognize  individual  triplets are currently  limited almost exclusive  to GNN 
and TNN triplets. 


























1 2 3 4 5 6 7 8 9
G A C T
 
Figure 4.2 | Target base composition varies between the active and inactive target sites A) Variation 
in the average occurrence of each bases differentiate classes independent of nucleotide position.  
Availability of triplet pools is currently limited to GNN and TNN triplets which inflates the total 
occurrence G and T relative to A and C.  B) Residues counts grouped by position within target 
triplets, indicates that thymine bases negatively impact binding at all three positions. C) Position 
specific nucleotide propensities suggest composition affects zinc finger binding Nucleotide 
propensities suggest Thymine typically makes a poor target.  Other bases also appear to have 
position specific affects, although to much smaller affects. Note: Because available pools target GNN 






for  identifying DNA  sequences most  amenable  to  site  specific  targeting  by  three‐module 
zinc  finger  arrays  generated  using OPEN.   We  implemented  input  encodings  at  various 
levels  of  abstraction  that  perform  comparably  well  on  our  dataset.    All  three  methods 









an  increased  chance  of  success  for  ZFP  targeting  by  OPEN.    Optimized  for  correlation 
coefficients, we were able  to  identify approximately half of  the  failed  sites  in  this dataset 


















1.   Naïve Bayes  is a probabilistic  classifier  that assumes  the  independence of each 
attribute,  this  makes  the  model  amenable  to  user  interpretation  without  compromising 
performance.  Naïve  Bayes  classifiers  commonly  perform  as  well  as  more  sophisticated 
classifiers.(12).  We  used  the  implementation  available  in  the  WEKA  package  version 


















2.   Support Vector Machines  (SVM)  find a hyper‐plane  in high‐dimensional  space 
that maximizes the distance between the different classes of data in high dimensional space. 
We  implemented  the  SVM  classifier  using  the wrapper  class  available  for  LIBSVM(14).  
Because SVM classifiers are sensitive to the number of positive and negative instances in the 
training  set,  and because our dataset  is unbalanced  (98 positive,  36 negative), we used  a 
variation of a leave‐one‐out cross validation technique.  For each test case, we removed that 
instance and generated 10 randomized balanced training sets, each consisting of 35 positive 









(G, A, C, T) was observed.   The  classifiers based on base  counts by position within  each 
triplet consist of 12 numbers from 0 to 3, adding up to a total of 9, representing the number 
of times each nucleotide was observed in each position of each triplet. For example, a target 
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Supplemental Table 4.S1:  Dataset of OPEN target sequences and labels 
Target 
5' - 3' 
Label  Target 
5' - 3' 
Label  Target 
5' - 3' 
Label 
GAGTGGTTA Inactive  GGAGCTGTA Active  GGCGACGAG Active 
GCGGTGGTT Inactive  TTTGAAGGT Active  GCTGAAGAA Active 
TAAGGGGAG Inactive  GGGGGAGCT Active  GAGGAGGTA Active 
GGGGCTGCG Inactive  TGTGCCGTA Active  GGAGATGTA Active 
GTATTTTGG Inactive  GGAGGTGGA Active  GACGGTGGA Active 
GTATGGTCT Inactive  GTAGGGGTC Active  GCGGACGTG Active 
GCTTGGGAC Inactive  GCTTGGGGC Active  GAGGGTTCT Active 
GAAGCTTTT Inactive  GAAGCATAA Active  GAGGCAGCA Active 
TGTGTGTTT Inactive  GGCGGCGAG Active  TTTGACGCT Active 
GAAGTATGG Inactive  GGTGCTGTG Active  GCTGGCGGT Active 
GAATTTGTG Inactive  GAAGCAGCT Active  GTTTGAGAT Active 
TTTGTCGGT Inactive  GACGCTGGT Active  GTGGACGAG Active 
GTTGTTTAA Inactive  GCAGTGTGG Active  GTTTGAGAG Active 
TTCGTGTGT Inactive  GTGGGCGGA Active  GGTGTGGGG Active 
GAGTTTGTT Inactive  GTGGGGGGT Active  GCAGCAGAA Active 
GTTTTTTGC Inactive  TGTGTGGCA Active  GGCTGAGTC Active 
TACGCCGGC Inactive  GGCGACGAC Active  GCCGTAGAT Active 
TTCGGTTCT Inactive  GAGGAGGGG Active  GTGTGGGGC Active 
TTCGTGTCT Inactive  GGTGATGAA Active  GACGCGGCG Active 
GAGGCTGCA Inactive  GCAGGTGCC Active  GGTGCTGCT Active 
TACGAAGGG Inactive  GTTGATTGG Active  GGATGAGAG Active 
GTGGTGTTT Inactive  GGCGTTTTT Active  GGTGGAGGA Active 
TTTTTTGCA Inactive  GCAGAGGGT Active  GACGTCGGG Active 
GATGAGTTT Inactive  GCTGAAGAT Active  GCAGCGGAT Active 
GCTTGAGCT Inactive  GAGGAAGGG Active  GGCGCTTCT Active 
GCCGCTGGA Inactive  GATGAAGGG Active  GCCGATGTC Active 
TTTGATGTT Inactive  GGAGCCGAC Active  GGAGGCGGC Active 
TGTGGCTGC Inactive  GCTGCTGAC Active  GAATGAGAC Active 
GACTGATGC Inactive  GGTGGTGGA Active  GACGAAGAT Active 
GGTGGATTA Inactive  GGTGGAGCA Active  GCTTGGGTC Active 
TTCGCATCT Inactive  GTCGTGGAA Active  GCTGGGGGA Active 
GATGCGGTG Inactive  GGCGGTGCC Active  GCGGGGGCG Active 
GCTGGCTCT Inactive  GCGGCCGCG Active  GCGGTGGCG Active 
GGGGCTGCC Inactive  GCTGACGAA Active  GCGTGGGCG Active 
GCTGCAGCC Inactive  GGCTGAGGC Active  GCGTTGGCG Active 
GCCGTCGCC Inactive  GCCGGTTGG Active  GAATTGGCG Active 
GTGGAATTA Active  GGAGCGGCA Active  GAGGGGGCG Active 
GCCGCTGCT Active  GCTGAGGCT Active  GATGAGGCG Active 
GGAGCTGCC Active  GGCGCGGCA Active  GACTGGGCG Active 
TCTGAGTGG Active  GGGTAGGTG Active  AACGCAGGC Active 
GGAGCAGCA Active  GCCGATGCT Active  AACGCCGAT Active 
GTCGCCGCT Active  GCTGAAGCA Active  GGCGGCGCC Active 
GCAGCAGGT Active  GTGGGTGCG Active  GCCTTTGAG Active 
GATGAAGCC Active  GTCGACGGG Active  GCCGACGTC Active 
GAGTTGTAA Active  GGCGCCGCC Active    
 
Active implies OPEN generated at least one zinc finger array that resulted in at least three fold 











the  design  of  zinc  finger  proteins  (ZFPs)  that  can  bind  to  specific DNA  sequences.  The 
current version of ZiFiT is based on a widely employed method of ZFP design, the ʺmodular 
assembly”  approach,  in which  pre‐existing  individual  zinc  fingers  are  linked  together  to 
recognize  desired  target  DNA  sequences.  Several  research  groups  have  described 
experimentally characterized zinc  finger modules  that bind many of  the 64 possible DNA 
triplets.  ZiFiT  leverages  the  combined  capabilities  of  three  of  the  largest  and  best 



















approximately  three  base  pairs  of  DNA  and,  when  appropriately  joined  together,  the 
resulting  ZF  arrays  are  capable  of  specifically  recognizing  longer DNA  sequence motifs 
(Figures 5.1 and 5.2). Three research groups have each described and characterized separate 












Figure 5.1 | Zinc Finger Modules and Binding Sites.  A)  A canonical zinc finger module consists of 
two anti-parallel beta strands and an alpha helix, with a zinc ion coordinated by the conserved 
cysteine(C) and histidine(H) residues pairs. The numbered amino acid residues at positions -1, +2, 
+3, and +6, relative to the amino-terminal end of the alpha helix, can form important base-specific 
contacts in the major groove of the double-stranded target DNA (not shown).  B) A ZFP consisting of 
3 linked ZF modules binds its target DNA site with amino acids of the recognition alpha helices (in the 
N- to C-terminal direction) contacting consecutive nucleotides in DNA running in the 3' to 5' direction. 
This can lead to confusion because the DNA target site is typically referred to in the 5' to 3' direction. 
Note that an “unnatural” extended array is shown to better illustrate the critical amino acid-nucleotide 




separated  by  a  fixed‐length  ʺspacer,ʺ  Figure  5.2B).  ZiFiT  output  provides  users  with 
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potential  ZFP  target  DNA  sequence(s)  within  the  region  of  interest,  together  with  a 
corresponding  array  of  ZF  modules  needed  to  construct  the  desired  ZFPs.  The  output 





Figure 5.2 | Comparison of Single ZF Array and Dimeric ZF Nuclease Sites.  a) Zinc Finger Protein 
Bound to a Single ZF Array Target Site: A single ZF array target site consists of three to eight 
adjacent DNA triplets (9 - 24 nt) on the same strand of DNA. Each triplet of DNA is recognized by one 
"finger" or "ZF module" (light blue ovals). The cartoon illustrates an array with three fingers (ZF1, ZF2, 
ZF3) bound to a single ZF array target site, in this case, a 9 nt DNA sequence.  b) Zinc Finger 
Nuclease Bound to a Dimeric ZF Nuclease Target Site:  A ZF nuclease target site consists of two 
single ZF array sites on complementary DNA strands, separated by a spacer of 5 or 6 nt. In this 
configuration, FokI endonuclease monomers (dark blue spheres), covalently linked to the C-terminal 
end of each ZF array domain, can form an active dimeric nuclease and induce a double-stranded 






A  canonical  zinc  finger module  consists  of  two  anti‐parallel  beta  strands  and  an 
alpha  helix  coordinated with  a  zinc  ion  via  cysteine  and  histidine  contacts  (1‐4). Amino 
acids in positions ‐1 to 6 (numbered relative to the start of the alpha helix) recognize specific 
DNA  triplet sequences, primarily by  forming base‐specific contacts  in  the major groove of 
the double‐stranded target DNA (Figure 5.1A). ZF modules are often referred to according 
to  these  ʺrecognitionʺ  residues  in  the alpha helix,  listed  in N‐  to C‐terminal direction; we 
refer to the other amino acids in the module as the finger backbone. As illustrated in Figure 
5.1B, a ZFP binds its target DNA site with the amino acids of the recognition helices (from 





ZiFiT  was  designed  to  take  advantage  of  ZF  module  sets  developed  and 
characterized by  three  independent  research groups.   Users can  specify whether modules 
should  be  chosen  from  only  one,  two,  or  all  three  of  these module  sets  (designated  as 
Barbas, Sangamo, or ToolGen, based on  the group  that described  them –  see below). The 
Zinc Finger Consortium has generated plasmids encoding modules from all three sets  in a 




the Zinc Finger Consortium and automatically provides  reference numbers  for  requesting 
these ready‐to‐assemble plasmid modules from Addgene, a non‐profit plasmid distribution 
service (http://www.addgene.org/zfc/). It should be noted that the designers of each module 





display  and  rational  design methods  by  the  Barbas  laboratory  at  The  Scripps  Research 
Institute  (11,12,15). Modules  are  available  for  recognition of  all GNN  triplets, most ANN 
and CNN triplets, and a few TNN triplets. These Barbas modules were developed under the 
assumption  that  individual ZF modules have virtually  complete positional  independence, 






triplets  (13,17,18).    Sangamo  modules  were  developed  under  the  assumption  that  the 




within a  three‐finger array has a distinct ZF module developed  for a given  triplet at  that 
position.  For this reason, if a user chooses to use Sangamo modules, ZiFiT restricts the user 











pre‐existing  individual zinc finger modules are  linked  together  to recognize desired  target 
sequences.    ZiFiT  is  available  at  http://bindr.gdcb.iastate.edu/ZiFiT/  or  can  be  accessed 
under  Software  Tools  from  the  Zinc  Finger  Consortium  website  at 
http://www.zincfingers.org/software‐tools.htm).    The  ZiFiT  website  includes  instructions 
and  examples  as  well  as  several  links  to  other  websites  that  provide  background 






form  multi‐finger  arrays  that  recognize  specific  sequences  in  double‐stranded  genomic 
DNA (Figure 5.2A). These multi‐finger arrays can be fused to other protein domains, such as 
transcriptional activation or repression domains, in order to target them to specific locations 
within  large  genomes  (1‐4).    Because  a  single  ZF  recognition  helix  typically  binds  three 
contiguous  nucleotides  in  DNA,  most  binding  sites  for  single  ZF  proteins  (which  we 
designate ʺsingle ZF array binding sitesʺ) have lengths that are multiples of three base pairs.  
However,  certain  ZF  modules  containing  aspartic  acid  in  the  +2  position  of  the  DNA 

















zinc  finger  nucleases  (ZFNs)  before  proceeding  to  the  main  sequence  input  screen 
(Figure 5.3).   Check boxes near  the  top of  the page allow users  to select which ZF module 
sets (Barbas, Sangamo, ToolGen) they wish to include in their search.  The DNA sequence of 
interest  (i.e.,  the sequence of  the region within which  the user wishes  to  identify potential 
ZFP  target sites) can be  submitted either  in FASTA  format or as a  raw DNA  sequence  in 
standard 5’ to 3’ orientation (both spaces and numbers are ignored).   Users can specify the 













Figure 5.3 | ZiFiT Input Window: In this example, the user has chosen to search for potential dimeric 
zinc finger nuclease (ZFN) sites. The DNA sequence of interest can be supplied in either FASTA 
format or as a raw DNA sequence, in standard 5’ to 3’ direction. Above the sequence input box, 
check boxes allow users to specify which sets of characterized ZF modules should be considered in 
designing a ZFN to recognize the desired target site. Below the sequence input box, drop down 
menus allow users to specify how many DNA triplets should be included in each array site:  a single 
array site may contain from 3 to 8 triplets; a dimeric nuclease site may contain 3 or 4 triplets in each 
array site (Left and Right), separated by a Spacer of either 5 or 6 nucleotides. Information that 
appears below the "Submit" button in this screenshot corresponds to "Advanced Option" parameters 
(see text). These have been revealed by selecting the "Advanced" link (to the right of the Submit 
button) which toggles between "Basic" and "Advanced."  
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Advanced  options  can  be  accessed  by  selecting  the  ʺAdvancedʺ  link  in  the  lower 




refers  to  the  target  site  overlap  that  can  occur with Asp  in  position  +2  of  the  helix  (see 
Materials  and  Methods);  iii)  choose  to  search  one  or  both  strands  of  the  input  DNA 
sequence for target sites, when searching for a single array site. By definition both strands 





GNN‐specific ZF modules have been more  thoroughly  characterized  than other modules. 
The ʺIgnore Asp overlapʺ option is particularly useful for troubleshooting: for example Asp 
in position +2 can cause unexpected results when the target site falls on the very 3ʹ end of a 
submitted  sequence.   An Asp  in position +2 of  the  first module  specifies an additional 3ʹ 
base.  If  this base  is not available, a partial  target site can be detected by ZiFiT and partial 










recognize  that  target  site.  As  shown  in  Figure  5.4,  the  double‐stranded  DNA  sequence 
(displayed  at  top)  represents  a  potential  dimeric  ZFN  target  site  identified  by  ZiFiT. 
Recognition triplets in the target site are color‐coded to match corresponding entries in the 
table of ZFP modules (displayed below the target site sequence). The table lists ZF modules 
that have been experimentally  shown  to bind  triplets  in  the displayed  target  site.  If more 
than one module  is available  for a given  triplet position, all modules  for  that position are 
displayed.   
Each ZF module  entry  includes  the  recognition helix  sequence of  the module,  the 
color‐coded  DNA  sequence  of  its  corresponding  target  triplet,  a  reference  number  for 
requesting  the  ZF  module,  if  desired,  from  the  Addgene  Zinc  Finger  Consortium 
website (http://www.addgene.org/zfc/),  and  the  original  source  of  the  module  (Barbas, 
Sangamo, or Toolgen).   When ZiFiT  identifies more than one potential ZFP/target site pair 
within  the  query  sequence,  additional  hits  are  also  displayed  and  can  be  viewed  by 








Figure 5.4 | Example of ZiFiT Output for a dimeric ZF nuclease target site.  For each "hit" identified 
by ZiFiT, the output consists of the DNA target site sequence and two tables that contain 
corresponding ZF protein modules that could be assembled to recognize the displayed target site.  
Each target site is displayed as a double-stranded DNA sequence, with triplets color-coded to 
facilitate identification of the corresponding ZF binding modules in the accompanying table.  Each row 
in the ZF module table displays information for a single zinc finger module. Entries in the columns 
indicate the Finger position (Finger) of this module, the amino acids at positions -1 through +6 
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corresponding to its recognition helix  (HELIX), the color-coded DNA triplet it recognizes (TRIPLET), a 
reference number to facilitate ordering the ZF module from the Zinc Finger Consortium 
(REFERENCE NUMBER), and the module set from which the indicated ZF module was derived 
(MODULE SOURCE). If more than one ZF module is known to recognize a given triplet sequence, all 
Figure 5.4 | continued available modules for that position are displayed.  The screenshot shown 
here has been truncated to display complete output for only one of several potential dimeric ZF 
nuclease target sites identified within the input query DNA sequence. 
 
Assembling and Evaluating Engineered ZFPs 
ZiFiT  is  designed  to  facilitate  the  experimental  generation  of  ZFPs  by  providing 
output  that  includes  reference  numbers  for  public‐domain,  ready‐to‐assemble  modules 
generated  by  the  Zinc  Finger  Consortium.  These  resources  can  greatly  simplify  the  ZF 
protein assembly process. All ZF modules used in ZiFiT can be requested through Addgene, 
a  non‐profit  plasmid  distribution  service  (see  http://www.addgene.org/zfc  for  additional 
details). A detailed protocol  for assembling and evaluating zinc  finger proteins using  this 
strategy has been published  recently  in Nature Protocols  (16). Other  research groups have 
also  described  PCR‐based  zinc  finger  assembly  protocols  (23,24).  Additional  general 
information  regarding  zinc  finger  proteins  and  their  applications  is  available  at  the Zinc 
Finger Consortium website at http://www.zincfingers.org.   
FUTURE DIRECTIONS 
ZiFiT will be updated  regularly  to  reflect growth  in ZFP assembly  resources  (e.g., 
collections of zinc  finger modules  and arrays) and  increasing availability of  experimental 
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data  regarding  the  in  vivo  efficacy  of  specific  ZF  proteins.  While  several  studies  have 
demonstrated  that  ZFPs  engineered  using  the modular  assembly  approach  can  function 
successfully,  other  studies  (both  published  and  unpublished)  have  shown  that  designed 
ZFPs  function with variable degrees of  success  (14,25,26). As noted  above,  in  the  current 
version  of ZiFiT,  the  order  in which  potential ZF  array  target  sites  are  displayed  in  the 
output  window  corresponds  to  the  order  in  which  they  occur  within  the  query  DNA 
sequence  ‐ no  ranking  is  implied. A  feature we plan  to  implement  in  the next version of 
ZiFiT is a scoring function that will rank and provide information for each hit (i.e., for each 
ZFP/target  site  pair)  in  the ZiFiT  output.  This  scoring  information  and  ranked  listing  of 
experimentally validated ZF target sites will provide additional guidance to assist users  in 
designing ZF arrays  that are most  likely  to  function.  In collaboration with  the Zinc Finger 
Consortium,  members  of  our  groups  have  designed  and  implemented  a  Zinc  Finger 











A  server  offering  software  similar  to  ZiFiT,  named  Zinc  Finger  Tools 
(http://www.zincfingertools.org)  has  been  developed  by  the  Barbas  lab  at  the  Scripps 
Institute, for use with their ZF module set (27). One significant advantage of ZiFiT is that it 
offers users the ability to choose modules from three different module sets  instead of only 
the  single Barbas  set, and users may  combine modules  from different archives  if desired. 
When  using  the  Barbas  Zinc  Finger  Tools  software,  a  user will  only  have  one  potential 
protein  to  test for any given  target site.   Because modular assembly does not always yield 
functional proteins  (14,25)  it  is  important  to have multiple potential zinc  finger arrays  for 
any given target site.   Also, ZiFiT was  intentionally designed to complement experimental 
resources made publicly available by the Zinc Finger Consortium and distributed through 
Addgene.   Zinc  Finger Tools  offers  a  scoring  function  to  assist users  in  choosing  among 
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Helix  Triplet  Reference #  Module Source 
QRSNLVR  GAA  ZF1  SGMO* 
DRSNLTR  GAC  ZF2  SGMO* 
RSDNLAR  GAG  ZF3  SGMO* 
QSSNLAR  GAT  ZF4  SGMO* 
QSGSLTR  GCA  ZF5  SGMO* 
ERGTLAR  GCC  ZF6  SGMO* 
RSDDLTR  GCG  ZF7  SGMO* 
QSSDLTR  GCT  ZF8  SGMO* 
QSGHLAR  GGA  ZF9  SGMO* 
DRSHLTR  GGC  ZF10  SGMO* 
RSDHLAR  GGG  ZF11  SGMO* 
QSSHLTR  GGT  ZF12  SGMO* 
QSGALTR  GTA  ZF13  SGMO* 
DRSALAR  GTC  ZF14  SGMO* 
RSDALTR  GTG  ZF15  SGMO* 
TTSALTR  GTT  ZF16  SGMO* 
KNWKLQA  AGA  ZF17  SGMO* 
QSGNLAR  GAA  ZF18  SGMO** 
DRSNLTR  GAC  ZF19  SGMO** 
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RSDNLAR  GAG  ZF20  SGMO** 
TSGNLVR  GAT  ZF21  SGMO** 
QSGDLTR  GCA  ZF22  SGMO** 
RSDDLQR  GCG  ZF23  SGMO** 
QSSDLTR  GCT  ZF24  SGMO** 
QSGHLQR  GGA  ZF25  SGMO** 
DRSHLAR  GGC  ZF26  SGMO** 
RSDHLTR  GGG  ZF27  SGMO** 
TSGHLVR  GGT  ZF28  SGMO** 
QSGALAR  GTA  ZF29  SGMO** 
DRSALAR  GTC  ZF30  SGMO** 
RSDALSR  GTG  ZF31  SGMO** 
TSGALTR  GTT  ZF32  SGMO** 
DRSDLTR  GCC  ZF33  SGMO** 
RSDHLTT  TGG  ZF34  SGMO** 
RADALMV  TTG  ZF35  SGMO** 
QSGNLAR  GAA  ZF36  SGMO*** 
DRSNLTR  GAC  ZF37  SGMO*** 
RSDNLTR  GAG  ZF38  SGMO*** 
TSANLSR  GAT  ZF39  SGMO*** 
QSGDLTR  GCA  ZF40  SGMO*** 
DRSDLTR  GCC  ZF41  SGMO*** 
RSDDLTR  GCG  ZF42  SGMO*** 
QSSDLQR  GCT  ZF43  SGMO*** 
QSGHLQR  GGA  ZF44  SGMO*** 
DRSHLAR  GGC  ZF45  SGMO*** 
TSGHLVR  GGT  ZF46  SGMO*** 
QRASLTR  GTA  ZF47  SGMO*** 
DRSALAR  GTC  ZF48  SGMO*** 
RSDALTR  GTG  ZF49  SGMO*** 
QSSALTR  GTT  ZF50  SGMO*** 
RSDHLSR  GGG  ZF51  SGMO*** 
RSDNLTQ  AAG  ZF52  SGMO*** 
RSDHLTQ  AGG  ZF53  SGMO*** 
RSDNLTE  CGG  ZF54  SGMO*** 
RSDALRE  CTG  ZF55  SGMO*** 
QSGHLTK  TGA  ZF56  SGMO*** 
RSDHLTT  TGG  ZF57  SGMO*** 
RSDKLVR  GGG  ZF58  Barbas 
QRAHLER  GGA  ZF59  Barbas 
TSGHLVR  GGT  ZF60  Barbas 
DPGHLVR  GGC  ZF61  Barbas 
RSDNLVR  GAG  ZF62  Barbas 
QSSNLVR  GAA  ZF63  Barbas 
TSGNLVR  GAT  ZF64  Barbas 
DPGNLVR  GAC  ZF65  Barbas 
RSDELVR  GTG  ZF66  Barbas 
QSSSLVR  GTA  ZF67  Barbas 
TSGSLVR  GTT  ZF68  Barbas 
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DPGALVR  GTC  ZF69  Barbas 
RSDDLVR  GCG  ZF70  Barbas 
QSGDLRR  GCA  ZF71  Barbas 
TSGELVR  GCT  ZF72  Barbas 
DCRDLAR  GCC  ZF73  Barbas 
QRANLRA  AAA  ZF74  Barbas 
DSGNLRV  AAC  ZF75  Barbas 
RKDNLKN  AAG  ZF76  Barbas 
TTGNLTV  AAT  ZF77  Barbas 
SPADLTR  ACA  ZF78  Barbas 
DKKDLTR  ACC  ZF79  Barbas 
RTDTLRD  ACG  ZF80  Barbas 
THLDLIR  ACT  ZF81  Barbas 
QLAHLRA  AGA  ZF82  Barbas 
ERSHLRE  AGC  ZF83  Barbas 
RSDHLTN  AGG  ZF84  Barbas 
HRTTLTN  AGT  ZF85  Barbas 
QKSSLIA  ATA  ZF86  Barbas 
RRDELNV  ATG  ZF87  Barbas 
HKNALQN  ATT  ZF88  Barbas 
QSGNLTE  CAA  ZF89  Barbas 
SKKALTE  CAC  ZF90  Barbas 
RADNLTE  CAG  ZF91  Barbas 
TSGNLTE  CAT  ZF92  Barbas 
TSHSLTE  CCA  ZF93  Barbas 
SKKHLAE  CCC  ZF94  Barbas 
RNDTLTE  CCG  ZF95  Barbas 
TKNSLTE  CCT  ZF96  Barbas 
QSGHLTE  CGA  ZF97  Barbas 
HTGHLLE  CGC  ZF98  Barbas 
RSDKLTE  CGG  ZF99  Barbas 
SRRTCRA  CGT  ZF100  Barbas 
QNSTLTE  CTA  ZF101  Barbas 
RNDALTE  CTG  ZF102  Barbas 
TTGALTE  CTT  ZF103  Barbas 
REDNLHT  TAG  ZF104  Barbas 
QAGHLAS  TGA  ZF105  Barbas 
RSDHLTT  TGG  ZF106  Barbas 
CPSNLRR  GAC  ZF107  ToolGen 
DKSCLNR  GCC  ZF108  ToolGen 
DRSALAR  GTC  ZF109  ToolGen 
HSSNFNK  GAC  ZF110  ToolGen 
HSSSLVR  GTT  ZF111  ToolGen 
ISSNLQR  GAT  ZF112  ToolGen 
KSSNLRR  GAG  ZF113  ToolGen 
QRAHLIR  GGA  ZF114  ToolGen 
QSFNLRR  GAG  ZF115  ToolGen 
QKGNLLR  GAA  ZF116  ToolGen 
QVSHLTR  GGA  ZF117  ToolGen 
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QHSHLVR  GGA  ZF118  ToolGen 
QSSHLTT  AGA  ZF119  ToolGen 
QSSHLNV  CGA  ZF120  ToolGen 
QKSNLTI  CAA  ZF121  ToolGen 
QKSNLII  CAA  ZF122  ToolGen 
QSSNLTK  GAA  ZF123  ToolGen 
QKSNLIR  GAA  ZF124  ToolGen 
QSSNLTR  GAA  ZF125  ToolGen 
QSSNLTV  CAA  ZF126  ToolGen 
QSSSLIR  GTA  ZF127  ToolGen 
QSSTLTR  GTA  ZF128  ToolGen 
QSTHLTQ  CGA  ZF129  ToolGen 
QSTHLTR  GGA  ZF130  ToolGen 
RSDELNR  GCG  ZF131  ToolGen 
RKDHLTR  GGG  ZF132  ToolGen 
RSDHLKT  AGG  ZF133  ToolGen 
RSDKLNR  GGG  ZF134  ToolGen 
RRSHLTR  GGG  ZF135  ToolGen 
RKSNLIR  GAG  ZF136  ToolGen 
SGSNFTR  GAG  ZF137  ToolGen 
VSSNLNV  AAT  ZF138  ToolGen 
VSSSLRR  GTG  ZF139  ToolGen 
VSSTLIR  GCT  ZF140  ToolGen 









High  failure  rates  associated with modular  assembly  in  vivo  (1)  have  driven  the 
development  of  more  complex  selection  methods  for  generating  zinc  finger  proteins 
designed  to  target  specific  sites  in  genomic  DNA  (2,3).    While  more  successful,  these 
selection methods  require  considerably more  time  and molecular  biology  expertise  than 
modular assembly.  By generating and testing novel modularly‐assembled ZFPs in vivo and 
in vitro, we identified low affinity as a leading problem for ZFPs assembled using currently 




the middle domain  (finger 2)  in a  fixed  three‐module  context  (fixed  finger 1 and  finger 3 
domains).   By attributing variations  in Kd  to  the variant middle domain, we were able  to 
estimate energy contributions  for  individual modules, which we combined  to predict ZFP 





accurately  predicted  in  vivo  and  in  vitro  performance  for  a  set  of  GNN‐based  ZFPs 
constructed by us.    In addition, we validated our  findings on an  independently generated 
dataset  (1).   Our accurate predictions of B2H performance  for modularly‐assembled ZFPs 





A  recent  study  reported  that DNA  targets  composed  of  exclusively GNN  triplets 
make the most reliable targets, suggesting that ZFP activity is dependent on the nucleotide 
composition of the target site (1).  Using linear system solutions based on either nucleotide 
base  counts  (G A T C)  or  base  counts  by  triplet position, we  identified  a  range  of DNA 
sequences which cannot be targeted with high affinity using Barbas, Toolgen, and Sangamo 
module  sets.  (1,4,5).  However,  a  similar  approach  to  identify  optimal  ZFP‐target  site 
combinations using  available data  for OPEN  (Oligomerized Pool Engineering) was much 
less informative (6).   
ZFPs  generated  using OPEN  generally  function with much  greater  activity  (and  




more  positively‐charged  residues  relative  to  those  currently  characterized  for  modular 
design.   This was particularly evident for modules  that  target cytosine‐rich  triplets; OPEN 
modules  targeting  purine‐rich  triplets  comprise  few  positively‐charged  non‐contact 
residues.  In addition, in ZFPs selected via OPEN. the overall number of positively‐charged 





Successful  OPEN‐engineered  zinc  finger  protein  arrays  typically  function  with 
increased activity  in  the B2H assay compared with  those generated by modular assembly 
(1,3,8).    However,  because  the  OPEN  protocol  requires  both  considerable  time  and 
molecular  biology  expertise,  it  is  desirable  to  identify  and  avoid  targets  for  which  the 
likelihood of obtaining a functional ZFP is low. Using alternative encodings for DNA target 
sequences as input for Naïve Bayes and Support Vector Machine classifiers, we were able to 
predict which  sequences could be  targeted by OPEN‐generated zinc  fingers  (with affinity 
sufficient  to provide greater  than 3‐fold activation  in  the B3H assay).   Our  top  classifiers 
achieved 84% overall accuracy, with a correlation coefficient of 0.55, specificity of 0.83 and 
sensitivity of 0.97, when trained and tested on a dataset of 126 ZFP target sites (98 positive; 




are most  amenable  to OPEN‐based  zinc  finger  targeting.    The  results  of  this  study  also 








Initially developed  to support modular assembly, ZiFiT can be used  to  identify  targets for 
either  individual  ZFP  arrays  or  for  ZF  nuclease  target  sequences  for  which  validated 
consortium reagents are available (7,8). 
ZiFiT has been  continually updated  to  reflect  advances  in materials, methods and 
understanding of zinc finger technology, including:  1) Scoring schemes that reflect expected 
success  rates  (1,4);  2) Organism‐specific  BLAST  capability  to  identify  potential  off‐target 
sites; 3) A seamless  interface with ZiFDB  to allow users  to search  for previously obtained 







Zinc  finger  nucleases  (ZFNs)  can  be  used  to  induce  site‐specific  double‐stranded 
breaks  in genomic DNA (10,11).   Imperfect repair of these breaks by non‐homologous end 
joining  (NHEJ)  often  results  in  frame‐shift  knockout  mutations  (12).    We  are  currently 
analyzing  the human and zebrafish genomes  to  identify candidates for ZFN‐induced gene 





the  human  or  zebrafish  genome.  The  high‐quality  potential  targets  for  ZFN  knockouts 




Standardized  experimental  reagents  and  protocols,  together  with  computational 
tools and scoring methods that have identified ZFP characteristics requisite for function, are 
transforming  zinc  finger  methodology  from  an  “art”  based  on  unreliable  theoretical 
constructs  and  requiring  both  high  levels  of  experimental  expertise  and  specialized 
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knowledge  ‐ possessed by only a handful of  research groups  ‐    into a  reliable  technology 
accessible  to  mainstream  molecular  biologists.    Currently  the  Zinc  Finger  Consortium 
supports  both modular  assembly  and  OPEN  (Oligomerized  Pool  ENgineering)  for  ZFP 
design.  As zinc finger technology continues to evolve, we plan to continue support for both 
methods.   
While  relatively  simple  to  implement,  low  success  rates  limit  the  use  of modular 
assembly based on  currently available modules.    In Chapter 2, we  identified affinity as a 
critical constraint  for modular assembly and provided an affinity‐based scoring scheme  to 
predict  activity  of  ZFPs  assembled  from  Barbas  GNN  modules.    An  important  future 
direction will be the generation and experimental evaluation of ZFPs comprising new ANN, 
TNN and CNN‐targeted modules, which will allow us  to expand our  scoring  schemes  to 
include ZFPs that target sequences that are not exclusively composed of GNN triplets.   
Specificity,  in  addition  to  sufficient  affinity,  is  essential  for  many  zinc  finger 
applications,  including  the minimization/elimination  of  off‐target  cleavage  by  zinc  finger 
nucleases (13).  We and others have performed preliminary microarray‐based DNA‐binding 
chip  experiments  that  offer  encouragement  for  additional  research  into  specificity‐based 
scoring schemes. Scoring schemes based on a combination of affinity and specificity should 
greatly advance the future application of ZFPs, especially in clinical settings. 
Recent  research  has  demonstrated  that  the  OPEN  method  produces  ZFPs  with 
superior activity (in B2H assays) compared to those currently produced by modular design.   
In  reaching  this  conclusion,  however, we  identified modules  from OPEN  selections  that 
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function extremely well  in numerous contexts.   Our preliminary  studies have  shown  that 
ZFPs constructed from these new modules function with almost double the activity of ZFPs 
constructed  from  current  module  sets.    If  an  expanded  study  verifies  our  preliminary 
results,  we  will  release  these  OPEN‐derived  modules  in  the  standard  ZF  Consortium 
framework for modular assembly.   
Although  very  robust,  the  current  OPEN  protocol  requires  significant molecular 
biology  expertise.   Current  consortium  efforts  are underway  to  simplify  the protocol.    In 
addition, module pools are available only for GNN and some TNN triplets.   Generation of 
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Engineered  zinc  finger  nucleases  can  stimulate  gene  targeting  at  specific  genomic 
loci  in  insect, plant and human cells. Although several platforms for constructing artificial 
zinc  finger arrays using  ‘‘modular assembly’’ have been described,  standardized  reagents 
and protocols that permit rapid, cross‐platform ‘‘mixing‐and‐matching’’ of the various zinc 
finger modules  are  not  available. Here we  describe  a  comprehensive,  publicly  available 
archive  of  plasmids  encoding  more  than  140  well‐characterized  zinc  finger  modules 











Zinc  finger  nucleases  (ZFNs)  can  be  used  to  introduce  targeted  double‐stranded 
breaks  (DSBs)  into  chromosomal  DNA  sequences,  thereby  stimulating  homologous 
recombination and gene targeting events at specific genomic loci in insect, plant and human 
cells  (1–7).  ZFNs  consist  of  an  engineered  Cys2His2  zinc  finger  DNA‐binding  domain 
(typically  three  (8–10) or  four6  fingers)  fused  to a non‐specific nuclease domain  from  the 
FokI restriction enzyme (Figure A.1). ZFNs bind as dimers  to  their  target DNA sites, with 
each  monomer  using  its  zinc  finger  domain  to  recognize  a  ʺhalf‐siteʺ  (Figure  A.1). 
Dimerization  of ZFNs  is mediated  by  the  FokI  nuclease domain, which  cleaves within  a 
spacer sequence  (typically  five or six base pairs  in  length)  that separates  the  two  inverted 
half‐sites (5,10,11) (Figure A.1). Because each zinc finger recognizes a three base pair  ‘sub‐
site,’ a three‐finger ZFN binds to a nine base pair half‐site and a four‐finger ZFN binds to a 
twelve base pair half‐site.  In principle, ZFN‐mediated gene  targeting can be used  to effect 
correction,  mutation,  deletion  or  insertion  at  any  endogenous  gene,  provided  that 
appropriate zinc finger domains can be engineered to target the locus of interest. Therefore, 




a  rapid and  facile method  for engineering  the zinc  finger arrays needed  to  target  specific 
DNA sequences of interest. 
Several  recent  reports  have  demonstrated  that  ‘‘modular  assembly’’ methods  can 
yield three‐finger arrays that can  in turn be used to generate active ZFNs (1–3,7,12). These 
modular assembly approaches involve the  joining together of individual, pre‐characterized 
finger  modules  to  create  multi‐finger  arrays  capable  of  recognizing  extended  DNA 
sequences.  Three  different  sets  of  modules,  each  with  well‐characterized  DNA‐binding 
specificities, have been described in the literature: 
1. Carlos Barbas  and  colleagues  have  constructed  a  set  of modules  that  target  all 
GNN, most ANN and CNN and a  few TNN  triplet subsites  (13–17). These modules were 
selected by phage display and in some cases optimized by targeted mutagenesis. The DNA‐
binding  specificities  of  these  domains were  each  verified  using  an  in  vitro  ELISA‐based 
specificity  assay.  All  of  these  modules  are  based  on  a  consensus  human  zinc  finger 
framework18  and  are  designed  to  be  used  at  any  position  (amino  terminal, middle  or 
carboxy terminal) in the context of a multi‐finger domain. The Barbas group has described 
web‐based software for using this set of modules (19). 




generated by altering  fingers  from  the  three‐finger Sp1 zinc  finger domain and have been 
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Figure A.1 | Schematic of a) a zinc finger nuclease and b) a zinc finger nuclease dimer bound to its 
target cleavage site. Individual zinc finger domains are depicted as colored spheres with F1 
representing the amino-terminal finger, F2 the middle finger and F3 the carboxy-terminal finger in a 
three-finger array. The FokI DNA cleavage domain is represented as a purple colored octagon. Note 
that the spacer sequence between the two 9-bp ‘half-sites’ can be five or six base pairs. 
 
3.  Scientists  at  ToolGen,  Inc.  identified  a  set  of  naturally  occurring  human  zinc 
fingers  that  recognize  a  range  of  different  triplet  subsites  (23).  The  DNA‐binding 
specificities  of  these modules were  determined  using  a  yeast‐based  one‐hybrid  reporter 
assay. Because these modules are derived from different human transcription factors, their 






and  ZFNs,  published  reports  suggest  that  the  process  does  not  always  yield  functional 
domains. Barbas  and  colleagues made  a  series of  80 different  three‐finger domains using 
their modules  and  found  that  all  of  these multi‐finger  arrays were  able  to  bind  to  their 
intended  target DNA site  in an  in vitro ELISA‐based DNA‐binding assay  (30).  In smaller‐
scale surveys, Cathomen and colleagues found that two out of four ZFNs they made using 
the  Barbas modules  (7)  and  Porteus  found  that  six  out  of  six  proteins made  using  the 
Sangamo  modules  (12)  could  stimulate  gene  targeting  in  human  cells.  However,  these 
results may  reflect  a  publication  bias  because  unsuccessful  attempts may  not  always  be 




assembly  does  not  always  work  is  the  failure  of  the  method  to  account  for  context‐
dependent  effects  on  DNA‐binding  that  can  occur  with  zinc  finger  domains  (31–35). 
Although  the overall  success  rate of modular  assembly  across  a broad  range of potential 
binding  sites  remains  to  be  determined,  the  relative  ease  of  this method  compared with 
other  more  labor‐intensive  selection‐based  approaches  makes  it  a  reasonable  potential 
strategy for constructing ZFNs. 
Given  the  imperfect  success  rate  of  modular  assembly,  multi‐finger  domains 
constructed  using  this  approach  should  ideally  be  screened  for  DNA‐binding  activity  
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before being  tested as ZFNs  in  cells.  In vitro  tests  (36) or mammalian  cell‐based  reporter 
assays (7) have been used for this purpose, but these methods can be time consuming and 
labor intensive. We prefer the use of a bacterial cell‐based two‐hybrid (B2H) reporter system 
(31,37–39), which  tests  the  ability  of  a  zinc  finger  domain  to  bind  a  given  target  DNA 
sequence. The B2H  reporter assay  is  rapid, easy  to perform and does not  require protein 
purification or mammalian cell culture or transfection. In the B2H reporter system, binding 
of  a multi‐finger  domain  to  its  target  site  leads  to  transcriptional  activation  of  a  readily 
assayable  lacZ  reporter  gene  (Figure  A.2).  Previous  work  has  shown  that  multi‐finger 
domains that activate reporter gene expression efficiently in the B2H also possess excellent 




constructing  ZFNs  by modular  assembly  that  enable  the  user  to  leverage  the  potential 
strengths  of  all  three  published  module  sets.  We  have  constructed  a  set  of  plasmids 
encoding a comprehensive archive of more than 140 zinc finger modules derived from the 
Barbas,  Sangamo  and  ToolGen  module  sets  (Supplementary  Table  A.S1  online).  We 
designed these plasmids on a standardized framework, which permits any combination of 
modules  to be  rapidly assembled  into arrays using only standard  restriction digest–based 
subcloning  techniques  (Figure  A.3).  Although  our  assembly  method  requires  two 
subcloning  steps  to  construct  a  three‐finger  array,  our  strategy  and  reagents  allow 
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researchers  to avoid  the need  for  specialized knowledge of zinc  finger  sequences and  for 
complicated oligonucleotide design or costly gene  synthesis  (17,19–21,40).  In addition, we 
describe  a  complementary  web‐based  ZiFiT  (Zinc  Finger  Targeter)  program,  which 
simplifies and automates the process of identifying target DNA sites that can potentially be 
targeted by multi‐finger domains made using our archive of modules. Following assembly, 










Figure A.2 | Schematic of the bacterial two-hybrid reporter system. Co-expression of the zinc finger-
Gal11P and alpha-Gal4 hybrid proteins in a B2H reporter strain leads to activated expression of a 
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Figure A.2 | continued lacZ reporter gene if the multi-finger domain interacts with a target DNA-
binding site located just upstream of the promoter39. This activation is mediated by recruitment of 
RNA polymerase complexes (that have incorporated alpha-Gal4) to the promoter by promoter-bound 
zinc finger-Gal11P proteins via interaction of Gal11P and Gal4. A three-finger array is depicted as 
three colored spheres (as in Figure. 1) and Gal11P represents a fragment of the yeast Gal11P protein 
(aa 263–352)39. The alpha-Gal4 hybrid protein consists of a portion of the E. coli RNA polymerase 
alpha-subunit (aa 1–248, encompassing the amino-terminal domain and inter-domain linker) and a 




have  shown  that  multi‐finger  domains  built  from  these  modules  can  be  fused  to 
transcriptional  regulatory domains  (e.g.,  the NF‐KB p65 domain  or  the KRAB  repression 
domain)  to create artificial  transcription  factors capable of  regulating  specific endogenous 
genes (20,21,40,47–50). In addition, various sets of these modules have been linked together 
in  random  combinations  to  generate  libraries  of  artificial  zinc  finger  transcription  factors 
(24,26,28,29,42,51).  These  libraries  have  been  screened  to  identify  members  capable  of 
inducing  specific  cellular  phenotypes,  an  approach  that  may  be  useful  for  functional 
genomics  studies  (52).  The  reagents  we  describe  here  should  greatly  simplify  the 
construction of both specific individual and combinatorial libraries of zinc finger arrays for 
these applications. 






Figure A.3 | Overview of restriction digest-based modular assembly. Plasmids pc3XB-F1, -F2 and -
F3 encode individual hypothetical finger modules from the archive cloned into plasmid pc3XB. Each 
finger coding sequence is flanked on the 5’ end by unique XbaI and XmaI sites and on the 3’ end by 
unique AgeI, BsgI and BamHI sites. The configuration of unique flanking restriction sites in all pc3XB-
based plasmids permits any two fingers (e.g., F1 and F2) to be joined together by ligating a finger F1-
encoding vector backbone (linearized by digestion with AgeI and BamHI) to a finger F2-encoding 
fragment (released from the plasmid by digestion with XmaI and BamHI). The resulting plasmid 
encodes a two-finger (F1 followed by F2) array which again is flanked on the 5’ end by XbaI and 
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Figure A.3 | continued XmaI and on the 3’ end by AgeI, BsgI and BamHI. (Note that ligation of 
compatible XmaI and AgeI overhangs destroys both sites.) A third finger (F3) can be added to the 
array by ligating an F1/F2-encoding AgeI/BamHI-digested vector backbone to a F3-encoding 
XmaI/BamHI-digested fragment. Note that plasmid maps are not to scale. 
 
members of the Consortium have committed to ensuring that future vectors developed by 
their  labs will be  compatible with  the plasmid  frameworks described  in  this protocol. By 
standardizing all of the steps, from modular assembly to functional testing, to expression in 
the ultimate  target cells, we believe our  reagents and protocols will define  the  limitations 































































Plasmids  and  expression  vectors  The  following  kits  of  plasmids  (together  with 
detailed  sequence  and  map  information)  are  available  through  Addgene 







reporter  plasmid with  binding  site  for  the  zinc  finger  array  encoded  by  positive  control 
plasmid pGP‐FB‐origBA; CAM®, primary Fʹ and secondary oriV origins of replication. pAC‐














the  Introduction page, select ZiFiT  from  the menu and  login. First  time users will need  to 
create an account.  







Sequences  may  be  entered  as  raw  data  or  in  FASTA  format.  Spaces  and  numbers  are 
ignored.  
5| Select the number of fingers desired for each array from the Left Array and Right Array 





The double‐strand cleavage occurs  in  the spacer. For  the ZFNs encoded by  the expression 






as well  as  a  list  of  fingers  for  array  assembly.  Each  finger  is  color‐coded  to match  the 
nucleotide  triplet  it  recognizes  (note  that along  the primary  strand of DNA  [i.e.—the one 








9| Linking  together F1 and F2. Using  the output  from ZiFiT as a guide, assemble desired 
modules into a three‐finger domain. (Note that for simplicity in the steps below, we use the 
naming  convention  F1,  F2,  and  F3  to  specify  finger  positions  within  the  context  of  a 
hypothetical  three‐finger domain where F1  is  the amino‐terminal  finger, F2  is  the middle 



















































13|  Add  1  ml  of  SOC  medium  immediately  following  electroporation  and  transfer 
resuspended cells to a sterile 13 ml culture tube. Allow the cells to recover by growing them 
at 37 °C for 20 min.  
14|  Transfer  the  1 ml  of  culture  to  a  sterile microfuge  tube  and  centrifuge  for  30  s  at 
16,000gin  a microcentrifuge. Remove  all  but  approximately  100‐200 ml  of  the media  and 
















































































































desired  modules  (particularly  when  constructing  multiple  arrays).  Sequencing  can  be 















































Figure A.4 | Strategy for constructing B2H expression vectors and transformation of B2H reporter 
strains. Zinc finger arrays assembled in the pc3XB plasmid can be cloned directly into vectors 
designed to express zinc finger arrays as a Gal11P hybrid protein (for use in B2H assays) using the 
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Figure A.4 | continued unique XbaI and BsgI restriction sites. To perform B2H assays, the resulting 
plasmid (pGP-FB-F1/F2/F3) is co-transformed with the pAC-KAN-alphaGal4 plasmid into a ‘‘B2H 
reporter strain’’ harboring reporter plasmid pBAC-ZFBS-lacZ (ZFBS ¼ zinc finger binding site). Note 
that the pGP-FB-F1/F2/F3, the pAC-KAN-alphaGal4 and the pBAC-ZFBS-lacZ plasmids confer 
resistance to ampicillin, kanamycin and chloramphenicol, respectively. Note that plasmid maps are 







































lac  repressor.  This  ensures  repression  of  the  strong  lacUV5  promoter,  which  directs 
























Visualize  digestion  on  a  1.5%  agarose  gel.  The  desired  plasmid  should  yield  a  ~300  bp 
fragment. This plasmid expresses a zinc finger‐Gal11p fusion protein from a strong lacUV5 
promoter  that can be repressed by  lac repressor. We will refer  to  this plasmid as pGP‐FB‐
F1/F2/F3 in the protocol steps below.  


































cool  slowly  (over  ~1  h)  to  25  °C.  Annealed  oligonucleotides  will  form  a  short  double‐
stranded DNA fragment with the overhangs shown in Figure A,5.  
 



















that  is  only  active  in  the  presence  of  a  trans‐acting  factor  encoded  by  the  trfA  gene. 
Transformax EPI300 cells express  trfA  from an  inducible promoter  that we have  found  is 
inducible  with  arabinose  (S.T.B.  and  J.K.J.,  unpublished  data).  When  the  trfA  gene  is 
induced in Transformax EPI300cells, the copy number of pBAC‐lacZ plasmid is increased in 




to  inoculate  two  3 ml  cultures  of  LB  containing  12.5  μg ml–1  chloramphenicol  and  grow 
overnight (14–18 h) at 37 °C.  
? TROUBLESHOOTING  
36|  Inoculate  1  ml  of  each  overnight  culture  into  9  ml  of  LB  containing  14  μg  ml–1 











Figure A.5 | Strategy for constructing B2H reporter vectors. The top half of the figure illustrates the 
design and annealing of oligonucleotides comprising the zinc finger binding site as described in Box 
2. The bottom half of the figure illustrates digestion of the plasmid pBAC-lacZ with BsaI and 
generation of extended overhangs by treatment with Pfu polymerase in the presence of a single 
deoxynucleotide (dCTP). Treatment with Pfu under these conditions will generate the specific 
overhangs shown that are complementary to the overhangs of the annealed oligonucleotide cassette. 
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Figure A.5 | continued Ligation of the vector backbone to the annealed oligonucleotides will 
generate the desired pBAC-ZFBS-lacZ reporter vector. Note that plasmid maps are not to scale. 
 





















as  the pBAC‐ZFBS‐lacZ plasmid  (ZFBS = Zinc Finger Binding Site)  in subsequent steps of 
the protocol. 
39|  Transformation  of  E.  coli  cells with  B2H  reporter  and  expression  vectors.  Transform 
strain KJBAC1 (which constitutively expresses high levels of lac repressor) with the pBAC‐





containing 12.5 μg ml–1 chloramphenicol and  incubate overnight at 37  °C. We  refer  to  the 





41|  Make  chemically  competent  cells  from  each  of  the  B2H  reporter  strain  overnight 




42| Doubly  transform  the ZFBS B2H  reporter  strain with  the pGP‐FB‐F1/F2/F3 expression 
vector  prepared  in  Step  30  above  and  the  compatible  pAC‐KAN‐alphaGal4  expression 
plasmid encoding the alpha‐Gal4 hybrid protein (Figure A.4). As a positive control, doubly 
transform  the BA B2H  reporter  strain with  the pGP‐FB‐origBA and pAC‐KAN‐alphaGal4 
expression  plasmids.  As  a  negative  control  for  assaying  basal  transcription  of  the  lacZ 
reporter gene, doubly transform both the ZFBS and BA B2H reporter strains with the pGP‐
FB (expressing the Gal11P fragment with no accompanying zinc finger domain) and pAC‐











Although  one  can  readily  obtain  transformants  of  KJBAC1  that  harbor  pAC‐KAN‐
alphaGal4, we have sometimes encountered difficulties with  introducing  the  reporter and 
zinc  finger‐Gal11P  expression  plasmids  into  these  cells. However,  the  procedure works 
consistently as described (i.e., transforming KJBAC1 first with the reporter plasmid and then 






43|  β‐galactosidase  assay  of  doubly  transformed  B2H  reporter  strain  cells.  For  each 
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transformant  to  be  assayed,  inoculate  two  overnight  cultures  (each  from  an  independent 






44| Subculture  saturated overnight  cultures  from Step  43 by diluting  them 1:40  into pre‐
warmed  LB‐containing  100  μg  ml–1  ampicillin,  30  μg  ml–1  kanamycin,  12.5  μg  ml–1 
chloramphenicol,  10 mM ZnSO4  and  500  mM  IPTG.  Monitor  the  growth  of  cultures  by 
measuring OD600 (relative to a media only blank) on a spectrophotometer and harvest them 








46|  Set  up  b‐galactosidase  assay  by  adding  15  μl  of  lysate  to  a  microtiter  plate  well 




47| Place microtiter plate  containing  b‐galactosidase  assay  reactions  in  a microtiter plate 






















the  units  obtained  in  the  presence  of  the Gal11P  control.  In  our  experience,  zinc  finger 
domains  that  mediate  three‐fold  activation  or  higher  will  have  a  high  probability  of 





50|  As  outlined  in  Figure  A.6,  DNA  sequences  encoding  zinc  finger  arrays  that  show 
significant activity in the B2H system can be transferred by standard restriction digest‐based 
subcloning techniques to specially designed expression vectors that permit their expression 











Isolate  the  B300  bp  fragment  by  electrophoresis  on  a  1.5%  agarose  gel  followed  by 
purification using a QIAquick Gel Extraction kit.  















Extraction  kit.  For  expression  in  plants,  use  vector  pDW1775  (see  Figure  A.6).  For 
expression in mammalian cells, use vector pST1374 (see Figure A.6).  
52| Ligate the purified expression vector backbone from Step 51 to the purified zinc finger‐







































Visualize  the digestions on a 1.5% agarose gel. Candidates  that have  the zinc  finger array 
sequence successfully cloned in should yield a ~400 bp or a ~340 bp fragment for the plant 
or mammalian  expression  vectors,  respectively.  In  both  of  these  vectors,  the  zinc  finger 
array is expressed as a ZFN (i.e., is fused to the amino‐terminal domain of the FokI nuclease 
domain  by  a  four  amino  acid  linker  of  sequence  LRGS)  and  harbors  an  SV40  nuclear 
localization signal. An in‐frame AcV5 or FLAG epitope tag is also encoded by the plant or 
mammalian  expression  vectors,  respectively.  Following  insertion  of  the  DNA  fragment 






Figure A.6 | Strategy for constructing plant or human ZFN expression vectors. Zinc finger arrays 
tested in the B2H system can be directly cloned from a pGP-FB-F1/F2/F3 expression vector using the 
unique XbaI and BamHI sites into a vector designed to express ZFNs in either plant (pDW1775) or 
human (pST1374) cells. The epitope tag (tag) in the plant ZFN expression vector is AcV5 whereas it 
is FLAG in the human ZFN expression vector. The nuclear localization signal (NLS) in both vectors is 






























































































three‐finger domain using  the B2H  reporter assay  requires 12–14 d. Construction of ZFN 
expression vectors requires 3–5 d. Note  that because our protocol has simplified all of  the 




















site  but  do  not  account  for  its  specificity  in  the  context  of  genomic DNA  sequences. A 
mammalian  cell‐based  reporter  assay  for  zinc  finger binding has  also been described  (7). 
However,  this  assay  requires  transient  transfections  of  human  cells  and  is  subject  to 
variability in results depending upon the absolute and relative concentrations of expression 
and reporter plasmids  introduced  into the cells. By contrast, the B2H system only requires 
transformations  of  bacterial  cells  and  the  reporter  episome  in  this  assay  is  strictly 
maintained at single copy. Thus,  the B2H system requires a zinc finger array  to be able  to 
find  its  specific,  single  copy  target  sequence  in  the  presence  of  competing  chromosomal 
E.coli DNA, thereby providing a stringent test for both DNA‐binding affinity and specificity.  
Depending  upon  the  specific  application,  certain  ZFNs  generated  by  modular 
assembly may not provide sufficiently high rates of gene targeting and/or may exhibit toxic 
effects. Both of  these  issues have been observed with ZFNs created by modular assembly 
(7,12). Because  four‐finger ZFNs have been  reported  to work well  in human cells  (6), one 
possible alternative approach is to simply add an additional fourth finger to one or both of 
the ZFNs. However, certain target sites may require zinc finger arrays with greater affinities 
and/or specificities  than can be achieved with modular assembly.  In  these cases, one may 
need to consider the use of more labor‐intensive selection protocols that account for context‐
dependent  effects  on  DNA‐binding  (31,59,60).  In  our  experience,  multi‐finger  domains 
identified by  such  selection methods  can exhibit higher efficiencies of gene  targeting and 
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reduced  toxicities  relative  to  domains  created  by modular  assembly  (S.  Pruett,  J.K.J.,  & 
M.H.P., unpublished data).  
Another potential  reason  for  the  inability of modular  assembled ZFNs  to mediate 
high efficiency gene targeting can be poor expression levels. The codons we used to encode 
our zinc finger plasmids have not been fully optimized for plant or human expression. The 
steady‐state  levels  of  ZFN  expression  can  be  monitored  using  Western  blots  with  an 
antibody directed against an epitope tag encoded in all of our expression vectors (AcV5 or 
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dedicates  this protocol  to  the memory of Robert L. Burghoff, a patient  teacher and  friend 
who always knew how to make molecular biology experiments work. Note added in proof: 
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Supplemental Table A.S1 | List of zinc finger modules cloned in the standardized pc3XB plasmid 
vector framework.  All zinc finger modules shown have been cloned into plasmid pc3XB (described in 
the text, also see Figure 3). Each module is assigned a unique ID (ID #) which is used by the ZiFiT 
software in its outputs. Plasmids encoding each module are named according to the convention 
pc3XB-“ID#” as described in the text (also see Figure 3). Original source and a reference are 
provided for each module (Source/Reference). Published DNA-binding specificities (Target 
Sequence) for each module are also shown (abbreviation: R=G or A). Finger position indicates 
whether a module was designed to function at a particular position within the context of a three-finger 
domain (F1 indicates the amino-terminal position, F2 the middle position, and F3 the carboxy-terminal 
position). The full amino acid sequence for each module is shown (Finger Sequence) with the 
recognition helix residues (-1, 1, 2, 3, 4, 5, and 6, numbered relative to the start of the finger alpha-





Finger Finger Sequence 
ZF1 SGMO;ref.1 GAA F1 PGEKPHICHIQGCGKVYGQRSNLVRHLRWH 
ZF2 SGMO;ref.1 GAC F1 PGEKPHICHIQGCGKVYGDRSNLTRHLRWH 
ZF3 SGMO;ref.1 GAG F1 PGEKPHICHIQGCGKVYGRSDNLARHLRWH 
ZF4 SGMO;ref.1 GAT F1 PGEKPHICHIQGCGKVYGQSSNLARHLRWH 
ZF5 SGMO;ref.1 GCA F1 PGEKPHICHIQGCGKVYGQSGSLTRHLRWH 
ZF6 SGMO;ref.1 GCC F1 PGEKPHICHIQGCGKVYGERGTLARHLRWH 
ZF7 SGMO;ref.1 GCG F1 PGEKPHICHIQGCGKVYGRSDDLTRHLRWH 
ZF8 SGMO;ref.1 GCT F1 PGEKPHICHIQGCGKVYGQSSDLTRHLRWH 
ZF9 SGMO;ref.1 GGA F1 PGEKPHICHIQGCGKVYGQSGHLARHLRWH 
ZF10 SGMO;ref.1 GGC F1 PGEKPHICHIQGCGKVYGDRSHLTRHLRWH 
ZF11 SGMO;ref.1 GGG F1 PGEKPHICHIQGCGKVYGRSDHLARHLRWH 
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ZF12 SGMO;ref.1 GGT F1 PGEKPHICHIQGCGKVYGQSSHLTRHLRWH 
ZF13 SGMO;ref.1 GTA F1 PGEKPHICHIQGCGKVYGQSGALTRHLRWH 
ZF14 SGMO;ref.1 GTC F1 PGEKPHICHIQGCGKVYGDRSALARHLRWH 
ZF15 SGMO;ref.1 GTG F1 PGEKPHICHIQGCGKVYGRSDALTRHLRWH 
ZF16 SGMO;ref.1 GTT F1 PGEKPHICHIQGCGKVYGTTSALTRHLRWH 
ZF17 SGMO;ref.2 AGA F1 PGEKPHICHIQGCGKVYGKNWKLQAHLRWH 
ZF18 SGMO;ref.1 GAA F2 PGERPFMCTWSYCGKRFTQSGNLARHKRTH 
ZF19 SGMO;ref.1 GAC F2 PGERPFMCTWSYCGKRFTDRSNLTRHKRTH 
ZF20 SGMO;ref.1 GAG F2 PGERPFMCTWSYCGKRFTRSDNLARHKRTH 
ZF21 SGMO;ref.1 GAT F2 PGERPFMCTWSYCGKRFTTSGNLVRHKRTH 
ZF22 SGMO;ref.1 GCA F2 PGERPFMCTWSYCGKRFTQSGDLTRHKRTH 
ZF23 SGMO;ref.1 GCG F2 PGERPFMCTWSYCGKRFTRSDDLQRHKRTH 
ZF24 SGMO;ref.1 GCT F2 PGERPFMCTWSYCGKRFTQSSDLTRHKRTH 
ZF25 SGMO;ref.1 GGA F2 PGERPFMCTWSYCGKRFTQSGHLQRHKRTH 
ZF26 SGMO;ref.1 GGC F2 PGERPFMCTWSYCGKRFTDRSHLARHKRTH 
ZF27 SGMO;ref.1 GGG F2 PGERPFMCTWSYCGKRFTRSDHLTRHKRTH 
ZF28 SGMO;ref.1 GGT F2 PGERPFMCTWSYCGKRFTTSGHLVRHKRTH 
ZF29 SGMO;ref.1 GTA F2 PGERPFMCTWSYCGKRFTQSGALARHKRTH 
ZF30 SGMO;ref.1 GTC F2 PGERPFMCTWSYCGKRFTDRSALARHKRTH 
ZF31 SGMO;ref.1 GTG F2 PGERPFMCTWSYCGKRFTRSDALSRHKRTH 
ZF32 SGMO;ref.1 GTT F2 PGERPFMCTWSYCGKRFTTSGALTRHKRTH 
ZF33 SGMO;ref.1 GCC F2 PGERPFMCTWSYCGKRFTDRSDLTRHKRTH 
ZF34 SGMO;ref.3 TGG F2 PGERPFMCTWSYCGKRFTRSDHLTTHKRTH 
ZF35 SGMO;ref.2 TTG F2 PGERPFMCTWSYCGKRFTRADALMVHKRTH 
ZF36 SGMO;ref.1 GAA F3 PGEKKFACPECPKRFMQSGNLARHIKTH 
ZF37 SGMO;ref.1 GAC F3 PGEKKFACPECPKRFMDRSNLTRHIKTH 
ZF38 SGMO;ref.1 GAG F3 PGEKKFACPECPKRFMRSDNLTRHIKTH 
ZF39 SGMO;ref.1 GAT F3 PGEKKFACPECPKRFMTSANLSRHIKTH 
ZF40 SGMO;ref.1 GCA F3 PGEKKFACPECPKRFMQSGDLTRHIKTH 
ZF41 SGMO;ref.1 GCC F3 PGEKKFACPECPKRFMDRSDLTRHIKTH 
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ZF42 SGMO;ref.1 GCG F3 PGEKKFACPECPKRFMRSDDLTRHIKTH 
ZF43 SGMO;ref.1 GCT F3 PGEKKFACPECPKRFMQSSDLQRHIKTH 
ZF44 SGMO;ref.1 GGA F3 PGEKKFACPECPKRFMQSGHLQRHIKTH 
ZF45 SGMO;ref.1 GGC F3 PGEKKFACPECPKRFMDRSHLARHIKTH 
ZF46 SGMO;ref.1 GGT F3 PGEKKFACPECPKRFMTSGHLVRHIKTH 
ZF47 SGMO;ref.1 GTA F3 PGEKKFACPECPKRFMQRASLTRHIKTH 
ZF48 SGMO;ref.1 GTC F3 PGEKKFACPECPKRFMDRSALARHIKTH 
ZF49 SGMO;ref.1 GTG F3 PGEKKFACPECPKRFMRSDALTRHIKTH 
ZF50 SGMO;ref.1 GTT F3 PGEKKFACPECPKRFMQSSALTRHIKTH 
ZF51 SGMO;ref.1 GGG F3 PGEKKFACPECPKRFMRSDHLSRHIKTH 
ZF52 SGMO;ref.3 AAG F3 PGEKKFACPECPKRFMRSDNLTQHIKTH 
ZF53 SGMO;ref.4 AGG F3 PGEKKFACPECPKRFMRSDHLTQHIKTH 
ZF54 SGMO;ref.5 CGG F3 PGEKKFACPECPKRFMRSDNLTEHIKTH 
ZF55 SGMO;ref.2 CTG F3 PGEKKFACPECPKRFMRSDALREHIKTH 
ZF56 SGMO;ref.6 TGA F3 PGEKKFACPECPKRFMQSGHLTKHIKTH 
ZF57 SGMO;ref.7 TGG F3 PGEKKFACPECPKRFMRSDHLTTHIKTH 
ZF58 Barbas;ref.8 GGG N/A PGEKPYKCPECGKSFSRSDKLVRHQRTH 
ZF59 Barbas;ref.8 GGA N/A PGEKPYKCPECGKSFSQRAHLERHQRTH 
ZF60 Barbas;ref.8 GGT N/A PGEKPYKCPECGKSFSTSGHLVRHQRTH 
ZF61 Barbas;ref.8 GGC N/A PGEKPYKCPECGKSFSDPGHLVRHQRTH 
ZF62 Barbas;ref.8 GAG N/A PGEKPYKCPECGKSFSRSDNLVRHQRTH 
ZF63 Barbas;ref.8 GAA N/A PGEKPYKCPECGKSFSQSSNLVRHQRTH 
ZF64 Barbas;ref.8 GAT N/A PGEKPYKCPECGKSFSTSGNLVRHQRTH 
ZF65 Barbas;ref.8 GAC N/A PGEKPYKCPECGKSFSDPGNLVRHQRTH 
ZF66 Barbas;ref.8 GTG N/A PGEKPYKCPECGKSFSRSDELVRHQRTH 
ZF67 Barbas;ref.8 GTA N/A PGEKPYKCPECGKSFSQSSSLVRHQRTH 
ZF68 Barbas;ref.8 GTT N/A PGEKPYKCPECGKSFSTSGSLVRHQRTH 
ZF69 Barbas;ref.8 GTC N/A PGEKPYKCPECGKSFSDPGALVRHQRTH 
ZF70 Barbas;ref.8 GCG N/A PGEKPYKCPECGKSFSRSDDLVRHQRTH 
ZF71 Barbas;ref.8 GCA N/A PGEKPYKCPECGKSFSQSGDLRRHQRTH 
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ZF72 Barbas;ref.8 GCT N/A PGEKPYKCPECGKSFSTSGELVRHQRTH 
ZF73 Barbas;ref.8 GCC N/A PGEKPYKCPECGKSFSDCRDLARHQRTH 
ZF74 Barbas;ref.9 AAA N/A PGEKPYKCPECGKSFSQRANLRAHQRTH 
ZF75 Barbas;ref.9 AAC N/A PGEKPYKCPECGKSFSDSGNLRVHQRTH 
ZF76 Barbas;ref.9 AAG N/A PGEKPYKCPECGKSFSRKDNLKNHQRTH 
ZF77 Barbas;ref.9 AAT N/A PGEKPYKCPECGKSFSTTGNLTVHQRTH 
ZF78 Barbas;ref.9 ACA N/A PGEKPYKCPECGKSFSSPADLTRHQRTH 
ZF79 Barbas;ref.9 ACC N/A PGEKPYKCPECGKSFSDKKDLTRHQRTH 
ZF80 Barbas;ref.9 ACG N/A PGEKPYKCPECGKSFSRTDTLRDHQRTH 
ZF81 Barbas;ref.9 ACT N/A PGEKPYKCPECGKSFSTHLDLIRHQRTH 
ZF82 Barbas;ref.9 AGA N/A PGEKPYKCPECGKSFSQLAHLRAHQRTH 
ZF83 Barbas;ref.9 AGC N/A PGEKPYKCPECGKSFSERSHLREHQRTH 
ZF84 Barbas;ref.9 AGG N/A PGEKPYKCPECGKSFSRSDHLTNHQRTH 
ZF85 Barbas;ref.9 AGT N/A PGEKPYKCPECGKSFSHRTTLTNHQRTH 
ZF86 Barbas;ref.9 ATA N/A PGEKPYKCPECGKSFSQKSSLIAHQRTH 
ZF87 Barbas;ref.9 ATG N/A PGEKPYKCPECGKSFSRRDELNVHQRTH 
ZF88 Barbas;ref.9 ATT N/A PGEKPYKCPECGKSFSHKNALQNHQRTH 
ZF89 Barbas;ref.10 CAA N/A PGEKPYKCPECGKSFSQSGNLTEHQRTH 
ZF90 Barbas;ref.10 CAC N/A PGEKPYKCPECGKSFSSKKALTEHQRTH 
ZF91 Barbas;ref.10 CAG N/A PGEKPYKCPECGKSFSRADNLTEHQRTH 
ZF92 Barbas;ref.10 CAT N/A PGEKPYKCPECGKSFSTSGNLTEHQRTH 
ZF93 Barbas;ref.10 CCA N/A PGEKPYKCPECGKSFSTSHSLTEHQRTH 
ZF94 Barbas;ref.10 CCC N/A PGEKPYKCPECGKSFSSKKHLAEHQRTH 
ZF95 Barbas;ref.10 CCG N/A PGEKPYKCPECGKSFSRNDTLTEHQRTH 
ZF96 Barbas;ref.10 CCT N/A PGEKPYKCPECGKSFSTKNSLTEHQRTH 
ZF97 Barbas;ref.10 CGA N/A PGEKPYKCPECGKSFSQSGHLTEHQRTH 
ZF98 Barbas;ref.10 CGC N/A PGEKPYKCPECGKSFSHTGHLLEHQRTH 
ZF99 Barbas;ref.10 CGG N/A PGEKPYKCPECGKSFSRSDKLTEHQRTH 
ZF100 Barbas;ref.10 CGT N/A PGEKPYKCPECGKSFSSRRTCRAHQRTH 
ZF101 Barbas;ref.10 CTA N/A PGEKPYKCPECGKSFSQNSTLTEHQRTH 
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ZF102 Barbas;ref.10 CTG N/A PGEKPYKCPECGKSFSRNDALTEHQRTH 
ZF103 Barbas;ref.10 CTT N/A PGEKPYKCPECGKSFSTTGALTEHQRTH 
ZF104 Barbas;ref.11 TAG N/A PGEKPYKCPECGKSFSREDNLHTHQRTH 
ZF105 Barbas;ref.11 TGA N/A PGEKPYKCPECGKSFSQAGHLASHQRTH 
ZF106 Barbas;ref.11 TGG N/A PGEKPYKCPECGKSFSRSDHLTTHQRTH 
ZF107 ToolGen;ref.12 GAC N/A PGEKPYKCKQCGKAFGCPSNLRRHGRTH 
ZF108 ToolGen;ref.12 GCC N/A PGEKPYTCSDCGKAFRDKSCLNRHRRTH 
ZF109 ToolGen;ref.12 GTC N/A PGEKPFMCTWSYCGKRFTDRSALARHKRTH 
ZF110 ToolGen;ref.12 GAC N/A PGEKPYKCKECGKAFNHSSNFNKHHRIH 
ZF111 ToolGen;ref.12 GTT N/A PGEKPFKCPVCGKAFRHSSSLVRHQRTH 
ZF112 ToolGen;ref.12 GAT N/A PGEKPYRCKYCDRSFSISSNLQRHVRNIH 
ZF113 ToolGen;ref.12 GAG N/A PGEKPYGCHLCGKAFSKSSNLRRHEMIH 
ZF114 ToolGen;ref.12 GGA N/A PGEKPYKCKECGQAFRQRAHLIRHHKLH 
ZF115 ToolGen;ref.12 GAG N/A PGEKPYKCHQCGKAFIQSFNLRRHERTH 
ZF116 ToolGen;ref.12 GAA N/A PGEKPFQCNQCGASFTQKGNLLRHIKLH 
ZF117 ToolGen;ref.12 GGA N/A PGEKPYKCGQCGKFYSQVSHLTRHQKIH 
ZF118 ToolGen;ref.12 GGA N/A PGEKPYVCRECGRGFRQHSHLVRHKRTH 
ZF119 ToolGen;ref.12 AGA N/A PGEKPYKCEECGKAFRQSSHLTTHKIIH 
ZF120 ToolGen;ref.12 CGA N/A PGEKPYECDHCGKSFSQSSHLNVHKRTH 
ZF121 ToolGen;ref.12 CAA N/A PGEKPYMCSECGRGFSQKSNLIIHQRTH 
ZF122 ToolGen;ref.12 GAA N/A PGEKPYKCEECGKAFTQSSNLTKHKKIH 
ZF123 ToolGen;ref.12 GAA N/A PGEKPFECKDCGKAFIQKSNLIRHQRTH 
ZF124 ToolGen;ref.12 GAA N/A PGEKPYECEKCGKAFNQSSNLTRHKKSH 
ZF125 ToolGen;ref.12 CAA N/A PGEKPYVCSKCGKAFTQSSNLTVHQKIH 
ZF126 ToolGen;ref.12 GTA N/A PGEKPYKCPDCGKSFSQSSSLIRHQRTH 
ZF127 ToolGen;ref.12 GTA N/A PGEKPYKCEECGKAFNQSSTLTRHKIVH 
ZF128 ToolGen;ref.12 CGA N/A PGEKPYECHDCGKSFRQSTHLTQHRRIH 
ZF129 ToolGen;ref.12 GGA N/A PGEKPYECHDCGKSFRQSTHLTRHRRIH 
ZF130 ToolGen;ref.12 GCG N/A PGEKPYVCDVEGCTWKFARSDELNRHKKRH 
ZF131 ToolGen;ref.12 GGG N/A PGEKPFLCQYCAQRFGRKDHLTRHMKKSH 
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ZF132 ToolGen;ref.12 AGG N/A PGEKPFQCKTCQRKFSRSDHLKTHTRTH 
ZF133 ToolGen;ref.12 GGG N/A PGEKPYVCDVEGCTWKFARSDKLNRHKKRH 
ZF134 ToolGen;ref.12 GGG N/A PGEKPYKCMECGKAFNRRSHLTRHQRIH 
ZF135 ToolGen;ref.12 GAG N/A PGEKPYICRKCGRGFSRKSNLIRHQRTH 
ZF136 ToolGen;ref.12 GAG N/A PGEKPYECKECGKAFSSGSNFTRHQRIH 
ZF137 ToolGen;ref.12 AAT N/A PGEKPYECDHCGKAFSVSSNLNVHRRIH 
ZF138 ToolGen;ref.12 GTG N/A PGEKPYTCKQCGKAFSVSSSLRRHETTH 
ZF139 ToolGen;ref.12 GCT N/A PGEKPYECNYCGKTFSVSSTLIRHQRIH 
ZF140 ToolGen;ref.12 GGT N/A PGEKPYRCEECGKAFRWPSNLTRHKRIH 
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to  a  nuclease  domain.  Dimers  of  ZFNs  can  create  targeted  double‐strand  DNA 
breaks,  which  can  stimulate  highly  efficient  gene  targeting  in  many  cell  types1 
(Supplementary Figure B.S1 online). We  found  that  the modular assembly method 
of  engineering  zinc‐finger  arrays  has  an  unexpectedly  higher  failure  rate  than 
previously  reported. Modular  assembly  advocates  linking  individual  zinc  fingers, 
each of which typically binds to a 3‐bp ‘subsite’ (Supplementary Figure B.S2 online). 






initial  experiences  using  these  reagents  suggested  that  modular  assembly  was 
inefficient (Supplementary Discussion and Supplementary Table B.S1 online). 
To perform a larger‐scale test, we assembled 168 zinc‐finger arrays designed 
for  104  diverse  target DNA  sites  (Supplementary  Table  B.S2  and  Supplementary 
Methods online). We tested these domains for DNA binding using a bacterial two‐
hybrid (B2H) assay (6), which accurately identifies arrays that lack activity as ZFNs 
in  human  cells  (Supplementary Discussion  and  Supplementary  Figures.  B.S3  and 
B.S4 online). For 79 of  the 104  target  sites, we did not obtain a  single  three‐finger 
array  that  scored positively  in  the B2H assay  (overall  failure  rate of ~76%; Fig. 1a 
and Supplementary Table B.S2). Notably, modular assembly was  far  less effective 
for  target  sites  composed  of  two,  one,  or  no GXX  subsites  (where X  is  any  base) 
compared with  those composed of  three GXX subsites  (Figure B.1A). Additionally, 
because  ZFNs  function  as  dimers,  we  would  expect  failure  rates  for  making  a 




arrays  that  are  positive  in  the  B2H  assay will  be  active  as  ZFNs  in  human  cells 
(Supplementary Figure B.S4). 
One  reason  for  the  apparent  discrepancy  between  previously  published 
studies2,3 and our results is that the former primarily used 9‐bp sites composed of 
two or  three GXX  subsites, whereas we used  sites with a more varied number of 
GXX subsites (Figure B.1B); this difference will critically affect the observed failure 
rate  (Figure  B.1A).  Our  study  represents  a more meaningful  evaluation  because 







Methods). Highly  effective  but more  labor‐intensive  selection‐based methods  for 
engineering  zinc  finger  arrays  have  been  previously  described  (Supplementary 





Figure B.1 | Large-scale evaluation of the modular assembly method for engineering zinc-finger 
arrays. A) Data for success and failure of modular assembly as judged by the B2H assay for all 104 
target DNA sites (see Supplementary Discussion for definition of success threshold) and for 
subsets of target sites containing three, two, one or no GXX subsites. ‘Successful’ sites are those for 
which at least one functional zinc-finger array was identified; ‘failed’ sites are those for which we 
failed to obtain a single successful array (see Supplementary Table 2 for details). Predicted failure 
rates for each set of target sites are indicated above the bars. B) Distributions of target DNA sites 
used in different modular assembly evaluation studies according to the number of GXX subsites 
present. The distribution of all 107,011 potential 9-bp sites that can be targeted using 141 zinc-finger 
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Supplementary Figure B.S1 ZFNs induce highly efficient gene targeting events.  (a) Schematic of a 
ZFN monomer (left) and a pair of ZFNs cleaving DNA as a dimer (right). (b) Schematic representing 
ZFN-enhanced recombination-based genome manipulation. ZFNs introduce site-specific double-
strand DNA breaks (DSBs) that can be harnessed to mediate gene targeting via homologous 






Supplementary Figure B.S2 Schematic illustrating the “modular assembly” method of engineering 
multi-finger domains Fingers from archives of pre-characterized modules are joined together to create 
three- finger domains capable of recognizing a 9 bp target DNA site. Single fingers (colored  spheres) 






Supplementary Figure B.S3 Schematic of the bacterial two-hybrid (B2H) reporter used to assess 
DNA-binding activities of zinc finger arrays.  In the B2H assay, the ability of a zinc finger array to bind 
a target DNA site is reflected as increased expression of a lacZ reporter gene encoding β-
galactosidase (1-3). The B2H requires the expression of two hybrid proteins: one a fusion between 
the test zinc finger array (ZFA) and a fragment of the yeast Gal11P protein (GP) and the other a 
hybrid of the RNA polymerase α-subunit and a fragment of the yeast Gal4 protein (G4). If the test 
ZFA binds to a target DNA site positioned upstream of a promoter, RNA polymerase complexes that 
have incorporated Rα hybrid proteins are recruited to the promoter and expression of the downstream 





Supplementary Figure B.S4 The B2H assay identifies zinc-finger arrays that fail to show significant 
activity as ZFNs in human cells.  23 different zinc-finger arrays (pink and light blue bars) which 
activated transcription in the B2H assay to various levels (fold-activations are indicated in 
parentheses on the x-axis) were tested as homodimeric ZFNs using a previously described human 
cell-based episomal recombination (HR) assay (1). The names of these 23 zinc-finger arrays are 
shown on the x-axis and details about their binding sites and the modules used to construct them can 
be found in Supplementary Tables B.S1 and B.S2 online. ZFN activity is reported as a percentage of 
EGFP-rescue relative to an I-SceI control. In addition, the episomal repair activities of control ZFNs 
previously shown to lack or possess significant activity as ZFNs on chromosomal targets in human 
cells (1) are shown for comparison (red and blue bars, respectively). Names of the control ZFNs are 
shown on the x-axis and are as previously described (1). Means of at least three independent 
experiments and standard deviations (error bars) are shown. ZFNs with mean episomal repair 
activities that are significantly higher than that of the inactive EB0 ZFN are indicated with one 
(p<0.05) or two (p<0.01) red asterisks. The expression levels of all ZFNs shown were verified by 




1.   Cornu, T.  I. et al.  (2008) DNA‐binding Specificity  Is a Major Determinant of  the 
Activity and Toxicity of Zinc‐finger Nucleases. Mol Ther 16, 352‐8.  
 
Supplementary Table B.S1 |   Small-scale tests of modular assembly using various activity assays.  
Thirty-six three-finger arrays (named “ZFA __” for zinc finger array) were assembled using modules 
based on the Zinc Finger Consortium Modular Assembly Kit 1.0 (1), and the identities of the three 
modules used to construct each three-finger array use the Consortium numbering scheme (F1, F2, 
and F3 are the amino-terminal, middle, and carboxy-terminal fingers, respectively).  All target binding 
sites are written 5’ to 3’ (note that the F3 module binds to the 5’ most triplet subsite while F1 binds to 
the 3’ most triplet subsite).  The number of GXX subsites in each target site is also indicated. For nine 
of the arrays, the amino acid sequence of the zinc finger backbone differs from the modules in the 
archive.  These arrays are noted in the far left column by a double asterisk, and their complete amino 
acid sequences are available upon request.  
Activity of 27 arrays was tested by electrophoretic mobility shift assays (EMSA).  A plus sign 
in the far right column indicates that the finger array caused a shift in mobility of a double-stranded 
oligonucleotide corresponding to the intended target sequence on polyacrylamide gels.  In all cases, 
binding could be competed away with an excess of the target oligonucleotide.  Western blots were 
performed for all zinc finger arrays to ensure they were expressed.    
Plant single-strand annealing (PSSA) assays (see Supplementary Methods online) were 
used to assess function of seven arrays, five of which were also tested by EMSA.  The PSSA assay 
tests the ability of the zinc finger array to function as a ZFN.  A minus sign in the table indicates that 
activity was comparable to negative controls in which plant protoplasts were not transformed with the 
ZFN construct.   
An episomal recombination (HR) assay was used to assess the activity of nine ZFNs in 
human 293T cells (see Supplementary Methods online). A plus sign indicates that ZFN activity in 
stimulating HR was >40% as compared to the activity of a control I-SceI meganuclease on the same 
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Supplementary Table B.S1 | continued target locus. *EMSA, electrophoretic mobility shift assay; a 
positive value indicates DNA binding that could be competed away by an excess of an 
oligonucleotide corresponding to the target site.  PSSA, plant single-strand annealing assay; a 
positive value indicates reporter gene function that is at least two-fold over background controls. HR, 
episomal recombination assay; a positive value indicates at least 40% activity as compared to I-SceI 
on the same target template. For further information on the activity assays, see Supplementary 
Methods online. **Finger arrays with backbone sequences that differ from the ZF finger archive. 
***Finger arrays previously described (2). 
 
Activity* 
ID#  F1  F2  F3  Target Sequence (F3-F2-F1) 
# GXX 
subsites Assay Results 
ZFA 1  73  72  60  5’-GGT-GCT-GCC-3’ 3 EMSA - 
ZFA 2  72  72  106 5’-TGG-GCT-GCT-3’ 2 EMSA - 
ZFA 3  15  19  43  5’-GCT-GAC-GTG-3’ 3 EMSA - 
ZFA 4  14  30  53  5’-AGG-GTC-GTC-3’ 2 EMSA - 
ZFA 5  12  23  44  5’-GGA-GCG-GGT-3’ 3 EMSA - 
ZFA 6  64  73  63  5’-GAA-GCC-GAT-3’ 3 EMSA - 
ZFA 7  58  72  59  5’-GGA-GCT-GGG-3’ 3 EMSA - 
ZFA 8  67  60  64  5’-GAT-GGT-GTA-3’ 3 EMSA - 
ZFA 9  61  61  63  5’-GAA-GGC-GGC-3’ 3 EMSA - 
ZFA 10  70  61  59  5’-GGA-GGC-GCG-3’ 3 EMSA - 
ZFA 11  10  23  40  5’-GCA-GCG-GGC-3’ 3 EMSA - 
ZFA 12**  15  19  43  5’-GCT-GAC-GTG-3’ 3 EMSA - 
ZFA 13**  4  21  39  5’-GAT-GAT-GAT-3’ 3 EMSA - 
ZFA 14**  15  31  132 5’-AGG-GTG-GTG-3’ 2 EMSA - 
ZFA 15  61  70  71  5’-GCA-GCG-GGC-3’ 3 EMSA + 
ZFA 16  62  68  63  5’-GAA-GTT-GAG-3’ 3 EMSA + 
ZFA 17  60  70  59  5’-GGA-GCG-GGT-3’ 3 EMSA + 
ZFA 18  67  66  65  5’-GAC-GTG-GTA-3’ 3 EMSA + 
ZFA 19  66  66  84  5’-AGG-GTG-GTG-3’ 2 EMSA + 
ZFA 20  62  62  62  5’-GAG-GAG-GAG-3’ 3 EMSA + 
EMSA - ZFA 21**  67  31  65  5’-GAC-GTG-GTA-3’ 3 PSSA - 
EMSA - ZFA 22**  8  24  57  5’-TGG-GCT-GCT-3’ 2 PSSA - 
EMSA - ZFA 23  15  31  49  5’-GTG-GTG-GTG-3’ 3 PSSA - 
EMSA - ZFA 24**  8  24  43  5’-GCT-GCT-GCT-3’ 3 PSSA - 




ZFA 26**  15  31  84  5’-AGG-GTG-GTG-3’ 2 PSSA - 
ZFA 27**  13  31  37  5’-GAC-GTG-GTA-3’ 3 PSSA - 
HR - ZFA 28***  61  65  65  5’-GAC-GAC-GGC-3’ 3 EMSA - 
ZFA 29  100  96  75  5’-AAC-CCT-CGT-3’ 0 HR - 
ZFA 30  61  80  61  5’-GGC-ACG-GGC-3’ 2 HR - 
ZFA 31  91  104  85  5’-AGT-TAG-CAG-3’ 0 HR - 
ZFA 32  83  103  104 5’-TAG-CTT-AGC-3’ 0 HR - 
ZFA 33  83  68  74  5’-AAA-GTT-AGC-3’ 1 HR - 
ZFA 34  100  104  72  5’-GCT-TAG-CGT-3’ 1 HR - 
ZFA 35  17  25  119 5’-AGA-GGA-AGA-3’ 1 HR - 










Supplementary Table B.S2 |  Modularly assembled zinc finger arrays, cognate target binding sites, 
and their activities in the B2H assay.  See legend to Supplementary Table B.S1 online for 
descriptive detail pertaining to each of this table’s columns.  In addition, the original source of the 
modules used to construct each array (B=Barbas group (1), S=Sangamo Biosciences (2,3), and 
T=Toolgen, Inc (4).) is indicated.  Because the Zinc Finger Consortium Modular Assembly Kit 1.0 
includes more than one module for certain subsites (3), we were able to construct 168 zinc finger 
arrays that could potentially recognize the 104 different target sites.  Additional details regarding the 
construction of the B2H zinc finger expression plasmids and the B2H binding site reporter plasmids 
are provided in Supplementary Methods online. Fold-activation of transcription in the B2H assay 
was determined for each zinc finger array using β-galactosidase assays as previously described (5).
 
β-galactosidase assays for each zinc finger array were performed a minimum of four times and 
means and standard errors of the mean are shown.  The expression of all zinc finger arrays that 
failed to activate transcription by more than 1.57-fold in the B2H assay were verified by Western blot 
using a monoclonal antibody which detects a FLAG epitope present on all arrays (data not shown). 
 









ZFA 37  75  75  74  B  5'-AAA-AAC-AAC-3' 0  1.152  0.030 
ZFA 38  91  78  74  B  5'-AAA-ACA-CAG-3' 0  1.097  0.030 
ZFA 39  73  91  74  B  5'-AAA-CAG-GCC-3' 1  1.325  0.095 
ZFA 40  100 101 74  B  5'-AAA-CTA-CGT-3' 0  1.347  0.037 
ZFA 41  83  68  74  B  5'-AAA-GTT-AGC-3' 1  1.166  0.106 
ZFA 42  91  93  75  B  5'-AAC-CCA-CAG-3' 0  0.974  0.075 
ZFA 43  68  93  75  B  5'-AAC-CCA-GTT-3' 1  0.980  0.010 
ZFA 44  100 96  75  B  5'-AAC-CCT-CGT-3' 0  0.900  0.105 
ZFA 45  64  86  77  B  5'-AAT-ATA-GAT-3' 1  1.606  0.037 
ZFA 46  90  75  78  B  5'-ACA-AAC-CAC-3' 0  0.850  0.022 
ZFA 47  85  75  79  B  5'-ACC-AAC-AGT-3' 0  1.001  0.028 
ZFA 48  86  83  79  B  5'-ACC-AGC-ATA-3' 0  1.036  0.028 
ZFA 49  83  100 79  B  5'-ACC-CGT-AGC-3' 0  1.235  0.016 
ZFA 50  63  59  79  B  5'-ACC-GGA-GAA-3' 2  1.386  0.068 
ZFA 51  91  83  80  B  5'-ACG-AGC-CAG-3' 0  0.955  0.027 
ZFA 52  72  91  80  B  5'-ACG-CAG-GCT-3' 1  1.236  0.007 
ZFA 53  70  95  80  B  5'-ACG-CCG-GCG-3' 1  1.266  0.040 
ZFA 54  100 65  80  B  5'-ACG-GAC-CGT-3' 1  1.799  0.060 
ZFA 55  71  73  80  B  5'-ACG-GCC-GCA-3' 2  1.295  0.031 
ZFA 56  82  59  82  B  5'-AGA-GGA-AGA-3' 1  1.287  0.021 
ZFA 57  119 117 119 T  5'-AGA-GGA-AGA-3' 1  0.911  0.012 
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ZFA 58  119 114 119 T  5'-AGA-GGA-AGA-3' 1  1.928  0.082 
ZFA 59  119 129 119 T  5'-AGA-GGA-AGA-3' 1  1.974  0.066 
ZFA 60  119 118 119 T  5'-AGA-GGA-AGA-3' 1  2.371  0.047 
ZFA 61  64  69  83  B  5'-AGC-GTC-GAT-3' 2  1.206  0.019 
ZFA 62  103 88  85  B  5'-AGT-ATT-CTT-3' 0  1.015  0.022 
ZFA 64  91  104 85  B  5'-AGT-TAG-CAG-3' 0  0.879  0.092 
ZFA 65  85  93  86  B  5'-ATA-CCA-AGT-3' 0  0.989  0.017 
ZFA 66  78  81  87  B  5'-ATG-ACT-ACA-3' 0  0.956  0.043 
ZFA 67  92  90  87  B  5'-ATG-CAC-CAT-3' 0  1.122  0.068 
ZFA 68  78  96  88  B  5'-ATT-CCT-ACA-3' 0  1.064  0.135 
ZFA 69  95  72  88  B  5'-ATT-GCT-CCG-3' 1  1.256  0.016 
ZFA 70  63  98  90  B  5'-CAC-CGC-GAA-3' 1  1.099  0.011 
ZFA 71  60  67  90  B  5'-CAC-GTA-GGT-3' 2  1.476  0.023 
ZFA 72  86  98  92  B  5'-CAT-CGC-ATA-3' 0  0.985  0.027 
ZFA 74  90  100 93  B  5'-CCA-CGT-CAC-3' 0  1.173  0.034 
ZFA 75  73  64  93  B  5'-CCA-GAT-GCC-3' 2  1.085  0.006 
ZFA 76  103 85  94  B  5'-CCC-AGT-CTT-3' 0  1.376  0.153 
ZFA 77  66  100 94  B  5'-CCC-CGT-GTG-3' 1  1.431  0.069 
ZFA 78  80  79  95  B  5'-CCG-ACC-ACG-3' 0  1.090  0.020 
ZFA 79  74  91  95  B  5'-CCG-CAG-AAA-3' 0  1.123  0.009 
ZFA 80  100 98  95  B  5'-CCG-CGC-CGT-3' 0  1.146  0.074 
ZFA 81  86  63  95  B  5'-CCG-GAA-ATA-3' 1  0.907  0.048 
ZFA 82  91  80  96  B  5'-CCT-ACG-CAG-3' 0  1.013  0.037 
ZFA 83  90  81  96  B  5'-CCT-ACT-CAC-3' 0  1.113  0.042 
ZFA 84  70  87  96  B  5'-CCT-ATG-GCG-3' 1  1.239  0.104 
ZFA 85  58  67  96  B  5'-CCT-GTA-GGG-3' 2  1.504  0.009 
ZFA 86  101 92  98  B  5'-CGC-CAT-CTA-3' 0  1.052  0.052 
ZFA 87  88  81  101 B  5'-CTA-ACT-ATT-3' 0  0.884  0.013 
ZFA 88  83  59  101 B  5'-CTA-GGA-AGC-3' 1  1.303  0.089 
ZFA 89  80  83  103 B  5'-CTT-AGC-ACG-3' 0  1.037  0.086 
ZFA 90  94  88  103 B  5'-CTT-ATT-CCC-3' 0  1.031  0.018 
ZFA 91  91  60  103 B  5'-CTT-GGT-CAG-3' 1  1.044  0.032 
ZFA 92  69  70  63  B  5'-GAA-GCG-GTC-3' 3  2.309  0.129 
ZFA 93  14  23  36  S  5'-GAA-GCG-GTC-3' 3  1.620  0.059 
ZFA 94  109 130 124 T  5'-GAA-GCG-GTC-3' 3  1.339  0.165 
ZFA 95  109 130 122 T  5'-GAA-GCG-GTC-3' 3  2.279  0.123 
ZFA 96  87  94  65  B  5'-GAC-CCC-ATG-3' 1  1.074  0.034 
ZFA 97  72  61  65  B  5'-GAC-GGC-GCT-3' 3  1.118  0.045 
ZFA 98  8  26  37  S  5'-GAC-GGC-GCT-3' 3  0.930  0.039 
ZFA 101  4  24  38  S  5'-GAG-GCT-GAT-3' 3  1.327  0.126 
ZFA 102  112 139 113 T  5'-GAG-GCT-GAT-3' 3  1.142  0.091 
ZFA 103  112 139 136 T  5'-GAG-GCT-GAT-3' 3  1.185  0.087 
ZFA 104  112 139 115 T  5'-GAG-GCT-GAT-3' 3  2.399  0.120 
ZFA 105  66  72  62  B  5'-GAG-GCT-GTG-3' 3  4.553  0.295 
ZFA 106  15  24  38  S  5'-GAG-GCT-GTG-3' 3  3.038  0.153 
ZFA 107  138 139 136 T  5'-GAG-GCT-GTG-3' 3  0.959  0.026 
ZFA 108  138 139 113 T  5'-GAG-GCT-GTG-3' 3  1.004  0.037 
ZFA 109  138 139 115 T  5'-GAG-GCT-GTG-3' 3  3.277  0.153 
ZFA 110  68  59  64  B  5'-GAT-GGA-GTT-3' 3  2.647  0.158 
ZFA 111  16  25  39  S  5'-GAT-GGA-GTT-3' 3  1.571  0.111 
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ZFA 112  111 118 112 T  5'-GAT-GGA-GTT-3' 3  1.645  0.071 
ZFA 113  111 129 112 T  5'-GAT-GGA-GTT-3' 3  2.013  0.083 
ZFA 114  111 117 112 T  5'-GAT-GGA-GTT-3' 3  2.489  0.136 
ZFA 115  111 114 112 T  5'-GAT-GGA-GTT-3' 3  3.840  0.308 
ZFA 116  58  60  64  B  5'-GAT-GGT-GGG-3' 3  2.390  0.065 
ZFA 117  11  28  39  S  5'-GAT-GGT-GGG-3' 3  0.959  0.098 
ZFA 118  131 140 112 T  5'-GAT-GGT-GGG-3' 3  1.985  0.067 
ZFA 119  133 140 112 T  5'-GAT-GGT-GGG-3' 3  2.444  0.103 
ZFA 120  134 140 112 T  5'-GAT-GGT-GGG-3' 3  6.665  0.290 
ZFA 121  60  78  71  B  5'-GCA-ACA-GGT-3' 2  1.388  0.014 
ZFA 122  100 80  71  B  5'-GCA-ACG-CGT-3' 1  1.274  0.031 
ZFA 123  81  90  71  B  5'-GCA-CAC-ACT-3' 1  0.851  0.023 
ZFA 124  59  73  71  B  5'-GCA-GCC-GGA-3' 3  1.574  0.099 
ZFA 125  9  33  40  S  5'-GCA-GCC-GGA-3' 3  0.953  0.111 
ZFA 126  71  70  71  B  5'-GCA-GCG-GCA-3' 3  3.276  0.111 
ZFA 127  5  23  40  S  5'-GCA-GCG-GCA-3' 3  0.887  0.068 
ZFA 128  58  72  71  B  5'-GCA-GCT-GGG-3' 3  1.186  0.045 
ZFA 129  11  24  40  S  5'-GCA-GCT-GGG-3' 3  1.157  0.039 
ZFA 130  65  69  71  B  5'-GCA-GTC-GAC-3' 3  0.867  0.046 
ZFA 131  2  30  40  S  5'-GCA-GTC-GAC-3' 3  0.897  0.052 
ZFA 132  72  69  71  B  5'-GCA-GTC-GCT-3' 3  1.365  0.049 
ZFA 133  8  30  40  S  5'-GCA-GTC-GCT-3' 3  1.116  0.092 
ZFA 134  61  69  71  B  5'-GCA-GTC-GGC-3' 3  1.077  0.024 
ZFA 135  10  30  40  S  5'-GCA-GTC-GGC-3' 3  0.999  0.039 
ZFA 136  70  66  71  B  5'-GCA-GTG-GCG-3' 3  1.915  0.050 
ZFA 137  7  31  40  S  5'-GCA-GTG-GCG-3' 3  0.819  0.051 
ZFA 138  95  79  73  B  5'-GCC-ACC-CCG-3' 1  1.000  0.032 
ZFA 139  59  87  73  B  5'-GCC-ATG-GGA-3' 2  0.974  0.043 
ZFA 140  103 63  73  B  5'-GCC-GAA-CTT-3' 2  1.137  0.057 
ZFA 141  66  71  73  B  5'-GCC-GCA-GTG-3' 3  1.061  0.036 
ZFA 142  15  22  41  S  5'-GCC-GCA-GTG-3' 3  0.914  0.023 
ZFA 143  59  61  73  B  5'-GCC-GGC-GGA-3' 3  1.182  0.049 
ZFA 144  9  26  41  S  5'-GCC-GGC-GGA-3' 3  0.814  0.021 
ZFA 145  132 116 130 T  5'-GCG-GAA-AGG-3' 2  1.342  0.134 
ZFA 146  132 124 130 T  5'-GCG-GAA-AGG-3' 2  1.736  0.063 
ZFA 147  132 122 130 T  5'-GCG-GAA-AGG-3' 2  1.759  0.054 
ZFA 148  132 123 130 T  5'-GCG-GAA-AGG-3' 2  2.136  0.064 
ZFA 149  102 59  70  B  5'-GCG-GGA-CTG-3' 2  1.522  0.088 
ZFA 150  59  66  70  B  5'-GCG-GTG-GGA-3' 3  1.751  0.124 
ZFA 151  9  31  42  S  5'-GCG-GTG-GGA-3' 3  2.774  0.116 
ZFA 152  114 138 130 T  5'-GCG-GTG-GGA-3' 3  1.029  0.046 
ZFA 153  129 138 130 T  5'-GCG-GTG-GGA-3' 3  1.272  0.039 
ZFA 154  118 138 130 T  5'-GCG-GTG-GGA-3' 3  1.384  0.059 
ZFA 155  117 138 130 T  5'-GCG-GTG-GGA-3' 3  1.953  0.050 
ZFA 156  60  66  70  B  5'-GCG-GTG-GGT-3' 3  2.229  0.208 
ZFA 157  12  31  42  S  5'-GCG-GTG-GGT-3' 3  3.298  0.266 
ZFA 158  70  106 70  B  5'-GCG-TGG-GCG-3' 2  2.713  0.181 
ZFA 159  7  34  42  S  5'-GCG-TGG-GCG-3' 2  0.856  0.034 
ZFA 160  78  86  72  B  5'-GCT-ATA-ACA-3' 1  0.988  0.024 
ZFA 161  62  100 72  B  5'-GCT-CGT-GAG-3' 2  1.703  0.012 
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ZFA 163  100 104 72  B  5'-GCT-TAG-CGT-3' 1  1.343  0.143 
ZFA 164  61  74  59  B  5'-GGA-AAA-GGC-3' 2  1.392  0.084 
ZFA 165  92  90  59  B  5'-GGA-CAC-CAT-3' 1  1.182  0.016 
ZFA 166  80  101 59  B  5'-GGA-CTA-ACG-3' 1  1.085  0.034 
ZFA 167  66  70  59  B  5'-GGA-GCG-GTG-3' 3  1.640  0.043 
ZFA 168  15  23  44  S  5'-GGA-GCG-GTG-3' 3  2.599  0.092 
ZFA 169  138 130 117 T  5'-GGA-GCG-GTG-3' 3  1.027  0.068 
ZFA 170  138 130 118 T  5'-GGA-GCG-GTG-3' 3  1.732  0.041 
ZFA 171  138 130 129 T  5'-GGA-GCG-GTG-3' 3  2.296  0.121 
ZFA 172  138 130 114 T  5'-GGA-GCG-GTG-3' 3  2.316  0.046 
ZFA 173  61  80  61  B  5'-GGC-ACG-GGC-3' 2  1.341  0.109 
ZFA 174  63  95  61  B  5'-GGC-CCG-GAA-3' 2  1.171  0.030 
ZFA 175  66  73  61  B  5'-GGC-GCC-GTG-3' 3  1.116  0.072 
ZFA 176  15  33  45  S  5'-GGC-GCC-GTG-3' 3  0.868  0.017 
ZFA 177  73  58  61  B  5'-GGC-GGG-GCC-3' 3  1.203  0.035 
ZFA 178  6  27  45  S  5'-GGC-GGG-GCC-3' 3  1.258  0.053 
ZFA 180  61  70  58  B  5'-GGG-GCG-GGC-3' 3  2.191  0.105 
ZFA 181  10  23  51  S  5'-GGG-GCG-GGC-3' 3  6.162  0.147 
ZFA 182  73  72  58  B  5'-GGG-GCT-GCC-3' 3  1.363  0.053 
ZFA 183  6  24  51  S  5'-GGG-GCT-GCC-3' 3  1.494  0.054 
ZFA 184  108 139 134 T  5'-GGG-GCT-GCC-3' 3  2.022  0.253 
ZFA 185  79  88  60  B  5'-GGT-ATT-ACC-3' 1  1.078  0.016 
ZFA 186  72  63  60  B  5'-GGT-GAA-GCT-3' 3  1.589  0.094 
ZFA 187  8  18  46  S  5'-GGT-GAA-GCT-3' 3  0.944  0.081 
ZFA 188  139 122 140 T  5'-GGT-GAA-GCT-3' 3  1.176  0.125 
ZFA 189  139 124 140 T  5'-GGT-GAA-GCT-3' 3  1.800  0.124 
ZFA 190  139 123 140 T  5'-GGT-GAA-GCT-3' 3  2.189  0.234 
ZFA 191  139 116 140 T  5'-GGT-GAA-GCT-3' 3  2.431  0.090 
ZFA 192  98  103 67  B  5'-GTA-CTT-CGC-3' 1  1.274  0.034 
ZFA 193  61  68  67  B  5'-GTA-GTT-GGC-3' 3  1.056  0.098 
ZFA 194  10  32  47  S  5'-GTA-GTT-GGC-3' 3  0.854  0.028 
ZFA 195  91  101 69  B  5'-GTC-CTA-CAG-3' 1  1.132  0.035 
ZFA 196  81  65  66  B  5'-GTG-GAC-ACT-3' 2  1.387  0.028 
ZFA 197  73  61  66  B  5'-GTG-GGC-GCC-3' 3  1.104  0.036 
ZFA 198  6  26  49  S  5'-GTG-GGC-GCC-3' 3  0.984  0.055 
ZFA 199  66  82  68  B  5'-GTT-AGA-GTG-3' 2  1.683  0.046 
ZFA 200  138 119 111 T  5'-GTT-AGA-GTG-3' 2  2.872  0.107 
ZFA 201  12  20  50  S  5'-GTT-GAG-GGT-3' 3  0.671  0.015 
ZFA 202  140 136 111 T  5'-GTT-GAG-GGT-3' 3  3.477  0.076 
ZFA 203  140 113 111 T  5'-GTT-GAG-GGT-3' 3  4.735  0.489 
ZFA 204  101 71  68  B  5'-GTT-GCA-CTA-3' 2  1.009  0.043 
ZFA 205  73  70  68  B  5'-GTT-GCG-GCC-3' 3  5.065  0.290 
ZFA 206  6  23  50  S  5'-GTT-GCG-GCC-3' 3  1.232  0.014 
ZFA 207  83  103 104 B  5'-TAG-CTT-AGC-3' 0  0.849  0.100 
ZFA 208  70  59  104 B  5'-TAG-GGA-GCG-3' 2  2.185  0.068 
ZFA 209  3  20  56  S  5'-TGA-GAG-GAG-3' 2  1.704  0.068 



























of  these  sites were  composed of  three GXX  subsites  and one was  composed of  two GXX 
subsites.  Since six of the seven arrays were only tested by EMSA, it is difficult to extrapolate 





In  previously  published  studies  from  our  groups,  we  observed  a  general 
correlation between  failure  to  activate  in  the B2H  assay  and  failure  to  show ZFN 
function in human cells (1).  To further assess this correlation, we tested the activities 
of  23 ZFNs  using  a  human  cell‐based  episomal  homologous  recombination  (HR) 




to 5.07‐fold.   As shown  in Supplementary Figure B.S4 online, we  found  that zinc 
finger arrays which activated transcription by 1.57‐fold or less in the B2H system all 
failed  to  show  significant activity as ZFNs  in human  cells  (nine out of nine ZFNs 
tested;  pink  bars  in  Supplementary  Figure  B.S4  online).  Conversely,  many 
(although not all) of  the zinc  finger arrays which activated  transcription by >1.57‐
fold  in  the B2H system showed significant activity as ZFNs  in  the episomal repair 
assay (light blue bars with red asterisks in Supplementary Figure B.S4 online). We 
conclude that zinc finger arrays that activate transcription by 1.57‐fold or less in the 




Analysis of our  results shows  that modular assembly  is  far  less effective  for  target 











A  fundamental  flaw with  the modular assembly method  (and a  likely  cause of  its 
low success rate) is its assumption that zinc finger domains behave as independent modular 
units. A number of studies have shown  that zinc  fingers can cross over and  interact with 
adjacent  fingers and neighboring  finger binding  sites  (2‐5). Various engineering  strategies 
have  been described  in  the  literature  that  account  for  these  context‐dependent  effects  on 
zinc  finger  DNA‐binding.  Greisman  and  Pabo  first  described  a  sequential  optimization 
strategy in which combinations of fingers that work well together are identified using serial 
selections  from  randomized  libraries  (6).  Isalan, Klug,  and  Choo  described  a  “bipartite” 




library  for  use  in  a  final  stringent  selection  (8).    A  limitation  of  all  of  these  different 
approaches  is  that  they  require  specialized  expertise  in  the  construction of multiple very 
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104 B2H  reporter  strains each harboring a  single  copy  target  site‐reporter plasmid 





match modules across  these different  sets.   We  chose not  to make “crossplatform” arrays 
because: 1: the Barbas website software does not advocate use of their modules with others 
(2), 2:  the Toolgen group discovered  that  their human zinc  fingers worked best with one 
another and not as well with other engineered modules, and 3:  the Sangamo modules are 
position‐specific and have linkers joining them that differ from the canonical TGEKP linker 
used  by  the Barbas  and Toolgen modules(4).  15  of  the  arrays we  constructed were  toxic 
when  expressed  in  the B2H  assay  and  these  proteins were  not  included  in  our  analysis. 
After  setting  aside  these  toxic  proteins, we  characterized  the  remaining  168  zinc  finger 







a  target  site  reporter  strain with  a B2H  zinc  finger  array‐Gal11P  expression vector  and  a 
compatible  plasmid  encoding  an  E.  coli  RNA  polymerase  alpha‐Gal4  hybrid  protein  (1).
 
 
Fold‐activation was  calculated  as  the  ratio  of  the  level  of  β‐galactosidase  (lacZ)  reporter 
activity in the presence and absence of the zinc finger array as previously described (5). All 





fold  transcriptional  activation  in  the  B2H  assay, we  re‐sequenced  the  zinc  finger  coding 
sequences  and  the  reporter  plasmid  binding  sites  from  the  same  cells  used  for  β‐
galactosidase assays  to  re‐confirm  the  identities of  the zinc  finger  recognition helices and 
binding sites  tested  in  these cells.   We performed  this additional re‐sequencing control on 
>80% of our samples  (94 of  the 115 zinc  finger array/binding site combinations)  that were 




Zinc  finger arrays were  fused  to  the FokI nuclease domain and  the resulting ZFNs 
were  transiently  expressed  in  tobacco  protoplasts.    Plasmids  encoding  these  ZFNs were 
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co‐transformed  with  a  target  plasmid  carrying  a  non‐functional  β‐glucuronidase  (GUS) 
gene.  The GUS  gene was  rendered  non‐functional  by  a  direct  duplication  of  part  of  its 
coding sequence. Between  the direct  repeats, a  recognition site was  inserted  for  the given 
ZFN being tested. After expression of the ZFN and cleavage of the GUS reporter, repair by 
single strand annealing can restore GUS function.  This can be measured by standard GUS 





phosphate  precipitation with  20  ng  of  the  respective  target  plasmid,  1  μg  of  the  donor 
plasmid  (pUC.Zgfp/REx),  and  100  ng  of  a  CMV‐driven  endonuclease  expression  vector 
encoding the ZFNs, I‐SceI (pRK5.LHA‐Sce1) or a control vector (pCMV.Luc). Two days after 
transfection, 50,000 cells were analyzed by flow cytometry (FACSCalibur, BD Bioscience) to 
determine  the  percentage  of  EGFP‐positive  cells.  The  number  of  DsRedExpress  (REx)‐









We  have  previously described ZiFiT,  a web‐based  software  program  that  enables 
users to rapidly identify potential zinc finger target sites within genes of interest (6). ZiFiT 
identifies  target sites for which zinc finger arrays might be made using modular assembly 
and  the Zinc  Finger Consortium Modular Assembly Kit  1.0  (1). Given  the  results  of  this 




To  assess  the  effectiveness of modular  assembly, we generated  a  large number of 





fold over negative controls was determined  to be  indicative of  target site recognition by a 
given protein. After measuring  the activity of  the 168 zinc finger arrays,  it was found  that 
the subsite composition of binding sites critically affected success rates.  Modular assembly 
was  far  less  effective  for  target  sites  composed  of  one  or  no GXX  subsites  (12%  and  0% 
success  rates,  respectively)  compared with  those  that  contain  three or  two  (59% and 29% 
success  rates,  respectively).    Based  on  these  results, we  provide  users  of  ZiFiT with  an 
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approximation of  the  likelihood  that a given  three  finger protein will  recognize  its  target.  
For example,  three  finger proteins comprised of  three GXX subsites will receive a score of 
0.59, reflecting the success rate observed in our survey.  Most users will be interested in the 
likelihood  that  two arrays will  function  together as a ZFN.   This can be approximated by 
multiplying the success rate of individual arrays.  For example, the likelihood of success that 
a ZFN with all GXX subsites will recognize its target is 0.59 X 0.59 = 0.35 or 35%.   Because 
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Custom‐made  zinc‐finger  nucleases  (ZFNs)  can  induce  targeted  genome 
modifications with high efficiency  in cell types  including Drosophila, C. elegans, plants, and 
humans. A  bottleneck  in  the  application  of  ZFN  technology  has  been  the  generation  of 
highly specific engineered zinc‐finger arrays. Here we describe OPEN  (Oligomerized Pool 





with high efficiencies (1to 50%)at 11 different  target sites  located within  three endogenous 
human genes  (VEGF‐A, HoxB13, CFTR), an endogenous plant gene  (tobacco SuRA), and a 
chromosomally‐integrated  EGFP  reporter  gene.  In  summary,  OPEN  provides  an  “open‐
source” method  for  rapidly engineering highly active zinc‐finger arrays,  thereby enabling 




A  reliable,  publicly  available method  for  creating  targeted  genome modifications 
with high efficiency would be broadly useful  for biological research and gene  therapy  (1). 
Although  strategies  have  been  developed  using  viral  vectors  or  short  double‐or  single‐
stranded  DNA  molecules  to  direct  homologous  recombination  (HR),  these  methods 
generally have low efficiencies even under optimal cell culture conditions (2). An alternative 
and more efficient strategy involves introducing a double‐stranded break (DSB) into a target 
locus of  interest. Repair of  this DSB by cellular mechanisms greatly  increases rates of HR‐
mediated gene targeting with an exogenous DNA molecule (3) or of gene mutation by error‐












together  single  fingers  with  pre‐characterized  specificities  (19‐23).  Although  easy  to 
perform, modular assembly has an efficacy rate for making functional ZFN pairs that is less 
than  6%  (24)  and  can  yield  ZFNs  with  low  activities  and/or  high  toxicities  (25,26). 
Alternative  approaches  involve  combinatorial  selection‐based  methods  that  yield  multi‐
finger domains possessing high DNA‐binding  affinities  and  specificities  (27‐29)  and high 
activities  and  low  toxicities when  expressed  as  ZFNs  in  human  cells  (25,26). However, 
selection‐based  methods  require  construction  and  interrogation  of  large  randomized 
libraries  (typically >108in size) and  therefore  remain  intractable  for all but a  few  labs  that 
possess the required expertise.  Here we describe the development and validation of OPEN 
(Oligomerized  Pool  ENgineering),  a  facile,  robust,  and  publicly  available  platform  for 
engineering  zinc‐finger  arrays.  OPEN  is  enabled  by  an  archive  of  zinc‐finger  pools 
constructed by the Zinc Finger Consortium, a group of academic laboratories committed to 










OPEN  ‐  a  rapid  and  robust  strategy  for  engineering  zinc‐finger  arrays  OPEN 
selections require an archive of pre‐selected zinc‐finger pools, each containing a mixture of 
fingers  targeted  to a different  three base pair subsite at a defined position within a  three‐
finger  protein  (Figure  C.1A  and  Experimental  Procedures).  Fully  enabling  OPEN  will 
require 192  finger pools  (64 potential  three bp  target subsites  for each position  in a  three‐
finger protein).  In  this  initial  report, we  created pools  (each  containing a maximum of 95 
different fingers) targeted to 66 subsites (48 GXX subsites and 18 TXX subsites; Figure C.1B). 
To perform an OPEN selection for a target site, appropriate finger pools from the archive are 










Figure C.1 | OPEN Method for Engineering Zinc-finger Arrays  A) OPEN zinc-finger pool 
construction. Zinc-finger domains are shown as spheres and associated 3 bp subsites as rectangles. 
Randomized finger in the library is rainbow colored. Note that the figure illustrates how finger pools 
for the middle position in a three-finger domain were made, but that pools for amino- or carboxy-
terminal fingers were also obtained by building libraries in which finger 1 or finger 3 were randomized, 
respectively (Experimental Procedures).  B) GXX and TXX target subsites for which finger pools have 
been constructed (highlighted in grey).  C) Schematic overview of OPEN selection for a target DNA 
site. Zinc-fingers and associated subsites represented as in (A). Details in Supplemental 
Experimental procedures. D) Schematic of the bacterial two-hybrid (B2H) system. ZFP = zinc-finger 















(Figure C.2A  and Table C.S1).For  each of  the  five  full EGFP  target  sites, various pairs of 
modularly  assembled  and OPEN‐selected ZFNs  (Table C.S2) were  tested  in  human  cells 




the  five  full ZFN  target sites  (EG223, EG292, EG382, and EG502). Although both methods 







Figure C.2 | OPEN ZFNs engineered to cleave EGFP gene sequences  A) Quantitative B2H assay of 
modular assembly (MA; red bars) and OPEN (green bars) zinc finger arrays. Mean fold-activation 
values (colored bars) and standard deviations (error bars) from three independent assays are shown. 
B) EGFP-disruption assay for testing ZFN activities in human cells.  C) Modularly assembled and 
OPEN ZFNs assessed using the EGFP-disruption assay. Error bars represent standard deviations. 
Single and double asterisks indicate p values <0.05 or <0.01, respectively. 
 
OPEN selection of zinc‐finger arrays  that bind  to sequences  in endogenous human and 
plant genes  





these14  full ZFN  target sites  (Tables C.S1 and C.S2), and 24 of 28 were deemed successful 
(Table C.S1). Using a subset of  these  finger arrays  (Table C.S2), we constructed ZFN pairs 




To  test whether  OPEN  ZFNs  induce mutations  by NHEJ  at  endogenous  human 
genes, we employed a CEL I nuclease‐based mutation detection assay (Figure C.3A) (9,10). 
We  found  that  all  four  VF2468  and  all  four  VF2471  ZFN  pairs  we  tested  generated 
detectable mutations  in  the endogenous VEGF‐Agene  in human 293 cells  (Figure C.3B).  In 
addition, mutations  could  be detected  at  the  endogenous HoxB13gene  in  293  cells  for  all 
ZFN pairs tested at the HX587, HX735 and HX761 sites (Figure C.3C). DNA sequencing of 
HoxB13alleles  amplified  from  cells  modified  by  HX587  ZFN  pair  B  (Supplemental 
Experimental  Procedures)  revealed  mutations  at  the  expected  location  with  an  average 
frequency  of  9.6%  (Figure C.S3A).  ZFN  pairs  targeted  to  three  sites  in  the  VEGF‐Agene 








transformed  with  a  construct  encoding  the  SR2163  ZFN  pair  were  regenerated  into 
individual plants  (Experimental Procedures). The SR2163 site  is present  in both SuRA and 
SuRB,  and  each  plant was  examined  for  evidence  of  cleavage  at  these  loci  using DNA 
sequencing. Among  66  transgenic  plants  surveyed,  three  had mutations  in  SuRA,  all  of 
which were deletions of a single base (Figure C.S3C). In one plant, both alleles of SuRA had 
the same deletion. No mutated alleles of SuRB were detected. This frequency of mutagenesis 







ZFN  pair  (10)  which  cleaves  the  human  IL2Rγ  gene.  Gene  targeting  frequencies  using 
VEGF‐A‐or IL2Rγ‐specific ZFNs and matched donor templates (Figure C.S4) were measured 
in  human  K562  cells  using  a  limited‐cycle  PCR/restriction  digest  assay  (Experimental 
Procedures) (15): mean targeting efficiencies of 7.7%, 4.5% and 4.1% were observed with the 





Figure C.3 | Highly Efficient Mutagenesis of Endogenous Human Genes by OPEN ZFNs A) 
Schematic of CEL I assay for assaying ZFN-induced mutations. (B-C) Mutation of the endogenous 
human VEGF-A gene B) and HoxB13 gene C) by OPEN ZFNs. Colored arrows indicate expected 
CEL I digestion products. Images shown are from representative experiments. 
 
Southern blot assays of cells modified by VEGF‐A‐specific ZFNs confirm  that,  if anything, 
the  PCR‐based  assay  tended  to  underestimate  gene  targeting  rates  (Figures  C.4B  and 
C.S5).Consistent with previous studies  (15), we observed higher rates of gene  targeting  in 
K562 cells which had been  transiently arrested  in G2 with vinblastine: 54%, 37%, and 44% 




Sequencing  of VEGF‐A  and  IL2Rγ  alleles  revealed  gene  targeting  events  at  the  expected 
locations and with the anticipated frequencies (Figure C.S6), but for all three target sites, we 
also observed high  frequencies of  insertion and deletion events at  the ZFN  cleavage  sites 
(presumably caused by error‐prone NHEJ). Unexpectedly, we found that 1.8% and 9.0% of 
alleles from cells treated with VF2468 and IL2Rγ ZFNs, respectively, contained evidence of 
both HR‐mediated  gene  targeting  and NHEJ‐mediated  insertion  events  at  a  single  allele. 
Interestingly,  analysis of  single  cell  clones  from vinblastine‐treated populations  of VEGF‐
AZFN‐modified cells indicates that gene targeting events are stably maintained (even after 
















Figure C.4 | Highly Efficient Gene Targeting of Endogenous Human Loci by OPEN ZFNs A) OPEN 
VEGF-A ZFNs and previously described IL2Rγ ZFNs induce efficient gene targeting at endogenous 
genes in human K562 cells. Top part shows representative gel images from limited-cycle 
PCR/restriction digest assays and bottom part shows gene targeting frequency means (colored bars) 
and standard errors (error bars) from multiple experiments. B) Gene targeting efficiencies of OPEN 
VEGF-A ZFNs assessed nine days post transfection by limited-cycle PCR/restriction digest and 
Southern blot assays. C) Vinblastine enhances gene targeting by OPEN VEGF-A and four-finger 
IL2Rγ ZFNs. Assays performed four days post-transfection. Data presented as in (A). D) Toxicities of 
OPEN VEGF-A and four-finger IL2Rγ ZFNs in human K562 cells. Means of GFP (green bars) and 
gene targeting ratios (purple bars) are shown. Error bars represent standard deviations. Single and 
double asterisks indicate p values <0.05 or <0.01, respectively. E) Gene targeting efficiencies of 
OPEN VEGF-A and four-finger IL2Rγ ZFNs in toxicity experiments of (D). Means and standard 
deviations (error bars) are shown of PCR-based assays performed four days post-transfection. 
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heterodimeric  FokI  nuclease  domain  variants which  significantly  reduce  ZFN‐associated 
toxicity (10,14). Both the variant IL2Rγ ZFN pair and the variant VF2471 ZFN pair showed 
no  significant  toxicity  as  judged  by  the GFP  toxicity  assay  (Figure C.4D,  green  bars).  In 









created  37  ZFN  pairs which mediate  highly  efficient modification  at  four  different  sites 
within  a  chromosomally  integrated  EGFP  reporter  gene,  six  different  sites within  three 
endogenous human genes (VEGF‐A, HoxB13, and CFTR), and one site within an endogenous 




studies  targeting  the EGFP gene, only  two  of  11  (~18%) modularly  assembled ZFN pairs 
tested  showed activity  in human  cells,  in  contrast  to 15 of 20  (75%) OPEN ZFN pairs.  In 
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addition,  at  the  one  target  site  for  which  both  methods  were  successful,  OPEN  ZFNs 
showed significantly more activity  than modularly assembled ZFNs. The  low efficacy rate 
observed with modular assembly is consistent with the results of a large‐scale assessment of 




be used  to engineer  three‐finger proteins  for ~4.1%  ((23*21*22)/(64*64*64)) of all possible 9 
bp target sites or ~0.16% (4.1%*4.1%) of all possible 18 bp ZFN sites. Because ZFNs can bind 
to sites  in which two “half‐sites” are separated by “spacer sequences” of five, six or seven 
base  pairs  (13,36)[K. Wilson  and M.H.P.,  unpublished  data),  one  should  be  able  to  find 
approximately  five  full ZFN  sites  in  any given kb of  random  sequence  (0.0016  *1000*  3). 
Thus, with the pools described in this report, one should be able to target multiple ZFN sites 
within a  typical  size gene.  Important goals  for  future work will be  to generate additional 
finger pools that expand the targeting range of OPEN and to test whether the approach can 
also be used to generate arrays composed of more than three‐fingers. 
While using ZFNs  to modify human genes, we observed  two  limitations  that have 
not  been  emphasized  in  previous  reports.  First,  not  all  zinc‐finger  arrays  that  possess 
sequence‐specific DNA‐binding activities (as measured in the well‐established B2H method) 
will function as ZFNs in human cells. ZFNs for one of the four sites targeted in the HoxB13 
locus,  for  three of  the  five sites  targeted  in  the VEGF‐A  locus, and  for one of  the  five sites 
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consistent with  a  repressive  state  in  K562  cells  (B.  Bernstein,  personal  communication). 
Additional studies will be needed  to determine whether  lack of ZFN activity results  from 
chromatin effects on DNA accessibility or other reasons such as ZFN expression/stability or 
target site methylation. Second, although  the use of vinblastine  increased  the frequency of 
gene  targeting, DNA  sequencing  reveals  that many  alleles  still  underwent  insertions  or 
deletions  caused  by  error‐prone  NHEJ  and  that  some  alleles  underwent  both  a  gene 
targeting event and an insertion. These findings demonstrate limitations in relying solely on 
PCR‐ or Southern blot‐based assays and  suggest  that DNA  sequencing  should always be 
performed to verify ZFN‐induced gene targeting events. 
Because OPEN  is  rapid,  reliable,  and publicly  available,  it will  foster wider usage 
and  larger‐scale  applications  of  engineered  zinc‐finger  technology.  OPEN  selections  are 
performed  in  E.  coli  and  do  not  require  specialized  equipment.  Although  our  ZFN 
validation  experiments were  performed  in  plant  and  human  cells, OPEN  should  also  be 
useful  for  generating  ZFNs  that  function  well  in  other  organisms  such  as  zebrafish, 




every  zebrafish  gene).  We  note  that  this  report  doubles  the  number  of  endogenous 
mammalian  genes  described  in  the  published  literature  ‐‐  from  three  (IL2Rγ, CCR5,  and 
DHFR) (15,37) to six ‐‐ that have been successfully modified using ZFNs. In conclusion, our 
publicly  available  OPEN  platform  will  enable  scientists  to  perform  the  research  and 








Randomized  zinc‐finger  libraries  constructed  by  cassette  mutagenesis  were 
introduced  into “B2H selection strains” harboring a 9 bp  target site as described  (38) and 










Each OPEN  selection was performed  in  two  steps: First, B2H  selection  strain  cells 
were  infected with  randomized zinc‐finger phage  libraries consisting of  three  recombined 
finger pools and then plated on NM media containing 3‐AT and streptomycin. Second, zinc 
finger‐encoding phagemids were rescued from surviving colonies, re‐introduced into fresh 
B2H  selection  strain  cells,  and  plated  on NM media  containing  a  gradient  of  3‐AT  and 





and  genomic  DNA  was  isolated  three  days  post‐transfection.  Limited‐cycle  PCR  was 





Human  K562  cells  were  transfected  with  ZFN  expression  plasmids  and  donor 
constructs and genomic DNA harvested four days post‐transfection. Limited‐cycle PCR was 
performed  with  radiolabeled  nucleotides  and  VEGF‐A‐  or  IL2Rγ‐specific  primers.  PCR 







The  transformation  of  tobacco  protoplasts  by  electroporation,  selection  for 
kanamycin  resistance,  and  regeneration  into  plantlets  was  carried  out  as  previously 
described  (16). DNA was  prepared  from  tissue  harvested  from  individual  plantlets  and 




ZFN  expression  vectors,  donor  templates,  and  plasmid  pmaxGFP  (Amaxa) were 
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All  master  randomized  zinc  finger  libraries  were  constructed  in  a  standard 
framework  consisting  of  three  tandem  repeats  of  the  middle  finger  of  the  murine 
transcription  factor Zif268  in which  the  recognition helix  residues have been  altered. For 
each library, recognition helix residues –1, 1, 2, 3, 5, and 6 were randomized using 24 codons 
(degenerate  sequence  5’VNS3’)  encoding  16  amino  acids  (excluding  cysteine  and  the 
aromatics). The  theoretical complexity of each  library  is  therefore 246= ~2 x 108 members. 
Each library was converted into infectious M13 phage particles as previously described (2). 
B2H selection strains each harbor: (1) a single copy episome bearing a target site of 
interest  positioned  upstream  of  a  promoter which  drives  co‐cistronic  expression  of  two 






steps:  In  a  first  step,  109  ampicillintransducing‐  units  (ATU)  of  randomized  zinc  finger 
phage  library were  introduced  into  >3 x  109 B2H  selection  strain  cells harboring  a  target 
subsite of  interest. Transformed cells were plated on histidine‐deficient NM/CCK medium 
plates containing 50 μM  isopropyl β‐d‐thiogalactoside  (IPTG) and 10 mM 3‐aminotriazole 
(3‐AT), a competitive  inhibitor of  the HIS3 enzyme. After  incubation  for 24 hours at 37°C 
followed by 18 hours at room temperature, surviving colonies were scraped from the plates 
and  infected with M13K07 helper phage  to  rescue  the zinc  finger‐encoding phagemids as 








at 37°C and  then  the 95 cultures were pooled  together. Plasmid DNA encoding  the  finger 
pools was  isolated  from 10 ml of  the pooled culture using a QIAgen miniprep kit and  for 
many pools a small number of random clones were sequenced with primer OK61. For finger 




sites  was  relatively  weak  under  the  initial  selection  conditions.  For  each  of  these  nine 
subsites, the second step of selection was repeated and plated on higher stringency plates to 
obtain  sequences  that more  closely  resembled  one  another.  The  higher  stringency  plates 
used were NM/CCK medium plates  containing 50  μM  IPTG, 20 mM 3‐AT, and 30  μg/ml 
streptomycin (for seven subsites: F1 GAT, F2 GAC, F2 GAG, F2 GCG, F2 TGA, F2 TAG, and 





For  each  amplification,  first  five  and  then  20  cycles  of  PCR were  performed  using  the 
following primers and annealing temperatures (primer names; initial annealing temp; final 
annealing  temp):  for  finger 1: OK1424 and OK1425; 55°C; 59°C,  for  finger 2: OK1426 and 











T4  polynucleotide  kinase  to  create  overhangs.  This  fragment was  then  ligated with  BbsI 




theoretical  library  complexity  of  ~8.6  x  105  (953).  Libraries  were  then  converted  into 
infectious M13 phage as previously described (1). 
All but six (see below) of the OPEN selections were performed in two stages. In the 
first stage, an OPEN  three‐finger  library was  introduced by  infection  into a B2H selection 
strain harboring  the full  target DNA sequence of  interest. >2.2 x 106 ATU of OPEN phage 
library (a number which ensures adequate oversampling of the maximal theoretical library 
diversity)  were  used  to  infect  >2  x  108  B2H  selection  strain  cells  and  the  resulting 
transformants were  plated  on  two  different NM/CCK medium  plates  containing  50  μM 
IPTG, 10 mM 3AT, and 20 μg/mL streptomycin or 50 μM IPTG, 25 mM 3AT, and 40 μg/mL 
streptomycin. After  36‐48  hours  of  incubation,  colonies were  harvested  from  the  highest 
stringency  plate  yielding  at  least  1000  colonies.  These  cells were  infected with M13K07 
helper  phage  to  rescue  zinc  finger‐encoding  phagemids,  thereby  creating  an  enriched 
library. In the second stage, 2.5 x 106 ATU of this enriched library were used to infect >2 x 
108 fresh B2H selection strain cells and the resulting transformants plated on a 245x245mm 




using  the method  of  Szybalski  (3). After  incubation  at  37°C  for  a minimum  of  48  and  a 
maximum of 96 hours, 12 surviving colonies were picked from the highest stringency edge 
of the plate and ZFP‐encoding plasmids were isolated by plasmid miniprep and sequenced 
with  primer  OK61.  For  six  of  the  sites  we  targeted  using  OPEN,  selections  were  (for 
historical reasons) performed  in a single step  instead of  two steps. For  five sites  (EG223L, 
EG223R, EG292L, EG292R, and EG382L), >3.1 x 106 ATU of OPEN phage library were used 
to infect >4 x 108 B2H selection strain cells and the resulting transformants were plated on a 
series  of NM/CCK medium  plates  containing  50  μM  IPTG,  40 mM  3AT,  and  60  μg/mL 
streptomycin, 50 μM  IPTG, 60 mM 3AT, and 80μg/mL  streptomycin, 0 μM  IPTG, 40 mM 
3AT, and 60 μg/mL streptomycin or 0 μM IPTG, 60 mM 3AT, and 80 μg/mL streptomycin. 
For  each  target  site, we  picked  colonies  from  the  highest  stringency  plates  that  yielded 
colonies. For one site (EG382R), 4.25 x 108 ATU of OPEN phage library were used to infect 
>109 B2H selection strain cells and the resulting transformants were plated on a 245x245mm 









in  the  EGFP  reporter  gene,  we  assembled  three‐finger  arrays  using  modules  from  the 
Barbas,  Sangamo,  and  Toolgen  archives  but we  did  not mix  and match modules  across 
platforms because: (1) the Barbas group does not suggest use of their modules with others 
(2,5)  the  Toolgen  group  discovered  that  their  human  zinc  fingers worked  best with  one 
another but not as well with other engineered modules  (6), and  (3)  the Sangamo modules 




Zinc‐finger‐encoding  plasmids  identified  from  OPEN  selections  were  co‐
transformed with an  α‐Gal4 expression plasmid  into a “B2H  reporter  strain” harboring a 





All  zinc  finger  arrays were  expressed  as ZFNs using  the Zinc  Finger Consortium 
mammalian  expression  vector pST1374  (4). Zinc  finger  arrays were  excised directly  from 









expresses  a  β‐galactosidase‐EGFP  fusion  protein  (Figure  2B).  293.EGFP  cells  were 
transfected  in  triplicate  in  24‐well  plates  using  calcium  phosphate  precipitation  as 
previously described (10). Transfection cocktails included 300 ng each of a CMV promoter‐
controlled  zinc  finger  nuclease  expression  vector,  100  ng  pDS.RedExpress  (Clontech, 
Mountain  view,  CA)  and  pUC118  to  1.5  μg.  600  ng  of  pRK5.SceI  plasmid  (11),  which 
expresses  the meganuclease  I‐SceI, was used  in place of GFP‐ZFN‐encoding plasmids  for 
negative  controls.  50,000  cells were  analyzed  by  flow  cytometry  two  and  five days post‐
transfection  to  determine  the  percentage  of  EGFP‐negative  cells.  The  number  of  REx‐




In  this  assay,  limited‐cycle  PCR  is  used  to  amplify  a  locus  of  interest  from  the 
genomic DNA  of  a  population  of  human  cells  transfected with  ZFN  expression  vectors 






pairs  of  ZFN‐encoding  plasmids  (100  or  250  ng  of  each  ZFN‐encoding  plasmid)  using 
Lipofectamine 2000 (Invitrogen). Genomic DNA was isolated from nuclease‐treated cells at 
3 days post‐transfection using the QIAgen Blood Mini kit. Limited‐cycle PCR (24 cycles) was 
performed  using  Platinum  PCR  SuperMix  Hi‐Fidelity  (Invitrogen)  or  its  equivalent 
constituent components (Invitrogen) with 50 ng of genomic DNA as template, 8 μCi of each 
[alpha‐32P]‐dATP  and  dCTP,  1  μM  each  of  gene‐specific  primers  (primers OK1681  and 
OK1682  for VEGF‐A  sites VF2468/VF2471, primers OK1706  and OK1718  for VEGF‐A  sites 
VF3537/VF3542/VF3552,  primers OK1733  and OK1734  for HoxB13  sites HX508/HX587  or 
primers OK1736 and OK1738 for HoxB13 sites HX735/HX761) and 1.25 μl DMSO in a 25 μl 
reaction volume. PCR products were cleaned up using Sephadex G‐50 columns (Roche) and 












2 x  106 Flp‐In T‐REx  293  cells were  transfected with pairs of plasmids  expressing 
ZFNs  (7.5  μg  of  each  ZFN‐encoding  plasmid)  and  50  μg  of  donor  plasmid  using 
nucleofection  with  solution  V  and  program  Q001  (Amaxa).  2  x  106  K562  cells  were 
transfected with ZFN  expression plasmid pairs  (5 or  7.5  μg of  each)  and matched donor 
construct (25 or 50 μg donor plasmid) using nucleofection with solution V and program T‐
16.  Genomic  DNA  was  harvested  3  or  4  days  post‐transfection  for  293  or  K562  cells, 
respectively, using a QIAgen Blood Mini kit. Transfection  efficiencies were monitored by 




Limited‐cycle PCR  assays  (24  cycles) were performed using Platinum PCR  SuperMix Hi‐
Fidelity  (Invitrogen)  or  its  equivalent  constituent  components  (Invitrogen)  with  4  ng 
genomic DNA,  8  μCi  of  each  [alpha‐32P]‐dATP  and  dCTP,  1  μM  each  of  gene‐specific 
primers  (OK1776 and OK1777  for VEGF‐A or OK1845 and OK1846  for  IL2Rγ) and 1.25 μl 
DMSO in a 25 μl reaction. Purified PCR product was digested with 25 units SalI or 10 units 
BsrBI  restriction  enzyme  for  2  hours  and  the  resulting  products  were  visualized  by 
electrophoresis on a 10% 1X TBE polyacrylamide gel. This gel was dried down and exposed 





restriction  enzymes  for  20 hrs,  electrophoresed  in  0.8%  tris‐acetate  agarose gels  (100 mM 
Tris‐HCl,  10 mM  EDTA,  pH  8.0 with  acetic  acid),  and  transferred  to  Zeta‐probe  nylon 
membrane (BioRad) using 25 mM sodium phosphate (pH 6.5) according to the procedure of 
Southern  (12)  as  modified  for  use  with  the  Turbo‐Blot  downward  transfer  apparatus 
(Schleicher & Schuell). The VEGF‐A DNA probe was generated by PCR amplification of a 
cloned  human  VEGF‐A  DNA  template  using  primers  OK1823  and  OK1824  which  was 
subsequently  labeled  (25 ng) with  [alpha‐32P]‐dCTP) using Rediprime  II  random priming 
reagents  (Amersham).  Following  hybridization  (20  hrs)  at  65°C  in  5  mL  ExpressHyb 
solution (Clontech), the filters were washed with 0.1X SSC/0.1% SDS at 65°C (2 hrs), blotted 
dry and exposed  to a phosphorimager screen and/or  film. The  filters were scanned  in  the 

















into One Shot Mach1‐T1  chemically  competent  cells  (Invitrogen) or  chemically  competent 
Top10 cells  (Invitrogen) and plated on LB plates containing 50 μg/ml kanamycin. Plasmid 
DNAs  from  transformants were sequenced with a primer designed  to bind  internal  to  the 




The  transformation  of  tobacco  protoplasts  by  electroporation was  carried  out  as 
previously described (13). Plasmids introduced into protoplasts (10 μg each) included those 
expressing ZFNs  that  recognize  the  left  (pRW242) and  right  (pRW246) half  sites of  target 
2163  in SuRA. Note that these constructs do not express the heterodimeric variants of FokI 
endonuclease.  Also  transformed  into  protoplasts  was  a  plasmid  expressing  neomycin 
phosphotransferase  (NPTII)  (pDW998).  The  CaMV  35S  promoter  was  used  to  drive 
expression of both the ZFNs and NPTII. Plasmid DNAs were linearized with BglII prior to 




DNA  was  prepared  from  tissue  harvested  from  individual  plantlets  using  the 
Epicentre  MasterPure  Plant  Leaf  DNA  Purification  Kit  following  the  manufacturer’s 
directions. An  initial PCR screen for mutations at the site of ZFN cleavage was performed 
using primers DVO4461 and DVO4462  to amplify a 445 bp  fragment  from both  the SuRA 
and SuRB  loci. PCR was performed with 100 ng of genomic DNA and  the  following PCR 
conditions: 94°C 2 min, followed by 34 cycles of 94°C 15 sec, 61°C 15 sec, 72°C 30 sec, and 
then  72°C  for  5 min. The  reactions were  run out on  a  0.8%  agarose gel, purified using  a 
QIAgen  QIAquick  Gel  Extraction  kit,  and  sequenced  with  DVO4462.  The  resulting 
sequences were examined  for double peaks, which not only  indicate sequence differences 




it  occurred  in  SuRA  or  SuRB.  The  primary  reaction  amplified  a  2.15  kb  fragment  using 
approximately 100 ng of genomic DNA as  template and primers DVO4565 and DVO4461 
for SuRA and DVO4429 and DVO4461 for SuRB. The second PCR reaction amplified a 2 kb 
fragment using 1  μl of  the primary PCR  reaction as  template and primers DVO4444 and 
DVO4461  for  SuRA  and  DVO4445  and  DVO4461  for  SuRB.  All  PCR  reactions  were 












SceI meganuclease  (14) with 25  μg pUC118 and 15 ng of pmaxGFP,  (2) 10  μg of plasmid 
encoding CAD  (caspase‐activated DNase)  protein  (15) with  25  μg  pUC118  and  15  ng  of 









post‐transfection  days  4  and  7  and  assayed  for  gene  targeting  using  the  limited‐cycle 
PCR/restriction digest assay as described above. Gene targeting ratios shown  in Figure 4D 




three‐independent  samples  and  t‐tests  of  significance  were  performed  by  comparing 
experimentally  determined  ratios  to  a  fixed  ratio  value  of  1  (i.e.‐‐no  change  in  value). 
Variant  heterodimer  FokI  domains  were  constructed  by  introducing  the  “+”  and  “‐“ 




Two‐color  fluorescence  in  situ  hybridization  (FISH)  was  performed  on  3:1 
methanolacetic  acid  fixed  cell  lines  using  bacterial  artificial  chromosome  clones  RP11‐
710L16  (6p21.1; VEGF‐A)  labeled  in Spectrum Orange  (Abbott‐Vysis, Downerʹs Grove,  Il.), 
or RP11‐142P4  (14q31.1;  copy number  control)  labeled  in Spectrum Green using  standard 
protocols. Images were captured using an Olympus BX61 fluorescent microscope equipped 







Figure C.S1 | ZiFiT 3.0 -- Web-based software for identifying potential sites targetable by OPEN 
selection A) Screen shot of ZiFiT 3.0 input page. We previously described ZiFiT, a web-based 
software program that enables users to rapidly identify potential zinc finger nuclease target sites 
within genes of interest (Sander et al., 2007; Wright et al., 2006). The original implementations of 
ZiFiT (versions 1.0 and 2.0) were both geared toward making zinc finger nucleases by modular 
assembly, and the output cross-referenced zinc finger modules available in the Zinc Finger 
Consortium Modular Assembly Kit 1.0 (Wright et al., 2006). With the implementation of OPEN, we 
have released ZiFiT Version 3.0 (http://www.zincfingers.org/software-tools.htm), which gives users 
the option of searching for target sites for which OPEN pools are available. The user pastes a DNA 
sequence (limited to 10,000 characters) into the text box at the top of the main window. Underneath 
the main window are three boxes corresponding to finger positions in the zinc finger array. Each box 
contains a list of the 64 possible nucleotide triplets. By default, triplets are checked for which OPEN 
pools are currently available from the Zinc Finger Consortium; however, users can manually select or 
deselect triplet pools to customize their search. Target site composition can be further restricted by 
options available under the "Advanced/Basic" toggle near the bottom of the screen. By selecting the 
"Submit" button, the sequence is searched for all target sites using the specified pools and an output 
is returned.  B) Screen shot of ZiFiT 3.0 output page. In addition to identifying zinc finger nuclease 
target sites in the input sequence, it may be desirable to identify matching or highly similar sites within 
a genome of interest. ZiFiT Version 3.0 enables the user to BLAST the genome sequence of a 
desired organism to identify duplicate or related target sites. The BLAST search is implemented by a 
button link and an organism selection menu provided for each target site returned in the output on the 
results page. Requests are submitted to the NCBI BLAST servers to provide maximum reliability and 
speed, and results are typically returned to ZiFiT within a minute. Note that BLAST scoring methods 
do not identify all matches near the end of a hit if they are separated by mismatches that lower the 
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Figure C.S1 | | continued score of the local alignment. As a result, hits to highly similar target sites 









Figure C.S2 | Schematic of target sites in the EGFP, VEGF-A, HoxB13, and CFTR genes Using 
ZFNs made by OPEN selections, we targeted A) five full ZFN sites in the EGFP reporter gene 
(EG223, EG292, EG382, EG502, and EG568), B) six sites in open chromatin regions of the human 
VEGF-A gene (VF2468, VF2471, VF3537, VF3540, VF3542, and VF3552), C) five sites in the first 
coding exon of the human HoxB13 gene (HX500, HX508, HX587, HX735, and HX761) and one site 
in the last coding exon of the human HoxB13 gene (HX2119, not shown), and D) one site in exon 10 





Figure C.S3 | DNA sequence analysis of endogenous human and plant genes mutagenized by 
OPEN ZFNs (A-C) Sequences of A) HoxB13 alleles from human 293 cells transfected with HX587 
ZFN pair B, B) CFTR alleles from human K562 cells transfected with CF877 ZFNs, and C) Figure 
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C.S3 | continued Sequences of SuRA alleles from tobacco plants transfected with SR2163 ZFNs 
(matching sequence from the SuRB gene is also shown). Numbers of each allele identified are shown 





Figure C.S4 | Schematics of donor templates and primers used for gene targeting experiments at the 
human VEGF-A and IL2Rγ genes. Donor templates were constructed for OPEN ZFN pairs that 
cleave at the VF2468 and VF2471 sites and for a previously described four-finger ZFN pair that 
cleaves in the IL2Rγ gene (Urnov et al., 2005). Each donor template consists of 1.5 kb of genomic 
DNA sequence centered on the cleavage site and introduces either an 11 bp insertion encoding a 
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Figure C.S4 | continued SalI restriction site at the center of the cleavage site (for VEGF-A targets) or 
a translationally silent point mutation which creates a BsrBI restriction site adjacent to the ZFN 
cleavage site (for IL2Rγ) (Urnov et al., 2005). Arrows indicate primers used for limited-cycle 




Figure C.S5 | Comparison of PCR-based and Southern blot methods for assaying gene targeting 
efficiencies. Limited-cycle PCR and Southern blot were used to assess gene targeting efficiencies in 
cells treated with different ZFNs under various conditions. Dotted red line represents where data 






Figure C.S6 | DNA sequence analysis of endogenous human alleles that have undergone gene 
targeting induced by ZFNs (A-C) Sequences of alleles sequenced from human K562 cells transfected 
with A) VF2468 ZFNs and donor, B) VF2471 ZFNs and donor, and C) IL2Rγ ZFNs and donor. Data 










Figure C.S7 | OPEN ZFNs induce stable multi-allelic alterations of an endogenous human gene FISH 
analysis indicated that K562 cells harbor four alleles of the VEGF-A gene (A, upper left panel) and we 
therefore wished to determine how many of these alleles could be altered in a single cell. Limiting 
 237 
 
Figure C.S7 | continued dilution cloning was used to isolate single cell clones from two vinblastine-
treated K562 cell populations which had undergone high frequencies of gene targeting: 45% and 26% 
with the VF2468 and VF2471 ZFN pairs, respectively (B, upper panel). (The VF2468 ZFN-treated 
cells also showed evidence of a 625 bp deletion (blue asterisks), a finding confirmed by sequencing 
of alleles from these cells (data not shown).) Individual clones from VF2468 ZFN-treated cells 
harbored no, one, three, or four alleles that had undergone a gene targeting event with some of the 
clones also containing the 625 bp deletion (B, lower left panel). Genotype analysis of individual cell 
clones from the VF2471 ZFN-treated cells revealed clones in which no, one, two, or three VEGF 
alleles had undergone a gene targeting event (B, lower right panel). All individual cell clones were 
genotyped more than thirty-five days post-transfection, demonstrating that gene targeting events we 
observed are stably maintained. FISH analysis of three cell clones in which all four VEGF-A alleles 
had undergone the VF2468 ZFN-induced gene targeting event confirmed the continued presence of 
four copies of VEGF-A per cell (A, upper right, and lower left and right panels). FISH was performed 
with a probe for VEGF-A (red) and a control probe for 14q which is present in two copies per cell 
(green). Taken together, these results demonstrate that OPEN ZFNs can be used to induce 




Table C.S1 | Sequences and B2H assays of zinc finger arrays selected by OPEN The subset of zinc 
finger arrays we converted to ZFNs for testing in human or plant cells are highlighted in green. As 
noted in the text, a small number of selections were performed in a single step on plates with fixed 
concentrations of IPTG, 3-AT, and streptomycin. For these selections, IPTG concentration shown is 
in μM, 3-AT concentration shown is in mM, and streptomycin concentration shown is in μg/ml. Fold-
activation of transcription in the B2H system was determined by comparing lacZ expression from B2H 
reporter strains harboring a zinc finger array (fused to a fragment of the yeast Gal11P protein) to 
matched strains harboring a control that does not express a zinc finger array. All determinations were 
performed in triplicate and the means and standard deviations of these means are shown. Certain 
target sites cause a higher basal level of lacZ expression in the quantitative B2H assay and the finger 
arrays tested on these sites may exhibit lower apparent fold-activations due to this effect (affected 
values are highlighted in yellow). Certain zinc finger arrays (marked by a “+” in the last column) 
harbor additional mutations outside of the three randomized recognition helices that were most likely 
introduced during library construction. The identities of these various mutations are available upon 
request. Although half-site EG502L did not yield OPEN zinc-finger arrays which activated by more 
than three-fold, we note that the basal level of transcription from the B2H reporter bearing this site 
was high, a situation which can artifactually lower the apparent foldactivation observed. 25 of the 28 
OPEN selections we performed for the human VEGF-A, human HoxB13, human CFTR, and tobacco 
SuRA genes yielded zinc-finger arrays whose sequences closely resembled one another. However, 
one of these 25 selections (for half-site VF3540R) yielded fingers with sequences that appeared to 
bind to an alternative site (discussed below). For 22 of the other 24 selections, we obtained at least 
one zinc-finger array which activated lacZ expression by more than three-fold in the quantitative B2H 
assay. The two remaining selections were also deemed to be successful because their reporters 
possessed a high basal level of transcription which can artifactually mask a higher true fold-activation. 
For one selection (site VF3540R), examination of the recognition helix sequences of the arrays 
obtained from OPEN selection suggests that these finger arrays do not bind to the intended nine base 
pair site but rather to the site that is shifted 3’ in register by 1 bp (i.e.--these arrays bind to the site: 5’- 
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Table C.S1 | continued GCG GCG GAC-3’ instead of 5’-GGC GGC GGA-3’). For example, for finger 
1, the Asp and Glu selected at position -1 and the Asn selected at position 3 of the recognition helix 
would be expected to specify cytosine and adenine, respectively, and not the adenine and guanine 
actually present in the subsite. Similarly, for finger 3, the Arg selected at position -1 and the Ser and 
Asp selected at position 3 of the recognition helix would be expected to specify guanine and cytosine, 



































         
   GTA GGG GTC    
OZ001 EG223L 50/40/60 QDSSLRR RQEHLVR DPTSLNR 4.24 0.17  
OZ002 EG223L 50/40/60 QQSSLLR RQEHLVR DPTSLNR 3.50 0.13  
OZ003 EG223L 50/40/60 QPSSLTR RKPHLVN QPTSLQL 0.79 0.03  
OZ004 EG223L 50/40/60 QQSSLLR RGEHLTR DQTVLRR 3.50 0.33  
OZ005 EG223L 50/40/60 QQSSLLR RGEHLTR EPTSLIR 3.17 2.10  
OZ006 EG223L 50/40/60 QPSSLTR RREHLVS DRRPLPR 1.74 0.65  
OZ007 EG223L 0/40/60 QGSALAR RREHLVR DPTSLNR 4.09 0.08  
OZ008 EG223L 0/40/60 QSSSLTR RGEHLTR ESGALRR 2.57 1.15  
OZ009 EG223L 0/40/60 QASALSR RREHLVR ESGALRR 5.23 0.94  
 
OZ010 EG223L 0/40/60 QSQALVR RVEHLNN DRTSLPR 0.76 0.09  
OZ011 EG223L 0/40/60 QQSSLLR RREHLVR DRTSLAR 3.65 0.23  
OZ012 EG223L 0/40/60 QQSSLLR RREHLVR DPTSLNR 4.29 0.38  
         
   GCA GCA GAA    
OZ013 EG223R 50/60/80 SQTQLVR QSTTLKR QRNNLGR 10.81 0.41  
OZ014 EG223R 50/60/80 RRQELGR QGETLKR QHPNLTR 5.57 0.36  
OZ015 EG223R 50/60/80 RRQELRR QGGTLNR QRNNLGR 10.36 1.40  
OZ016 EG223R 50/60/80 RTQELKR QSGTLKR QGPNLGR 8.43 0.98  
OZ017 EG223R 50/60/80 NNAQLTR QSGTLHR QRPNLGR 6.53 0.55  
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Table C.S1 (continued) 
OZ018 EG223R 50/60/80 RRQELGR QGGTLKR QHPNLTR 9.05 0.42  
OZ019 EG223R 0/60/80 RRQELGR QSGTLKR QRNNLGR 9.74 0.73  
OZ020 EG223R 0/60/80 RGVELKR QSGTLHR QRPNLTR 11.48 1.63  
OZ021 EG223R 0/60/80 RPQELAR QSGTLKR QHPNLTR 8.39 0.46  
OZ022 EG223R 0/60/80 RRQELVR QSGTLKR QHPNLTR 9.38 0.62  
OZ023 EG223R 0/60/80 HKGQLNR QSGTLKR QRNNLGR 8.74 0.41  
OZ024 EG223R 0/60/80 RQQELDR QSGTLHR QHPNLTR 11.92 0.98  
         
   GGT GAT GAA    
OZ025 EG292L 50/40/60 TSTRLMI LLHNLTR QRNNLGR 4.40 0.13  
OZ026 EG292L 50/40/60 DKTKLNV VRHNLTR QDGNLGR 3.33 0.09  
OZ027 EG292L 50/40/60 TNQKLVV VAHNLRR QHPNLTR 4.89 0.81  
OZ028 EG292L 50/40/60 DRPTLRR QGGNLVR QGDNLGR 1.10 0.04  
OZ029 EG292L 50/40/60 TRQRLTV VNHNLTR LGENLRR 3.69 0.59  
OZ030 EG292L 50/40/60 TNQKLEV VRHNLQR QHPNLTR 5.43 0.40  
OZ031 EG292L 0/40/60 TTTKLAI VRHNLTR LGENLRR 3.48 1.00  
OZ032 EG292L 0/40/60 TKQRLEV VPHNLKR QSVNLRR 4.54 0.67  
OZ033 EG292L 0/40/60 HMSPLRV QRETLKR DVGNLGR 1.05 0.22 + 
 
OZ034 EG292L 0/40/60 TSQRLAV VAHNLRR QRNNLDR 6.25 1.16  
OZ035 EG292L 0/40/60 RRLALNR LSQTLKR AGDNLGR 0.80 0.08  
OZ036 EG292L 0/40/60 TRQRLTV VRHNLTR QRNNLGR 5.39 0.87  
         
   GGC GAC GAC    
OZ037 EG292R 50/60/80 APSKLLR EQGNLLR DGGNLGR 5.65 0.65  
OZ038 EG292R 50/60/80 APSKLDR LGENLRR DGGNLGR 4.74 0.05  
OZ039 EG292R 50/60/80 APSKLDR LGENLRR DGGNLGR 5.57 1.03  
OZ040 EG292R 50/60/80 APSKLQV EKQNLAR DPSNLRR 7.59 0.53  
OZ041 EG292R 50/60/80 APSKLMR DKANLTR DQGNLIR 6.00 0.17  
OZ042 EG292R 0/60/80 APSKLDR LSENLAR DPSNLRR 1.53 92.11  
OZ043 EG292R 0/60/80 APSKLDR DDANLTR DPSNLRR 0.81 0.16  
OZ044 EG292R 0/60/80 APSKLDR LGENLAR DPSNLRR 6.40 1.64  
Z045 EG292R 0/60/80 APSKLDR LGENLRR DPSNLRR 1.38 0.17  
Z046 EG292R 0/60/80 APSKLDR DSSNLRR DQGNLIR 8.40 2.07  
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Table C.S1 (continued) 
  GCC GAT GTC    
Z047 EG382L 50/40/60 KTTNLKR LSQTLKR HAHRLSD 1.06 0.40  
Z048 EG382L 50/40/60 TNRDLGR LSENLKR DPTSLNR 3.39 0.15  
Z049 EG382L 50/40/60 VRKDLVR LLHNLTR DRTPLNR 6.02 0.37  
Z050 EG382L 50/40/60 HRRDLDR VAHNLTR DSSPLTR 5.50 0.28  
Z051 EG382L 50/40/60 HQRDLMR VRHNLTR DPTSLNR 7.93 0.07  
Z052 EG382L 0/40/60 DSPTLRR VRHNLTR DRTSLAR 16.44 1.39  
Z053 EG382L 0/40/60 DSPTLRR VRHNLTR DRTSLAR 13.84 1.53  
Z054 EG382L 0/40/60 MRRDLDR VAHNLRR DPTSLNR 6.90 0.57  
Z055 EG382L 0/40/60 VRKDLDR IKENLMR DRSSLRR 21.18 2.30  
        
  GGC GAC GAG    
Z056 EG382R 
1-step 
gradient APSKLDR DVSNLAR RRDGLRR 10.15 0.24  
Z057 EG382R 
1-step 
gradient APSKLDR DRGNLTR RQDLLIR 5.83 0.28  
Z058 EG382R 
1-step 
gradient APSKLDR DSSNLRR VHWNLMR 9.06 0.25  
Z059 EG382R 
1-step 
gradient APSKLDR LVENLRR RVENLHR 5.84 1.27  
Z060 EG382R 
1-step 
gradient APSKLDR DGSNLRR REDNLGR 5.66 0.36  
Z061 EG382R 
1-step 
gradient APSKLDR DASNLAR VHWNLMR 9.21 0.47  
Z062 EG382R 
1-step 
gradient APSKLDR DRGNLQR RQDLLIR 6.39 1.12  
Z063 EG382R 
1-step 
gradient APSKLDR DKANLTR RHDQLTR 5.89 0.33  
Z064 EG382R 
1-step 
gradient VPSKLKR MRENLAR RIDNLGR 5.20 0.67  
Z065 EG382R 
1-step 
gradient APSKLDR DNANLKR RRDGLRR 5.37 1.01  
Z066 EG382R 
1-step 
gradient APSKLTV DGSNLAR RIDNLGR 0.79 0.08  
        
  GAT GCG GTG    
Z067 EG502L 
2-step 
gradient TKQHLAV RMDMLKR RPDALPR 1.62 0.02  
Z068 EG502L 
2-step 
gradient TRQNLDT RRDTLER RPDALPR 2.42 0.02  
Z069 EG502L 
2-step 
gradient TKQRLVV RTDTLAR RPDALPR 2.23 0.49  
Z070 EG502L 
2-step 
gradient TNQRLAV RTDTLAR RPDALPR 1.88 0.10  
Z071 EG502L 
2-step 
gradient TRQNLDT RRDTLRR RPDALPR 1.75 0.79  
Z072 EG502L 
2-step 
gradient EGNNLAR RRDDLQR RGDVLGK 1.33 0.10  
Z073 EG502L 
2-step 
gradient TKQRLDV RTDTLAR RRDRLGL 2.23 0.14  
Z074 EG502L 
2-step 
gradient TKQRLDV RTDTLAR RPDALPR 2.02 0.19  
        
  GGC GAC GAG    
Z075 EG502R 
2-step 
gradient APSKLMR DRANLTR RPDNLPR& 9.47 0.53  
Z076 EG502R 
2-step 
gradient SPSKLIR DGSNLAR RVDNLPR 10.74 0.53  
Z077 EG502R 
2-step 
gradient AQSKLAR DGSNLRR RQDGLGS 7.73 1.26  
Z078 EG502R 
2-step 
gradient SNSKLAR DMSNLSR RTENLTR 5.70 1.08  
Z079 EG502R 
2-step 
gradient APSKLDR DESNLRR RTSNLTR 10.28 1.61 + 
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Z080 EG502R 
2-step 
gradient APSKLDR DGSNLRR RPDNLPR 8.72 0.51  
Z081 EG502R 
2-step 
gradient APSKLDR LQENLAR VHWNLMR 9.20 0.69  
Z082 EG502R 
2-step 
gradient APSKLDR DESNLRR RVDNLPR 9.98 1.62  
        
  GCC GTC GCC    
Z083 EG568L 
1-step 
gradient SNKDLTR DHSSLKR DPSNLRR 2.97 0.41  
Z084 EG568L 
1-step 
gradient DSPTLRR DPSVLKR EHRGLKR 1.31 0.30  
Z085 EG568L 
1-step 
gradient VRKDLDR DSAVLTR EHRGLKR 1.11 0.12  
Z086 EG568L 
1-step 
gradient DSPTLRR DREVLRR ERRALKR 3.99 1.47  
Z087 EG568L 
1-step 
gradient HQRDLMR DSAVLTR EKRRLAG 1.17 0.28  
Z088 EG568L 
1-step 
gradient HNRDLTR DISVLHR EKRRLAL 1.03 0.07  
Z089 EG568L 
1-step 
gradient VRKDLAR DREVLRR DHSNLSR 1.37 0.14  
Z090 EG568L 
1-step 
gradient TARALVR DHSVLKR ERRGLHR 1.54 0.12 + 
Z091 EG568L 
1-step 
gradient DRRDLGR DRGGLRR EHRGLNR 1.04 0.05  
Z092 EG568L 
2-step 
gradient DSPTLRR RTDGLRR DHSNLSR 5.49 0.74  
Z093 EG568L 
2-step 
gradient DSPTLRR RTDGLRR DHSNLSR 5.55 0.85  
Z094 EG568L 
2-step 
gradient DSPTLRR RTDGLRR DHSNLSR 5.20 1.08  
Z095 EG568L 
2-step 
gradient DSPTLRR RTDGLRR DHSNLSR 5.65 0.55  
Z096 EG568L 
2-step 
gradient DSPTLRR RTDGLRR DHSNLSR 5.13 0.15  
Z097 EG568L 
2-step 
gradient DSPTLRR RTDGLRR DHSNLSR 5.04 0.51  
Z098 EG568L 
2-step 
gradient HNTRLAV DREVLRR ERRGLAR 0.78 0.15  
        
  GCC GCT GCT    
Z099 EG568R 
2-step 
gradient TARALVR LSQTLKR LKHDLGR 10.04 2.23 + 
Z100 EG568R 
2-step 
gradient LKKDLLR LSQTLNR LRHDLHR 6.00 0.98  
Z101 EG568R 
2-step 
gradient DPSTLRR LRDSLKR LGHTLNR 7.01 1.81  
Z102 EG568R 
2-step 
gradient DPSTLRR LRDSLKR LGHTLNR 7.88 0.86  
Z103 EG568R 
2-step 
gradient DPSTLRR LRDSLKR LGHTLNR 7.32 1.49  
Z104 EG568R 
2-step 
gradient DPSTLRR LRDSLKR LGHTLNR 7.62 0.39  
Z105 EG568R 
2-step 
gradient HRRDLDR VAHSLKR LKHDLRR 2.25 1.63  
Z106 EG568R 
2-step 
gradient HRRDLDR LRDSLKR LGHTLNR 7.67 0.26  
        
  GTG GAA TTA    
Z107 CF877L 
2-step 
gradient RKHILDT QGGNLVR QQTGLAA 1.92 0.58 + 
Z108 CF877L 
2-step 
gradient RKSVLLV QGGNLVR QTTGLKS 2.31 0.51  
Z109 CF877L 
2-step 
gradient RTSSLKR RREHLTR QPTGLTA 2.83 0.20  
Z110 CF877L 
2-step 
gradient RNFILQR QGGNLVR QVNGLKA 1.61 0.15 + 
Z111 CF877L 
2-step 
gradient RKGVLRI QGGNLVR QQTGLNV 2.20 1.90 + 
Z112 CF877L 
2-step 
gradient RTSSLKR RREHLTR QPTGLTA 2.52 0.55  
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Z113 CF877L 
2-step 
gradient RKSVLHN QGGNLVR QTTGLKS 1.61 0.20  
Z114 CF877L 
2-step 
gradient RNFILQR QGGNLVR QQTGLAA 2.95 0.18  
Z115 CF877L 
2-step 
gradient RNFILQR QGGNLVR QVNGLKA 2.71 0.12  
Z116 CF877L 
2-step 
gradient RRHVLER QGGNLVR QQTGLNV 2.53 0.38  
Z117 CF877L 
2-step 
gradient RKSVLLV QGGNLVR QQTGLAA 3.87 0.33  
Z118 CF877L 
2-step 
gradient RNFILQR QGGNLVR QQTGLNV 3.55 0.08  
        
  GAG TGG TTA    
Z119 CF877R 
2-step 
gradient RQSNLSR RKEHLDI QMTGLNA 2.78 0.35  
Z120 CF877R 
2-step 
gradient RQSNLAR RKEHLVG QASGLNS 2.53 0.01  
Z121 CF877R 
2-step 
gradient RQSNLSR RKEHLSI QRTGLTA 2.91 0.19  
Z122 CF877R 
2-step 
gradient TTHNLMR RADHLKV QGTGLRA 4.72 0.59  
Z123 CF877R 
2-step 
gradient TKHNLVR RREHLNI QTSGLTA 5.03 0.63  
Z124 CF877R 
2-step 
gradient TKHNLVR RREHLNI QTSGLTA 4.41 0.20  
Z125 CF877R 
2-step 
gradient TKHNLVR RQEHLNI QPTGLKV 4.00 0.85  
Z126 CF877R 
2-step 
gradient TAHNLMR RREHLTI QMTGLNA 2.57 0.28  
Z127 CF877R 
2-step 
gradient RMSNLDR RREHLTI QGTGLRA 1.60 0.02  
Z128 CF877R 
2-step 
gradient TTHNLMR RKEHLSI QMTGLNA 2.12 0.07  
Z129 CF877R 
2-step 
gradient RQSNLSR RKEHLDI QMTGLNA 2.55 0.07  
Z130 CF877R 
2-step 
gradient RPHNLLR RADHLKV QTTGLNA 2.47 0.22  
Z131 CF877R 
2-step 
gradient KHSNLTR RREHLTI QPTGLRA 2.08 0.12  
Z132 CF877R 
2-step 
gradient RQSNLSR RSEHLAI QRVGLHA 1.28 0.05  
Z133 CF877R 
2-step 
gradient KHSNLTR RADHLKV QNTGLHA 3.24 0.05  
Z134 CF877R 
2-step 
gradient RQSNLSR RNEHLVL QKTGLRV 3.71 0.19  
Z135 CF877R 
2-step 
gradient KHSNLTR RREHLTI QMTGLNA 2.25 0.07  
Z136 CF877R 
2-step 
gradient KHSNLTR RREHLTI QMTGLNA 2.16 0.06  
Z137 CF877R 
2-step 
gradient RHSNLTR RQEHLNI QMTGLNA 2.26 0.04  
Z138 CF877R 
2-step 
gradient KKTNLTR RREHLTI QQTGLNV 2.52 0.41  
Z139 CF877R 
2-step 
gradient KHSNLTR RKEHLSI QMTGLNA 2.74 0.03  
Z140 CF877R 
2-step 
gradient KHSNLTR RKEHLTI QRTGLSI 2.99 0.48  
Z141 CF877R 
2-step 
gradient KHGNLTR RREHLTI QQTGLNV 2.87 0.08  
Z142 CF877R 
2-step 
gradient KHSNLTR RKEHLDI QMTGLNA 2.73 0.16  
        
  GCT GAC GAA    
Z143 VF2471L 
2-step 
gradient QRTDLSR DKGNLSR QHPNLTR 5.71 0.14  
Z144 VF2471L 
2-step 
gradient TKQGLQR LQENLTR QHPNLTR 9.95 1.57  
Z145 VF2471L 
2-step 
gradient QRQALDR DNSNLAR QRNNLGR 6.33 0.14  
Z146 VF2471L 
2-step 
gradient GRQALDR DKANLTR QRNNLGR 6.85 0.97  
Z147 VF2471L 
2-step 
gradient QTADLRR DSGNLTR QGPNLSR 6.59 1.69 + 
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Z148 VF2471L 
2-step 
gradient QRQALDR DNSNLAR QRNNLGR 5.04 1.01  
Z149 VF2471L 
2-step 
gradient TKQGLQR LQENLTR QHPNLTR 6.78 0.36  
Z150 VF2471L 
2-step 
gradient GRQALDR DKANLTR QRNNLGR 5.74 1.02  
Z151 VF2471L 
2-step 
gradient TKQGLQR LPENLTR QGPNLSR 6.08 1.02  
Z152 VF2471L 
2-step 
gradient TKQGLQR LGENLRR QRNNLGR 5.79 1.49  
Z153 VF2471L 
2-step 
gradient ARQGLNR DKANLTR QGPNLSR 6.00 0.34  
Z154 VF2471L 
2-step 
gradient TKQGLQR LRENLAR QHPNLTR 8.01 0.05  
        
  GTG GAC GAG    
Z155 VF2471R 
2-step 
gradient RHTVLRV DRANLLR RGDNLNR 8.42 0.60  
Z156 VF2471R 
2-step 
gradient RPFTLAR DRANLLR RADNLGR 9.19 0.80  
Z157 VF2471R 
2-step 
gradient RPFTLAR DRANLLR RADNLGR 9.36 0.57  
Z158 VF2471R 
2-step 
gradient RNFILQR DRSNLTR RHDQLTR 6.84 0.46  
Z159 VF2471R 
2-step 
gradient RPFTLAR DRANLLR RADNLGR 9.80 1.20  
Z160 VF2471R 
2-step 
gradient RSTLLRV DASNLAR RGDNLNR 9.22 3.83  
Z161 VF2471R 
2-step 
gradient RPFTLAR DRANLLR RADNLGR 9.02 0.33  
Z162 VF2471R 
2-step 
gradient RKTILTT DRANLLR RADNLGR 11.54 0.69  
Z163 VF2471R 
2-step 
gradient RNSVLQL DEGNLSR RIDNLGR 8.88 0.76  
Z164 VF2471R 
2-step 
gradient RASVLDI DRGNLTR REDNLGR 6.90 0.24  
Z165 VF2471R 
2-step 
gradient RNFILQR DPSNLAR RRDGLRR 5.40 0.09 + 
Z166 VF2471R 
2-step 
gradient RNFILQR DRANLRR RHDQLTR 9.67 1.17  
        
  GGT GGT GGA    
Z167 VF3537L 
2-step 
gradient LRHHLEA HNHHLVR QNSHLRR 5.07 0.60  
Z168 VF3537L 
2-step 
gradient LRHHLEA MKHHLTR QTTHLRR 4.56 2.10  
Z169 VF3537L 
2-step 




gradient LRHHLEA MKHHLTR QTTHLRR 4.97 0.18  
Z171 VF3537L 
2-step 
gradient TKQKLQV HNHHLVR QTDHLKR 5.77 0.44  
Z172 VF3537L 
2-step 
gradient MKHHLAR EAHHLSR QNSHLRR 5.46 0.96  
Z173 VF3537L 
2-step 
gradient LRHHLEA LPHHLQR QNSHLRR 5.00 0.79  
Z174 VF3537L 
2-step 
gradient RKQHLDA HNHHLVR QTTHLRR 7.21 0.53  
Z175 VF3537L 
2-step 
gradient LRHHLEA MKHHLGR QSQHLKR 3.37 0.07  
Z176 VF3537L 
2-step 
gradient MKHHLDA LPHHLQR QGGHLAR 5.38 0.09  
Z177 VF3537L 
2-step 
gradient LRHHLEA MSHHLIR QNSHLRR 6.39 0.32  
Z178 VF3537L 
2-step 
gradient LRHHLEA MSHHLIR QNSHLRR 4.58 0.15 + 
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  GGC GGC GCC    
Z179 VF3537R 
2-step 
gradient RGDHLDR LKEHLTR DPSNLRR 14.24 3.89  
Z180 VF3537R 
2-step 
gradient RGDHLDR LKEHLTR DPSNLRR 8.29 0.66  
Z181 VF3537R 
2-step 
gradient RGDHLDR LKEHLTR DPSNLRR 5.29 3.37  
Z182 VF3537R 
2-step 
gradient APSKLDR EASKLKR DPSNLRR 3.28 0.03  
Z183 VF3537R 
2-step 
gradient RGDHLDR LKEHLTR DPSNLRR 13.74 7.23  
Z184 VF3537R 
2-step 
gradient APSKLKR ERSHLKR DPSNLRR 1.03 0.11  
Z185 VF3537R 
2-step 
gradient APSKLKR EQSKLVR DPSNLRR 3.99 0.18  
Z186 VF3537R 
2-step 
gradient RGDHLDR LKEHLTR DPSNLRR 7.03 5.32  
Z187 VF3537R 
2-step 
gradient VPSKLKR ERSKLKR DPSNLRR 12.53 0.80  
        
  GGT GGA GGA    
Z188 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QNSHLRR 13.95 0.37  
Z189 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QNSHLRR 15.08 1.41  
Z190 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QNSHLRR 14.09 0.76  
Z191 VF3540L 
2-step 
gradient LRHHLEA QSPHLKR QGGHLKR 4.09 2.71  
Z192 VF3540L 
2-step 
gradient KHSNLTR RNENLAR RIDKLGP 4.45 0.32  
Z193 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QQAHLAR 12.73 1.36  
Z194 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QMSHLKR 15.85 5.11 + 
Z195 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QNSHLRR 14.00 1.17  
Z196 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QAGHLTR 13.06 1.05  
Z197 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QQAHLAR 10.80 0.44  
Z198 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QQAHLAR 14.31 1.08  
Z199 VF3540L 
2-step 
gradient IPNHLAR QSAHLKR QQAHLAR 14.58 0.60 + 
        
  GGA GGC GGC    
Z200 VF3540R 
2-step 
gradient EESNLRR RPDVLAR RVDDLGR 15.71 0.65  
Z201 VF3540R 
2-step 
gradient EESNLRR RPDVLAR RVDDLGR 16.79 1.38  
Z202 VF3540R 
2-step 




gradient DEANLRR RKDDLKR REDSLPR 7.92 1.49  
Z204 VF3540R 
2-step 
gradient DEANLRR RKDDLKR REDSLPR 7.15 0.79  
Z205 VF3540R 
2-step 
gradient EESNLRR RRESLVR REDSLPR 12.93 0.83  
Z206 VF3540R 
2-step 
gradient DEANLRR RKDDLKR REDSLPR 10.23 4.44  
Z207 VF3540R 
2-step 
gradient EESNLRR RRESLVR REDSLPR 11.05 2.29  
Z208 VF3540R 
2-step 
gradient DEANLRR RKDDLKR REDSLPR 8.34 0.09  
Z209 VF3540R 
2-step 
gradient DEANLRR RKDDLKR REDSLPR 7.95 0.09  
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Table C.S1 (continued) 
  GCT GCT GAC    
Z210 VF2468L 
2-step 
gradient LRQTLAR VAHSLKR DPSNLRR 5.98 1.20  
Z211 VF2468L 
2-step 
gradient LRQTLAR VAHSLKR DPSNLRR 6.68 1.26  
Z212 VF2468L 
2-step 
gradient LRQTLAR VAHSLKR DPSNLRR 5.93 0.85  
Z213 VF2468L 
2-step 
gradient TKQVLDR VKHSLQR DPSNLRR 4.38 0.65  
Z214 VF2468L 
2-step 
gradient LRQTLAR VAHSLKR DPSNLRR 5.68 0.06  
Z215 VF2468L 
2-step 
gradient TKQVLDR VKHSLQR DPSNLRR 3.63 0.09  
Z216 VF2468L 
2-step 
gradient MKNTLTR QRSDLTR DPSNLRR 5.47 0.21  
Z217 VF2468L 
2-step 
gradient TGQILDR VAHSLKR DPSNLRR 7.19 2.15  
Z218 VF2468L 
2-step 
gradient LRQTLAR VAHSLKR DPSNLRR 6.84 0.43  
Z219 VF2468L 
2-step 
gradient GRLALLR VAHSLKR DPSNLRR 6.34 0.69  
        
  GGA TGA GAG    
Z220 VF2468R 
2-step 
gradient RQDRLDR QREHLVT RRDNLNR 9.50 0.19  
Z221 VF2468R 
2-step 
gradient RQDRLDR QKEHLAG RRDNLNR 9.65 1.51  
Z222 VF2468R 
2-step 
gradient RQDRLDR QKEHLAV RGDNLKR 10.22 1.00  
Z223 VF2468R 
2-step 
gradient RQDRLDR QNEHLKV RADNLRR 11.92 3.09  
Z224 VF2468R 
2-step 
gradient THAHLTR QREHLNG RADNLGR 11.96 1.07  
Z225 VF2468R 
2-step 
gradient THAHLTR QREHLTG RRDNLNR 11.54 0.52  
Z226 VF2468R 
2-step 
gradient RNDRLLR QKEHLTV RRDNLNR 11.55 0.53  
Z227 VF2468R 
2-step 
gradient RQDRLDR QKEHLAG RRDNLNR 11.59 1.15  
Z228 VF2468R 
2-step 
gradient THAHLTR QREHLVT RRDNLNR 11.69 1.17  
Z229 VF2468R 
2-step 
gradient THAHLTR QNEHLTG RGDNLAR 10.69 0.51  
Z230 VF2468R 
2-step 
gradient THAHLTR QREHLNG RGDNLKR 14.10 0.15  
Z231 VF2468R 
2-step 
gradient THAHLTR QREHLVT RIDNLGR 12.63 1.65  
        
  GAG GAG GGG    
Z232 VF3542L 
2-step 
gradient KLTNLTR REDNLDR RIDKLGG 4.80 0.39  
Z233 VF3542L 
2-step 
gradient RQMNLDR RQDNLGR RIDKLGG 5.88 1.39  
Z234 VF3542L 
2-step 
gradient KHHNLLR RDDNLQR RMEHLPR 5.22 0.47  
Z235 VF3542L 
2-step 




gradient KHSNLTR RADNLGR RMEHLPR 4.44 0.41  
Z237 VF3542L 
2-step 
gradient KQSNLLR REDNLDR RRHGLGR 4.71 0.60  
Z238 VF3542L 
2-step 
gradient RMSNLDR REDNLGR RDDGLGR 3.13 0.12  
Z239 VF3542L 
2-step 
gradient RASNLTR REDNLDR RRWGLGR 4.38 0.40  
Z240 VF3542L 
2-step 
gradient KHSNLTR RDDNLQR RNDKLVP 5.18 0.45  
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Table C.S1 (continued) 
  GAC GCG GCG    
Z241 VF3542R 
2-step 
gradient EEANLRR RRDDLTR REDVLGR 8.53 1.23  
Z242 VF3542R 
2-step 
gradient EEANLRR RSDDLRR RLDMLAR 8.72 1.11  
Z243 VF3542R 
2-step 
gradient EESNLRR RRDDLTR RLDMLAR 11.42 0.12  
Z244 VF3542R 
2-step 
gradient EESNLRR RRDDLTR RLDMLAR 13.12 1.53  
Z245 VF3542R 
2-step 
gradient EEANLRR RRDDLTR RLDMLAR 9.96 0.16  
Z246 VF3542R 
2-step 
gradient EESNLRR RRDDLTR RKDLLHR 10.16 0.55  
Z247 VF3542R 
2-step 
gradient EQSNLRR RRDDLTR RLDMLAR 8.42 1.54  
Z248 VF3542R 
2-step 
gradient EESNLRR RRDDLTR RLDMLAR 12.11 0.66  
Z249 VF3542R 
2-step 
gradient EESNLRR RRDDLLR RIDNLGR 12.25 0.70  
Z250 VF3542R 
2-step 
gradient EEANLRR RRDDLTR RTDLLGR 8.98 0.60  
Z251 VF3542R 
2-step 
gradient EEANLRR RRDDLTR RLDMLAR 10.25 1.46  
Z252 VF3542R 
2-step 
gradient EEANLRR RKEDLAR RLDMLAR 11.82 0.37  
        
  GGC GCC GCC    
Z253 VF3552L 
2-step 
gradient VPSKLLR DPSVLTR EHRGLKR 4.29 0.30  
Z254 VF3552L 
2-step 
gradient TPSKLLR DPSVLTR EHRGLKR 7.39 1.10  
Z255 VF3552L 
2-step 
gradient SNSKLDR DPSVLTR EHRGLKR 3.30 0.23  
Z256 VF3552L 
2-step 
gradient SPSKLVR DPSVLTR EGGTLRR 2.88 0.10 + 
Z257 VF3552L 
2-step 
gradient SPSKLVR DPSVLTR EHRGLKR 3.22 0.15  
Z258 VF3552L 
2-step 
gradient TPSKLLR DSSVLRR ERRGLAR 33.85 27.58  
Z259 VF3552L 
2-step 
gradient TPSKLLR DSSVLRR ERRGLAR 20.62 20.68  
Z260 VF3552L 
2-step 
gradient SPSKLVR DSSVLRR ERRGLAR 14.89 11.80  
Z261 VF3552L 
2-step 
gradient TPSKLLR DSSVLRR ERRGLAR 49.72 42.09  
Z262 VF3552L 
2-step 
gradient VPSKLLR DPSVLTR EHRGLKR 4.30 0.30  
        
  GCG GAC GTG    
Z263 VF3552R 
2-step 
gradient KHDTLHR DRGNLTR RGDALAR 36.42 20.49  
Z264 VF3552R 
2-step 
gradient KNDTLAR DRANLRR RPDALSR 8.12 0.82  
Z265 VF3552R 
2-step 
gradient KNDTLAR DRANLRR RPDALSR 8.03 1.21  
Z266 VF3552R 
2-step 
gradient KHDTLHR DRGNLTR RGDALAR 29.45 48.83  
Z267 VF3552R 
2-step 
gradient KKHTLVK LRENLAR RMDALMR 30.79 5.40  
Z268 VF3552R 
2-step 
gradient KNDTLAR DNSNLAR RGDALAR 3.93 0.17  
Z269 VF3552R 
2-step 
gradient KKHTLTK DRGNLQR RGDALAR 9.93 2.89  
Z270 VF3552R 
2-step 
gradient RNHTLAR DNSNLAR RGDALAR 4.67 4.12  
Z271 VF3552R 
2-step 
gradient KNDTLAR ESGNLAR RGDVLGK 8.83 0.45  
Z272 VF3552R 
2-step 
gradient RSDTLAR DQGNLRR RPDALPR 10.32 1.44  
Z273 VF3552R 
2-step 
gradient KRHTLTR DSGNLTR RLDVLGN 3.91 0.48  
        
 248 
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  GGG GCT GCC    
Z274 HX508L 
2-step 
gradient RSAHLQA LSQTLKR ERRGLAR 2.12 0.23  
Z275 HX508L 
2-step 
gradient RSAHLQA LSQTLKR EHRGLKR 3.43 0.23  
Z276 HX508L 
2-step 
gradient RSAHLQA LSQTLKR EHRGLKR 6.31 2.17 + 
Z277 HX508L 
2-step 
gradient RGEHLTN LSQTLKR EHRGLKR 3.61 0.72  
Z278 HX508L 
2-step 
gradient RSAHLQA LSQTLKR DPSNLRR 2.75 0.15  
Z279 HX508L 
2-step 
gradient RRLHLTN LSQTLKR DPSNLRR 1.89 0.04  
Z280 HX508L 
2-step 
gradient RRLHLTN LSQTLKR DPSNLRR 2.34 0.13  
        
  GCC GAT GCT    
Z281 HX508R 
2-step 
gradient AKRDLDR LMHNLTR LKHDLRR 5.74 0.65  
Z282 HX508R 
2-step 
gradient HRRDLDR LMHNLTR LKHDLRR 7.92 0.93  
Z283 HX508R 
2-step 
gradient AKRDLDR LLHNLTR LKHDLRR 4.79 0.37  
Z284 HX508R 
2-step 
gradient DGSTLNR VRHNLTR VQNSLTR 8.53 1.36  
Z285 HX508R 
2-step 
gradient DGSTLNR IRHNLTR LKHDLRR 6.19 0.18  
Z286 HX508R 
2-step 
gradient AKRDLDR LLHNLTR LKHDLRR 4.87 0.45  
Z287 HX508R 
2-step 
gradient LKKDLLR IKHNLAR LKHDLRR 14.03 4.08  
Z288 HX508R 
2-step 
gradient DSSTLAR VRHNLTR LKHDLRR 2.92 1.96  
Z289 HX508R 
2-step 
gradient DGSTLRR VRHNLTR VSNSLAR 5.88 0.19  
Z290 HX508R 
2-step 
gradient AKRDLDR VNHNLTR LKHDLRR 9.20 4.01  
Z291 HX508R 
2-step 
gradient DGSTLNR VRHNLTR LKHDLRR 15.46 14.60  
        
  GGG GCT GCG    
Z292 HX761L 
2-step 
gradient KQDHLTK LSQTLKR RLDMLAR 8.12 2.53  
Z293 HX761L 
2-step 
gradient KQDHLTK LSQTLKR RLDVLAR 5.32 2.71  
Z294 HX761L 
2-step 
gradient KQDHLRV LSQTLKR RPDGLAR 14.19 1.10  
Z295 HX761L 
2-step 
gradient KKDHLHR LSQTLKR RLDMLAR 13.99 1.72  
Z296 HX761L 
2-step 
gradient KQDHLRV LSQTLKR RPDGLAR 13.85 4.18  
Z297 HX761L 
2-step 
gradient KQDHLTK LSQTLKR RLDMLAR 10.47 2.07  
Z298 HX761L 
2-step 
gradient KQDHLTK LSQTLKR RLDMLAR 11.51 0.66  
Z299 HX761L 
2-step 
gradient KQDHLRV LSQTLKR RLDMLAR 9.86 0.62  
Z300 HX761L 
2-step 
gradient KKDHLHR LSQTLKR RLDMLAR 14.09 0.79  
Z301 HX761L 
2-step 
gradient KKDHLHR LSQTLNR RLDMLAR 11.23 0.76  
Z302 HX761L 
2-step 
gradient KKDHLHR LSQTLNR RLDMLAR 6.65 1.55  
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Table C.S1 (continued) 
  GCC TTT GAG    
Z303 HX761R 
2-step 
gradient AKRDLDR SPNGLII VHWNLKR 4.07 0.06  
Z304 HX761R 
2-step 
gradient DRRGLVR SPNGLQV SASNLTR 3.31 0.58  
Z305 HX761R 
2-step 
gradient AKRDLDR SPNGLII VHWNLKR 4.01 0.20  
Z306 HX761R 
2-step 
gradient AKRDLDR SPNGLEI VHWNLMR 3.32 0.02  
Z307 HX761R 
2-step 
gradient AKRDLDR SPNGLII VHWNLKR 3.53 0.49  
Z308 HX761R 
2-step 
gradient LKKDLLR SQLGLQV SASNLHR 2.44 0.07 + 
Z309 HX761R 
2-step 
gradient MRRDLLR SQLGLSV SASNLTR 2.67 0.05 + 
Z310 HX761R 
2-step 
gradient MRRDLER SPNGLVI VHWNLMR 2.92 0.08  
Z311 HX761R 
2-step 
gradient MRRDLLR SQLGLSV SASNLTR 2.81 0.44 + 
Z312 HX761R 
2-step 
gradient AKRDLDR SPNGLVI VHWNLMR 3.63 0.17  
Z313 HX761R 
2-step 
gradient MRRDLLR SQLGLSV SASNLTR 2.55 0.38 + 
Z314 HX761R 
2-step 
gradient MRRDLLR SQLGLSV SASNLTR 2.94 0.14 + 
        
  GGT GCT GTG    
Z315 HX500L 
2-step 
gradient RQQKLDT LSQTLKR RGDALAR 2.76 0.13  
Z316 HX500L 
2-step 
gradient TTTKLAI LSQTLKR RGDVLGK 2.88 0.55  
Z317 HX500L 
2-step 
gradient TTTKLAI LSQTLKR RGDVLGK 3.48 0.71  
Z318 HX500L 
2-step 
gradient RRSRLDV LSQTLKR RGDALAR 3.15 0.06  
Z319 HX500L 
2-step 
gradient TTTKLAI LSQTLKR RGDVLGK 4.10 0.16  
Z320 HX500L 
2-step 
gradient TTTKLAI LSQTLKR RGDVLGK 3.86 0.19 + 
Z321 HX500L 
2-step 
gradient TNQKLQV LSQTLRR RGDALAR 3.11 0.11  
Z322 HX500L 
2-step 
gradient RQQKLDT LSQTLKR RGDVLGK 2.90 0.50  
Z323 HX500L 
2-step 
gradient TTTKLAI LSQTLKR RGDVLGK 4.09 0.22 + 
Z324 HX500L 
2-step 
gradient TTTKLAI LSQTLNR RGDVLGK 4.93 0.40  
Z325 HX500L 
2-step 
gradient TTTKLAI LSQTLNR RGDVLGK 5.65 1.02  
        
  TAC GCC GGC    
Z326 HX500R 
2-step 
gradient DPSNLIR DSAVLTR RKEPLGR 0.96 0.06  
Z327 HX500R 
2-step 
gradient PLARLEE DRSVLRN KRVSLQG 1.11 0.22  
Z328 HX500R 
2-step 
gradient VRSPLPD DVSVLRR KRVSLGA 0.96 0.04  
Z329 HX500R 
2-step 
gradient PLARLEE DRSVLKR KRVSLQG 1.40 0.17  
Z330 HX500R 
2-step 
gradient SRLGLVA DHSVLKR KNISLNH 1.01 0.27  
Z331 HX500R 
2-step 
gradient PLARLEE DHTVLRR KRVSLQG 0.93 0.04  
Z332 HX500R 
2-step 
gradient DRSNLRK DRTTLKR DGGHLSR 1.19 0.01 + 
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Table C.S1 (continued) 
  GCA GTG TGG    
Z333 HX587L 
2-step 
gradient NKTDLGR RMDVLTR RSDHLSL 5.73 0.16 + 
Z334 HX587L 
2-step 
gradient NKTDLGR RMDVLTR RSDHLSL 4.87 0.54 + 
Z335 HX587L 
2-step 
gradient NKTDLGR RMDVLTR RSDHLSL 5.15 0.34 + 
Z336 HX587L 
2-step 
gradient NKTDLGR RMDVLTR RSDHLSL 5.40 0.35 + 
Z337 HX587L 
2-step 
gradient NKTDLGR RMDVLTR RSDHLSL 4.94 0.29 + 
Z338 HX587L 
2-step 
gradient NKTDLGR RMDVLTR RSDHLSL 5.00 0.52 + 
Z339 HX587L 
2-step 
gradient NKTDLGR RADSLGR RADHLPQ 2.51 0.33  
Z340 HX587L 
2-step 
gradient NKTDLGR RRDMLRR RMDHLAG 14.45 2.74  
Z341 HX587L 
2-step 
gradient NKTDLGR RADSLGR RADHLPQ 3.10 0.16  
Z342 HX587L 
2-step 
gradient TPTDLNR RRDTLRR RMDHLAG 5.49 0.17  
Z343 HX587L 
2-step 
gradient NKTDLGR RADSLGR RADHLPQ 3.34 0.22  
Z344 HX587L 
2-step 
gradient LKHGLLR RKDGLMR RSEHLGI 3.55 0.33  
        
  GCC GGT TGG    
Z345 HX587R 
2-step 
gradient DESTLRR MKHHLGR RSDHLSL 8.15 0.73  
Z346 HX587R 
2-step 
gradient AKKDLRR LRQHLVR RSDHLSL 2.32 0.32  
Z347 HX587R 
2-step 
gradient LKKDLLR LRQSLTR RSDHLSL 3.10 0.99  
Z348 HX587R 
2-step 
gradient VRKDLDR MKHHLGR RSDHLSL 4.05 0.12 + 
Z349 HX587R 
2-step 
gradient SKKSLTR EAHHLSR RSDHLSL 7.00 0.27 + 
Z350 HX587R 
2-step 
gradient DPSTLRR LPHHLQR RMDHLAG 4.66 0.64  
Z351 HX587R 
2-step 
gradient LAKDLVR HKHRLVT RSDHLSL 3.74 0.29  
Z352 HX587R 
2-step 
gradient SKKSLTR QAHILKR RSDHLSL 7.03 0.64  
Z353 HX587R 
2-step 
gradient HRRDLDR QRHHLVR RSDHLSL 4.60 0.16 + 
Z354 HX587R 
2-step 
gradient DPSTLRR LPHHLKR RSDHLSL 7.25 0.16 + 
Z355 HX587R 
2-step 
gradient MRRDLLR LGHHLVR RSDHLSL 3.94 0.27  
Z356 HX587R 
2-step 
gradient DPSTLRR QTHHLQR RSDHLSL 4.48 0.33  
        
  TCT GAG TGG    
Z357 HX735L 
2-step 
gradient SKPNLKM RQDNLGR RMDHLAG 3.58 0.69  
Z358 HX735L 
2-step 
gradient SKPNLKM RQDNLGR RSDRLAL 2.29 0.12 + 
Z359 HX735L 
2-step 
gradient SKPNLKM RADNLGR RSDRLAL 2.20 0.47 + 
Z360 HX735L 
2-step 
gradient SKPNLKM RADNLGR RSDRLAL 2.32 0.21  
Z361 HX735L 
2-step 
gradient TKPNLKI RGDNLVR RSDHLSL 2.84 0.36 + 
Z362 HX735L 
2-step 
gradient SKPNLKM RQDNLGR RRDRLRI 2.63 0.28  
Z363 HX735L 
2-step 
gradient SKPNLKM RGDNLGR RSDHLSL 3.01 0.12 + 
Z364 HX735L 
2-step 
gradient SNRNLKT RQDNLGR RKAGLHI 2.56 0.67  
Z365 HX735L 
2-step 
gradient TKPLLKI RQDNLGR RSDRLAL 1.70 0.09  
Z366 HX735L 
2-step 
gradient SNRNLRI RADNLGR RSDRLAL 1.96 0.14  
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Table C.S1 (continued) 
  GAG GAA GGG    
Z367 HX735R 
2-step 
gradient KHSNLTR QGANLVR RNDKLVP 4.85 0.88 + 
Z368 HX735R 
2-step 
gradient KLTNLTR QKVNLAR RIDKLGG 4.72 1.15  
Z369 HX735R 
2-step 
gradient KHSNLTR QHTNLTR RIDKLGG 5.51 0.94 + 
Z370 HX735R 
2-step 
gradient KKTNLTR QMSNLDR RIDKLGG 6.88 1.22  
Z371 HX735R 
2-step 
gradient KLTNLTR QMSNLDR RGDKLGH 4.65 1.24  
Z372 HX735R 
2-step 
gradient KHSNLTR QRVNLAR RIDKLGG 4.13 0.92  
Z373 HX735R 
2-step 
gradient KHSNLTR QKVNLAR RGDKLGP 5.25 0.52  
Z374 HX735R 
2-step 
gradient KHSNLTR QLANLGR RIDKLGG 4.66 0.53 + 
Z375 HX735R 
2-step 
gradient KHSNLTR QKVNLAR RGDKLGP 4.53 0.96  
Z376 HX735R 
2-step 
gradient RQSNLSR QMSNLDR RIDKLGG 4.90 1.80 + 
Z377 HX735R 
2-step 
gradient KHSNLTR QQTNLAR RGDKLGP 5.59 0.65  
        
  GCT GGC TCT    
Z378 HX2119L 
2-step 
gradient HRPSLVR ERGHLTR QRNALAG 1.22 0.02  
Z379 HX2119L 
2-step 
gradient KHQTLQR ERGHLNR QRNALAG 1.26 0.37  
Z380 HX2119L 
2-step 
gradient ATGDLRR ENSGLKR QNNALTG 1.01 0.30  
Z381 HX2119L 
2-step 
gradient AKQGLRR LKEHLTR QRNTLQG 1.41 0.06 + 
Z382 HX2119L 
2-step 
gradient RSLTLLR EQSKLTR ARNLLRG 0.77 0.05  
Z383 HX2119L 
2-step 
gradient TKQVLDR ENSKLKR QRNALAG 1.46 0.38  
Z384 HX2119L 
2-step 
gradient NKQALDR LHENLKR QRNALAG 2.47 0.42  
Z385 HX2119L 
2-step 
gradient HKLTLVR ERGHLIR QRNTLKG 2.69 1.12  
Z386 HX2119L 
2-step 
gradient GMLALRR LHENLKR ARNALGG 0.95 0.08  
        
  TTC GGT TCT    
Z387 HX2119R 
2-step 
gradient RPSHLVT EAHHLGR ARHLLKG 1.28 0.21  
Z388 HX2119R 
2-step 
gradient LHKLLVI EPHHLMR QRNALAG 0.71 0.05  
Z389 HX2119R 
2-step 
gradient RENHLRI ERHQLVR QRNALGG 0.92 0.04 + 
Z390 HX2119R 
2-step 
gradient RHHHLDV EKHQLIR QRNTLKG 1.41 0.29  
        
  TTC GGA GAA    
Z391 SR2163L 
2-step 
gradient RPNHLAI QSPHLKR QSNNLTR 8.40 0.29  
Z392 SR2163L 
2-step 
gradient RPNHLTA QSAHLKR LGENLRR 5.74 0.34  
Z393 SR2163L 
2-step 
gradient RPNHLAI QSPHLKR QSNNLTR 8.10 0.05  
Z394 SR2163L 
2-step 
gradient RANHLTI QSAHLKR LGENLRR 6.41 0.87  
        
  GAT GGA GGC    
Z395 SR2163R 
2-step 
gradient SQQALGV QSAHLKR ESGHLKR 1.70 0.23  
Z396 SR2163R 
2-step 
gradient TKQHLAV QSAHLKR ESGHLRR 1.89 0.04 + 
Z397 SR2163R 
2-step 
gradient SKQALAV QSAHLKR ENSKLRR 1.89 0.13 + 
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Table C.S1 (continued) 
Z398 SR2163R 
2-step 
gradient TNQRLDV QNPHLTN KNVSLVG 0.89 0.02  
Z399 SR2163R 
2-step 
gradient SKQALAV QSAHLKR ENSKLRR 1.74 0.07 + 
Z400 SR2163R 
2-step 
gradient TKQHLAV QSAHLKR ESGHLRR 2.08 0.25 + 
Z401 SR2163R 
2-step 
gradient SKQALAV QSAHLKR ESGHLKR 1.75 0.15  
        
        
     high basal   
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Zinc  fingers  are  the  most  abundant  DNA  binding  motif  encoded  by  eukaryotic 
genomes  and  one  of  the  best  understood  DNA  recognition  domains.  Each  zinc  finger 
typically binds a three nucleotide target sequence, and it is possible to engineer zinc finger 
arrays that recognize extended DNA sequences by linking together individual zinc fingers. 
Engineered zinc  finger proteins have proven  to be valuable  tools  for gene  regulation and 
genome modification because they target specific sites in a genome. Here we describe ZiFDB 
(Zinc Finger DataBase; http://bindr.gdcb.iastate.edu/ZiFDB), a web‐accessible resource  that 
compiles  information  on  individual  zinc  fingers  and  engineered  zinc  finger  arrays.  To 
enhance its utility, ZiFDB is linked to the output from ZiFiT – a software package that assists 
biologists in finding sites within target genes for engineering zinc finger proteins. For many 




the  requisite DNA  binding  activity  for  their  experiments. ZiFDB will  also  be  a  valuable 









1, +3 and +6  (relative  to  the beginning of  the α‐helix) contact nucleotides at  the 3’, middle 
and 5’ end of the target nucleotide triplet. Zinc fingers can function as monomers, making it 
possible  to  link  zinc  fingers  together  in  extended  arrays  that  recognize  unique  DNA 
sequences. Such artificial or engineered zinc finger arrays (ZFAs) are often fused to effector 
domains  (e.g.  transcriptional activation domains or nucleases), and engineered zinc  finger 
fusion  proteins  are  proving  increasingly  valuable  as  reagents  for  gene  regulation  and 
genome modification (2)  
A simple approach for engineering ZFAs is known as ‘modular assembly,’ wherein 












that  zinc  fingers  are  not  always  modular  and  that  a  better  understanding  of  context‐
dependent effects is needed to increase the reliability of modular assembly.  
To minimize  the  context  dependence  associated with modular  design,  sequential 





that  context‐dependent  effects  are  addressed  through  the  process  of  selection.  Selection‐
based  approaches,  however,  require  considerable molecular  biological  expertise  and  are 
time‐consuming. Recently, a selection platform was described, called OPEN (Oligomerized 




even  the  simplified OPEN  strategy  remains more  labor‐intensive and difficult  to perform 
than modular assembly. 
Because many  scientists  are  interested  in  generating  zinc  finger  proteins  for  gene 
regulation and genome modification, we implemented a zinc finger database (ZiFDB) – an 
archive  of  information  about  zinc  fingers  and  engineered  ZFAs.  The  database  is  one  of 
several,  integrated  resources  provided  by  the  Zinc  Finger  Consortium 
(http://www.zincfingers.org),  a  group  of  academic  laboratories  dedicated  to  improving 
methods  for  engineering  ZFAs  and  developing  new  applications  for  their  use.  The 
Consortium  has  previously  created  a  repository  of  zinc  finger‐encoding  plasmids which 
simplify and facilitate modular assembly of ZFAs (17). Consortium labs also developed and 
validated the OPEN platform for ZFA engineering (11, 16). Further, Consortium supported 
software,  called  ZiFiT  (Zinc  Finger  Targeter),  allows  users  to  scan  DNA  sequences  to 
identify potential sites for which ZFAs might be engineered by either modular assembly or 
OPEN (18). A particularly important feature of ZiFDB is its linkage to ZiFiT, which allows 









1.   Sangamo  BioSciences:  Sangamo  Biosciences  designed  zinc  fingers  that  recognize 
GNN triplets at each of the three positions in a three finger array (7). It is assumed 
that  these  fingers  function optimally  in  the position  for which  they were designed. 





















the  recognition  helix:  positions  ‐1  to  +7  relative  the  start  of  the  alpha  helix  that 
contacts DNA in the finger. 
iii. Position within a three‐finger array: As indicated above, some fingers were designed to 
function  optimally  at  certain  positions  within  a  three  finger  array.  The  fingers 
described by Sangamo BioSciences, for example, were selected at different positions 
within a three finger protein, and the recognition helices for the same triplet target at 
different positions  in a  three  finger protein usually differ  (7). These differences are 
likely  due  to  position  and  context‐dependent  effects.  In  addition,  the  fingers 
generated by OPEN were  selected  to  function  in a  specific position within a  three 




iv.   Source:  The  name  of  the  group  that  generated  the  zinc  finger  is  provided.  The 







vii. Experiment: A  link directs  the user  to  information describing  the method used  to 
generate  the  finger,  relevant  functional data,  and  other  observations made  by  the 
experimenter. 
 




supported  by  ZiFDB.  Each  three  finger  array  in  the  database  has  a  unique  numerical 
designator, and the following information is provided: 
i.   Identification numbers  (IDs) of  the  component  fingers: The  IDs  correspond  to  the 
zinc  finger  designator  and  are  hyperlinks  that  allow  a  user  to  look  up  detailed 
information about individual fingers in an array. 












Figure D.1 | Sample output from the finger search page when GGG is provided as the target and the 
position and source are left blank. 
DATABASE INTERFACE 
To  retrieve  information  about  a  particular  zinc  finger,  any  combination  of  three 
search criteria can be used: triplet target, finger position and/or finger source. By providing 
partial information, a list of all fingers matching the input is returned (Fig. 1). By clicking the 




When  searching  for  information  about  an  array,  the  user  provides  the  nucleotide 
triplets (subsites) recognized by each finger in the array. The database returns not only the 








that match only  two of  the  inputted  subsites,  the matching  subsites and  their  recognition 
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helices are colored  in red  for easy  identification. The output also provides  the amino acid 
sequence  of  the  array,  IDs  for  each  finger  in  the  array,  and  IDs  for  related  articles  or 




To  enhance  its  utility, ZiFDB  is  interfaced  directly with ZiFiT  –  a web  accessible 



















Experiments.  The  objects  representing  the  Java  classes  are mapped  to  a MySQL  version 
4.0.15 database using Hibernate.  Apache Tomcat version 5.5.15 is used as the servlet engine 
for  the  web  site.  The  web  application  uses  Struts  1.2  to  implement  the  model‐View‐





provided  by  the  Zinc  Finger  Consortium.  ZiFDB  houses  information  on  individual  zinc 
fingers, including the 141 zinc finger modules currently made available as a clone library by 
the Consortium.  Importantly,  the database also provides users with  information on ZFAs 
and their target sequences, and we believe this feature will be particularly valuable for the 
rapidly  growing  number  of  molecular  biologists  interested  in  generating  ZFAs  for 
modification or  regulation of  their genome  locus of  interest. Further, analysis of  the data 







`Future versions of ZiFDB will  allow users  to directly  input  information on novel 
zinc fingers or zinc finger arrays. To ensure data quality, a shadow database will be created 
that is associated with the persistent database. Users will be permitted to submit data to the 
shadow database where  it will be held pending  approval by  the  curator  and  subsequent 
















ANN‐3ʹ  family  of  DNA  sequences  and  their  use  in  the  construction  of  artificial 
transcription factors. J. Biol. Chem., 276, 29466‐29478. 
4.   Dreier,B., et al., (2005) Development of zinc finger domains for recognition of the 5ʹ‐
CNN‐3ʹ  family  DNA  sequences  and  their  use  in  the  construction  of  artificial 
transcription factors. J. Biol. Chem., 280, 35588‐35597. 
5.   Dreier,B., Segal,D.J., and Barbas,C.F.  (2000)  Insights  into  the molecular recognition 
of the 5ʹ‐GNN‐3ʹ family of DNA sequences by zinc finger domains. J. Mol. Biol., 303, 
489‐502. 
6.   Segal,D.J.,  et  al.,  (1999) Toward  controlling  gene  expression  at will:  selection  and 




8.   Desjarlais,J.R.  and  Berg,J.M.  (1992)  Toward  rules  relating  zinc  finger  protein 








11.   Ramirez,C.L.,  et  al.,  (2008)  Unexpected  failure  rates  for  modular  assembly  of 
engineered zinc fingers. Nat. Methods, 5, 374‐375. 
12.   Greisman,H.A. and Pabo,C.O.,  (1997) A general  strategy  for  selecting high affinity 
zinc finger proteins for diverse DNA target sites. Science, 275, 657‐661. 
13.   Isalan,M.,  Choo,Y.,  and Klug,A.,  (1997)  Synergy  between  adjacent  zinc  fingers  in 
sequence‐specific DNA recognition. Proc. Natl. Acad. Sci. USA, 94, 5617‐5621. 
14.   Joung,J.K., Ramm,E.I., and Pabo,C.O., (2000) A bacterial two‐hybrid selection system 
for  studying  protein‐DNA  and  protein‐protein  interactions.  Proc.  Natl.  Acad.  Sci. 
USA, 97, 7382‐7387. 
15.   Hurt,J.A.,  et  al.,  (2003) Highly  specific  zinc  finger  proteins  obtained  by  directed 
domain  shuffling  and  cell‐based  selection.  Proc. Natl.  Acad.  Sci. USA,  100,  12271‐
12276. 




18.   Sander,J.D.,  et  al.,  (2007)  Zinc  Finger  Targeter  (ZiFiT):  an  engineered  zinc 
finger/target site design tool. Nucleic Acids Res., 35, W599‐605. 
















guidance.    She  encouraged  independent  thought  and  fostered  an  environment  for 
independent  learning.   Her  tireless patience, optimism, dedication, and  solid belief  in her 







  I would  like  to  thank  the members  of my  lab  Jae‐Hyung Lee, Michael Terribilini, 





grandparents  for  fostering  and  supporting  a  family‐wide  thirst  for  education  and 
knowledge. Iʹd like to thank my four sisters by reference (youʹve spoiled me rotten in all the 
important sisterly ways) and Suzanne by name; sheʹs earned  it putting up with me  in our 
daily  carpools  to  and  from  campus. Most  of  all,  Iʹd  like  to  thank my wife  Julie, without 













Iowa State University  B.S. 2004    Computer Science     
Iowa State University  Ph.D. 2008*    Bioinformatics and Computational Biology 











Sum 2003  CS 103  Computer Literacy and Applications     3  60 
Fall  2003   CS 103  Computer Literacy and Applications   3  60 
Spr  2004   CS 309  Software Development  3  80 
Fall  2006  BCB 444/544  Introduction to Bioinformatics  4   32 




M.,  Fu,  F.,  Porteus,  MH.,  Dobbs,  D.,  Voytas,  DF.,  Joung,  JK.  (2006).  Standardized 










Terribilini, M., Honavar, V., Dobbs, D.  (2008) Unexpected  similarities  in  structure and 
nucleic  acid  binding  sites  of  diverse  telomerase  proteins  revealed  by  combining 
structure prediction  PSB 2008 and machine learning Pac Symp Biocomput PSB08 




6. Maeder,  ML.,  Thibodeau‐Beganny,  S.,  Osiak,  A.,  Wright,  DA.,  Anthony,  RM., 
Eichtinger,M.,  Jiang,  T.,  Foley,  JE.,  Winfrey,  RJ.,  Townsend,  JA.,  Unger‐Wallace,  E., 
Sander,  JD., Muller‐Lerch, F., Fu, F., Pearlberg,  j., Gobel, C., Dassie,  JP., Pruett‐Miller, 
SM., Porteus, MH.,  Sgroi, DC.,  Iafrate,  JA., Dobbs, D., McCray, PB.  Jr, Cathomen, T., 
Voytas, DF.,  Joung,  JK.  (2008) Rapid “open‐source”  engineering of  custom zinc‐finger 
nucleases for highly efficient gene modification Molecular Cell 31, 294‐301 
7. Fu, F, Sander, JD., Maeder, ML., Thibodeau‐Beganny, S., Joung, JK., Dobbs, D., Miller, 
L., Voytas, DF.  (2009) Zinc  Finger Database  (ZiFDB):  a  repository  for  information  on 
C2H2 zinc fingers and engineered zinc finger arrays Nucleic Acids Research ‐ In Press 
8. Sander,  JD.*, Zaback, P.*,  Joung,  JK., Voytas, DF., Dobbs, D.  (2008) An  affinity‐based 









binding  sites  in  proteins:  use  of  structural  and  evolutionary  information  leads  to 
improved performance (In preparation) 




(2009). Using  an  Error Detection  Strategy  for  Improving Web Accessibility  for Older 






















• Sander,  JD.  ,  Fu,  F.,  Townsend,  J., Winfrey, R., Wright, D., Honavar, V., Voytas, D., 
Dobbs, D. (2005) Designing C2H2 zinc finger proteins to target specific sites in genomic 
DNA. Growth Factor and Signal Transduction, Ames, Iowa. Poster Presentation. 
• Sander,  JD.,  Terribilini, M.,  Lee,  JH.,  Jernigan,  LR., Honavar, V., Dobbs, D.  (2006) A 
Computational Method  to  Identify RNA Binding  Sites  in Proteins.  4th Annual Rocky 
Mountain Bioinformatics Conference 12/2/2006, Snowmass, CO. Oral Presentation. 
• Zaback, P., Sander, JD., Fu, F., Voytas, D., Dobbs, D. (2006) Designing C2H2 zinc finger 
proteins  to  target  specific  genomic  sites.  4th Annual  Rocky Mountain  Bioinformatics 
Conference 12/1/2006, Snowmass, CO. Oral Presentation . 
• Sander,  JD.  , Zaback, P.,,  Fu,  F., Townsend,  J., Winfrey, R., Wright, D., Honavar, V., 
Voytas, D., Dobbs, D. (2006) Designing C2H2 zinc finger proteins to target specific sites 
in  genomic DNA.  Sixth Annual  Joint  Bioinformatic  Symposium Ames,IA  July  13‐14. 
Poster Presentation.  
• Terribilini, M., Sander, JD. , Olson, B., Lee, J‐H., Jernigan, R., Honavar, V. and Dobbs, D. 
(2006) A  computational method  to  identify  amino  acid  residues  involved  in  protein‐
RNA  interactions.  Sixth  Annual  Joint  Bioformatics  Symposium  Ames,  IA  July  13‐14 
Poster Presentation.  
• Minion,  F.  C.,  VanDyk,  T.,  and  Sander,  JD.,  (2006)  Screening  a  Mycoplasma 
hyopneumoniae Lambda Library Using Hyperimmune and Convalecent Antisera, and 








(2006) A  computational method  to  identify  amino  acid  residues  involved  in  protein‐






• Sander,  JD.*, Zaback, P., Fu, F.,  Joung,  J.K., Voytas, D.F., Dobbs, D.  (2007) Designing 
C2H2 Zinc Finger Proteins  to Target Specific Genomic Sites. 11th Annual International 
Conference  on  Research  in  Computational  Molecular  Biology  (RECOMB  07).  San 
Francisco, CA. Poster Presentation. 
• Sander,  JD*.,  Zaback,  PZ*,  Fu,  F.,  Voytas,  DF.,  Dobbs,  D.,  (2008)  An  affinity‐based 
scoring  scheme  accurately predicts DNA‐binding  activity  of modularly‐designed  zinc 
finger  proteins.  Structural  Bioinformatics  and  Computational  Biophysics,  an  ISMB 
Satellite Meeting (3Dsig at ISMB 2008), Toronto, Canada. Oral and Poster Presentation. 
 
